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Summary 
The discovery of the association of Helicobacter pylori with gastric diseases 25 years ago 
opened a new view on the development of gastric disease and its relationship to 
microorganisms. With almost 50% of the human population having H. pylori in their 
stomachs, it is important to understand the real mechanisms by which the bacterium is able to 
cause gastric diseases such as gastritis, peptic ulcers and gastric cancer. Until now, several 
host as well as pathogenicity factors have been linked to the development of disease. One of 
them is the presence of the CagA protein and the Cag Type IV Secretion system (T4SS).  
The Cag T4SS is encoded by 27 to 30 genes in a pathogenicity island. Several of these genes 
show homology to the prototype T4SS found in Agrobacterium tumefaciens, the virB system. 
Upon contact with the host cells, the Cag proteins assemble in a pilus-like structure.Through 
this structure, bacteria are able to translocate CagA, the only known effector protein, into 
eukaryotic cells. Once inside the eukaryotic cells, CagA interferes with several cellular 
processes, including cytoskeletal organization and kinase activity. The activity of CagA 
depends greatly on its tyrosine phosphorylation, catalyzed by several Src-kinase family 
members. Besides CagA translocation, the Cag apparatus itself is able to induce the 
production of chemokines from epithelial cells, such as IL-8, which are relevant for the 
immune response. Therefore, it is important to understand the precise mechanism of 
interaction of the Cag T4SS with the host cell, which was the purpose of this work. 
In a first important observation, neutrophil-like cells, differentiated HL-60 cells (dHL60), 
were disturbed in their motility towards a chemoattractant in vitro. Using 2-dimensional 
(under agarose gel) as well as 3-dimensional (collagen matrix) conditions, the motility defect 
was found to be dependent on the presence of the CagA protein of H. pylori. Despite this 
activity, CagA showed a very low translocation into dHL-60 cells. In the search for the cause 
of this behaviour, it was discovered that integrin β1 levels on these cells varied in comparison 
to the parental HL-60 cell line, which showed normal CagA translocation levels. Using 
murine β1 integrin knockout cell lines, it was found that integrin β1 is essential for CagA 
translocation, acting as a receptor for the Cag T4SS. The presence of integrin β1 on the cell’s 
surface could be correlated with the level of CagA translocation. Additionally, it was 
discovered that the interaction does neither require the cytoplasmic part of the integrin β1, nor 
its cytoplasmic signaling through the integrin-linked kinase (ILK). The interaction between 
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the Cag apparatus and the integrin β1 was confirmed to be direct, without involving 
extracellular matrix proteins as bridging elements.  
From all 27 to 30 components of the Cag apparatus, three proteins showed a direct interaction 
with the integrin β1: CagA, CagY and CagI. In preliminary studies, the exact domain on the 
integrin β1 interacting  with CagY has been limited to the PSI domain. Equally, the EGF and 
the β-tail domain (βTD) interact with CagA and CagI. Additionally, a specific antibody that 
limits the ability of integrin β1 to bend and extend (9EG7), eliminates translocation of CagA 
into the eukaryotic cell, suggesting that a switch between active and inactive conformations of 
integrin β1 is essential for CagA translocation. Furthermore, interference with lipid raft 
formation in the eukaryotic cell membrane and the clathrin pathway abrogated CagA 
translocation. In contrast, IL-8 induction, but not CagA translocation, required integrin β1 
signaling via ILK. These data revealed the independence of both of these events, CagA 
translocation and IL-8 induction, tightly related with the Cag T4SS. 
In order to get more insight into the structure of the Cag T4SS on the surface of H. pylori, 
cryo-electronmicroscopy studies have been started. Preliminary data show very regular pilus-
like appendages on the bacterial surface, which still have to be verified as the Cag T4SS 
needles in future studies. The discovery of the integrin β1 as a receptor for the Cag apparatus 
and the involved cellular processes in the eukaryotic cell will provide more insight in the 
complicated but fascinating relationship between H. pylori and its host. 
ZUSAMMENFASSUNG 
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Zusammenfassung 
Die Entdeckung der Assoziation von Helicobacter pylori mit Magenerkrankungen vor 25 
Jahren hat eine neue Sichtweise auf die Entwicklung von Magenkrankheiten und seine 
Beziehung zu Mikroorganismen eröffnet. Fast 50% der menschlichen Bevölkerung ist mit H. 
pylori in ihren Mägen besiedelt. Daher ist es wichtig die wirklichen Mechanismen zu 
verstehen, durch welche das Bakterium Magenkrankheiten wie zum Beispiel Gastritis, 
Magengeschwüre und Magenkrebs verursachen kann. Bis jetzt wurden mehrere Wirts- sowie 
bakterielle Faktoren mit der Entwicklung der Krankheit verknüpft. Einer dieser Faktoren ist 
die Anwesenheit des CagA Proteins und des Cag Typ IV Sekretionssystems (T4SS). 
Das Cag T4SS wird von 27 bis 30 Genen einer Pathogenitätsinsel kodiert. Einige dieser Gene 
zeigen Homologie zu einem prototypischen T4SS, dem virB System, welches in 
Agrobacterium tumefaciens gefunden wird. Nach Kontakt mit den Wirtzellen bilden die Cag 
Proteine eine Pilus-ähnliche Struktur. Durch diese Struktur, können die Bakterien das einzige 
bekannte Effektorprotein, CagA, in die Wirtszellen translozieren. In der eukaryotischen Zelle 
stört CagA mehrere zellulare Vorgänge, wie zum Beispiel die Zytoskellett-Organisation und 
die Aktivität der Src-Kinase. Die Aktivität von CagA hängt maßgeblich von seiner 
Tyrosinphosphorylierung ab, die durch mehrere Mitglieder der Src-Kinase-Familie katalysiert 
wird. Außer der CagA-Translokation kann auch der Cag-Apparat selbst die Produktion von 
Chemokinen, wie zum Beispiel IL-8, aus Epithelzellen induzieren, die relevant für die 
Immunantwort sind. Daher ist es wichtig, den präzisen Mechanismus der Wechselwirkung 
des Cag-T4SS mit der Wirtszelle zu verstehen. 
In einer ersten wichtigen Beobachtung wurden Granulozyten-ähnliche Zellen, differenzierte 
HL-60 Zellen (dHL-60), in ihrer Beweglichkeit in vitro in Richtung von Chemoattraktanzien 
gestört. Unter 2-dimensionalen (Agarose-Gel) sowie 3-dimensionalen (Collagen-Gel) Matrix-
Bedingungen konnte gezeigt werden, dass die Beeinträchtigung der Beweglichkeit von der 
Anwesenheit des CagA-Proteins abhängig war. Trotz dieser Aktivität zeigte CagA eine sehr 
niedrige Translokation in dHL-60 im Vergleich zu HL-60-Zellen. Dies konnte auf eine stark 
reduzierte Menge von Integrin β1 in diesen Zellen, im Vergleich zu der ursprünglichen HL60 
Zelllinie, zurückgeführt werden. 
Mit Hilfe von murinen Integrin β1-Knockout Zelllinien konnte gezeigt werden, dass Integrin 
β1 essentiell für die CagA-Translokation ist, indem es als Rezeptor für das Cag-T4SS dient. 
Die Anwesenheit von Integrin β1 auf der Oberfläche der Zelle konnte mit der Menge der 
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CagA-Translokation korreliert werden. Die Funktion des T4SS erfordert weder den 
zytoplasmatischen Teil des Integrins β1, noch seine Signaltransduktion durch die Integrin-
linked kinase (ILK). Die Wechselwirkung zwischen dem Cag-Apparat und dem Integrin β1 
konnten als direkt und unabhängig von Matrixproteinen bestätigt werden. 
Von allen 30 Genprodukten des Cag-Apparates zeigten drei Proteine eine direkte 
Wechselwirkung mit dem Integrin β1: CagA, CagY und CagI. In vorläufigen Studien konnte 
die PSI Domäne auf dem Integrin β1 für die Wechselwirkung mit CagY identifiziert werden, 
während die EGF- und die β-tail Domäne (β-TD) mit CagA und CagI interagiert. Ein Integrin 
β1-spezifischer Antikörper (9EG7), der die Fähigkeit von Integrin β1 zur 
Konformationsänderung einschränkt, verhindert die Translokation von CagA in die 
eukaryotische Zelle, was nahelegt, dass ein Umschalten zwischen dem aktiven und dem 
inaktiven Zustand des Integrins β1 entscheidend für die CagA-Translokation ist. Weiterhin 
wurde durch die Zerstörung der Lipid rafts in der eukaryotischen Zellmembran und des 
Clathrin-abhängigen Aufnahmewegs die CagA-Translokation unterbunden. In Gegensatz zur 
CagA-Translokation erfordert die IL-8 Induktion eine Integrin β1 Signaltransduktion über 
ILK. Diese Daten offenbaren die Unabhängigkeit dieser beiden Ereignisse, der CagA-
Translokation und der IL-8 Induktion, die beide mit dem Cag T4SS assoziiert sind. 
Um mehr Einblick in die Struktur des Cag-T4SS auf der Oberfläche von H. pylori zu erhalten, 
wurden Kryo-Elektronenmikroskopie-Studien begonnen. Vorläufige Daten zeigen sehr 
regelmäßige Pilus-ähnliche Anhänge auf der bakteriellen Oberfläche, die dem Cag-T4SS 
entsprechen könnten. Die in dieser Arbeit beschriebene Entdeckung des Integrins β1 als ein 
Rezeptor für den Cag-Apparat und die beteiligten zellulären Prozesse in der eukaryontischen 
Zelle führen zu einen besseren Einblick in die komplizierte aber faszinierende Beziehung 
zwischen H. pylori und seinem Wirt. 
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1 Introduction 
Helicobacter pylori (H. pylori) is a bacterium associated with gastric diseases, and it is 
considered to be the cause of gastric cancer. To get to know the bacteria better, it is necessary 
to know in which environment it is able to thrive and survive. This introduction will describe 
the biology of the stomach and associated pathologies to explain further the bacterium and the 
outcome of its presence in the stomach in more detail. 
1.1 The Host’s biology 
H. pylori grows in one of the most aggressive environments inside the body, with so many 
mechanical stresses and low pH conditions (pH 2-5) that even the human body had to learn to 
protect itself from it by the creation of mucus (Allen and Garner, 1980). The stomach is 
generally divided into three sections: Fundus, Corpus and Antrum. The stomach’s connection 
to the esophagus is limited by the Cardia and to the duodenum (first part of the intestine) by 
the Pyloric Valve (Figure 1-1). Each section has a distinct histological conformation. The 
fundus and corpus present parietal cells, which are responsible for the production of acid in 
form of hydrochloric acid (HCl); D cells produce somatostatin, and ECL cells which produce 
histamine. The antrum contains D-cells and ECL cells but no parietal cells. Instead, it 
contains G-cells, which produce gastrin. 
Corpus
Antrum
FundusCardia
Pylorus
Duodenum
Lesser curvature
Greater curvature
Mitoses
Glands
Epithelium
A B
 
Figure 1-1 Stomach sections and histological distribution in the stomach mucosa 
(A) Parts in which the stomach is anatomically divided. (B) Schematic distribution of the cells in the 
mucosal epithelia (Adapted from Croft,LN 1967) 
The physiological function of the stomach depends on its ability to coordinate the secretion of 
acid in the gastric juice for digestion, and its regulation for the protection of the mucosa. It 
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can be described as a coordinated hormonal system. In the Antrum, G-cells detect stimuli 
from neural origin or of paracrine origin. As a response, gastrin is secreted and released into 
the bloodstream to find its destination: the ECL cells, parietal cells and D cells. Gastrin 
induces directly acid secretion by binding to the parietal cells through its receptor. The same 
effect can gastrin achieve indirectly by binding to ECL cells. The ECL cells secrete histamine 
as response to gastrin. Histamine binds through the H3-receptors on the parietal cells in order 
to induce the acid secretion. By gastrin binding to D cells in combination with histamine, it 
stimulates the opposite effect through the stimulation of somatostatin secretion. Somatostatin 
reduces the gastrin release and, at the same time, the acid release by the parietal cells (Joseph 
et al., 2003). All this activity in the stomach environment influences the behavior and 
development of H. pylori related gastritis, which shall be explored later on. 
1.2 General changes in stomach biology associated with 
Helicobacter pylori’ presence 
The stomach physiology can be altered by the presence of H. pylori, but this is not the rule. 
To date there has not been a satisfactory explanation to the fact that, even though a high 
percentage of people have the bacterium in their stomachs, only a small proportion develops 
the pathologies that are normally associated with the bacterium’s presence. It is known that 
bacteria can reside in both major regions of the stomach: the antrum, which is in the majority 
of the cases, or in the corpus region, which is in a small minority (Cave, 2001). While 
colonization of antrum is not often related to disease, colonization of the corpus is, however, 
associated with chronic inflammation of the gastric mucosa. Chronic inflammation can 
develop in atrophic gastritis, defined by a loss of gastric glandular cells, which can turn into 
an intestinal metaplasia. Intestinal metaplasia is defined by changes in the gastric epithelia 
that results in resemblance to intestinal epithelia. If untreated, these changes can further 
develop into gastric cancer (De Vries and Kuipers, 2007).  
Coordination of the hormonal environment is essential for the stomach function and, in 
presence of H. pylori, several changes seem to be constant. Important changes are the excess 
of gastrin in plasma, the hypochlorhydria in antrum in initial infections, and the 
hyperchlorhydria in chronic infections. These effects on the acid regulation as well as in the 
hormonal equilibrium of the stomach might be the previous steps that drive the histological 
changes mentioned above.  
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1.3 Helicobacter pylori 
1.3.1 History 
Each disease has a story of discovery, but in the case of gastritis it is an adventure. For many 
years gastritis related diseases were not well understood and were linked to stress or nutrition 
disorders that caused swelling in the stomach lining and, if not treated, ulceration or stomach 
cancer. 
Looking back to the first reports of gastric diseases, several causes were related to the 
presence of ulcers. Some early 1900s case reports described some gastric diseases, as the 
stomach syphilis that included sightings of spirochetes in the biopsies of removed stomach 
tissue from patients with ulcers (Graham, 1922). However, there were problems to confirm 
these sightings and they were therefore uncommon in the literature. Until the 1960s, case 
reports can be found where bacilli or bacteria absence in the extracted tissue of ulcers were 
dismissed by problems in the extraction and conservation of tissue material. Nevertheless, 
there was no doubt that the diseases of gastritis and gastric cancer were associated with the 
presence of a bacterium and its treatments included injections of heavy metal (including 
mercury) and 14 million units of penicillin (Madding et al., 1964). Even though this treatment 
was accepted as standard therapy, the difficulties to confirm the presence of bacteria gave way 
to other views shortly after. These new views opposed the idea of infectious agents being the 
cause of disease, dismissing it and considering environmental factors as the only cause of 
gastric diseases. Within these environmental factors, alcohol consumption, genetic 
predisposition (since it presented itself often in members of the same family) and 
consumption of acetylsalicylic acid were counted. Only one notion seemed to remain constant 
within these two ways of thinking: the discovery of a relationship between the presence of 
atrophic gastritis and pernicious anemia and its development to intestinal metaplasia as fore 
step of cancer development. However, in the second half of the 60’s, an atrophic gastritis as 
consequence of an infective agent was considered as “medical curios” (Croft, 1967). 
It took approximately 20 years, the combination of two Australian medical doctors, Barry J. 
Marshal and J.E. Warren, and an Easter holiday to discover a bacterium from biopsy material 
from a patient presenting gastritis. This bacterium seemed related to Campylobacter spp., 
since it grew in the same conditions. It was described as a small spirochete with only two 
spirals and up to five polar flagella, making it differed from Campylobacter spp., which 
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presenta a typical single polar flagella (Marshall and Warren, 1984). A name was given as 
Campylobacter pylori or Pyloric Campylobacter (PC), today known as Helicobacter pylori.  
Nevertheless, the old dispute was still not settled and in 1985, in order to prove their theory 
right, the connection between disease and bacteria, Barry J. Marshall decided to apply the 
Koch postulates himself. He drank a 10 ml solution of bacteria and after 10 days of infection, 
colonization of the stomach was proven and related to the development of gastritis (Marshall 
et al., 1985) confirming for the first time a link between the presence of H. pylori and the 
gastritis symptoms. With their discovery, they finally resolved a “medical curious” into a fact 
and they brought back the old point of view seen in the beginning of the 1900’s: a 
microorganism could be the cause of gastric cancer. Years later the World Health 
Organization (WHO) declared H. pylori as a Carcinogenic Type I, classifying a 
microorganism as cause of cancer. Their work did not only change the view of gastritis 
related maladies. They opened a possibility for many other diseases, whose exact cause have 
not yet been found.  Because of their work and as recognition of Marshall and Warren’s 
contribution to science, they were awarded the Nobel Prize of Physiology and Medicine in 
2005. 
1.3.2 Microbiological aspects of Helicobacter pylori 
In 1986 Campylobacter pylori was described as a gram-negative curved bacillus, which 
initially was grown on Brain Heart Infusion (BHI) media with an atmosphere containing 10% 
CO2 at 37°C during 3 to 6 days. The initial metabolic studies revealed a bacterium catalase- 
and oxidase-positive, with a 50% chance of growth at 42°C and urease positive. As for 
antibiotic sensitivity, it was described to resist to penicillin, erythromycin, tetracycline, 
gentamycin and cephalothin; and partial resistance to rifampicin and tinidazole (Marshall and 
Warren, 1984). Today it is considered a different genus based on 16S rRNA sequencing 
(Olsen GY, 1994), and it is given the name of Helicobacter pylori (H. pylori). More than 18 
species of Helicobacter spp. are found in the stomachs or intestine of mammals. In some 
mammals, gastric diseases similar to those caused by H. pylori in humans are present, as it is 
the case for Helicobacter felis in mice and Helicobacter mustelae in ferrets (Owen, 1998). 
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1.3.3 Epidemiology: Tendencies, transmission and eradication  
H. pylori has been present within the human population since the original migration of 
humans from East Africa more than 58000 years ago (Falush et al., 2003; Linz et al., 2007). 
Today it is estimated to be present in 50% of the human population (Blaser, 1993), with 
stronger presence in Africa (90%), America (50%) and Asian populations than within 
European countries (20%). Because of that close and old relationship, anthropological studies 
to confirm the evolution history of the human populations and its migrations from Africa to 
the rest of the world, are using the genetic information of H. pylori and its variation between 
strains to uncover the answers behind their theory ( de Thé, 2007). 
H. pylori’s presence in the human stomach, as said before, can cause gastric ulcers and 
increase the risk of gastric cancer (Suerbaum and Michetti, 2002), which  is today the 4th most 
common cancer in the United States (Greenlee et al., 2000). To explore the possibility of a 
prophylaxis management of H. pylori infections, several studies have evaluated the benefit in 
preventive eradication of the bacterium even in cases where no sign of disease is present. 
These studies hoped to diminishing future health costs. From these studies, no conclusive 
results were obtained. These results have somehow been expected by some scientist, as 
Martin J. Blaser. He considers H. pylori part of our normal flora and proposes that H. pylori 
have evolved with humans. In his opinion, H. pylori eradication should only be necessary 
when disease appears (Blaser, 1997). Some truth could be in there. In recent reports, there 
have been cases were esophageal pathologies have appeared once the bacterium has been 
eradicated from the stomach. These reports have established a negative correlation between 
H. pylori presence and esophagus diseases, as if the presence of H. pylori would protect from 
them (McColl et al., 2008). Additionally to these reports, there are several indications of not 
only the bacteria’s presence being the cause of disease. There are as well dietary factors like 
high consumption of processed carbohydrates (Rocco and Nardone, 2007), genetic 
polymorphism in the host (Algood and Cover, 2006) and patterns in physical activity (Cheng 
et al., 2000). 
The relationship between presence of the bacteria and disease is not the only aspect of H. 
pylori that remains to be defined. H. pylori ways of transmission are surrounded by the same 
veil of unknowns. While various publications state that infection with H. pylori occurs early 
in the childhood and propose a horizontal transmission from the parents to the child or from 
siblings ( de Thé, 2007). Others define a fecal-oral or oral-oral transmission. Some even 
define H. pylori as water borne pathogen (Engstrand, 2001). Although these studies are 
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central for transmission prevention, no real correlation has been made yet. With no way to 
prevent its transmission, the only possibility left is the eradication by the use of antibiotics.  
The eradication treatment recommended today is called the PPI triple / quadruple therapy 
defined by the use of a Proton Pump Inhibitor (PPI), omeprazole, in combination with a set of 
antibiotics as metronidazole, clarithromicin and/or tetracycline. The constant emergence of 
antibiotic resistance in combination with low compliance of the therapy by the patient makes 
the eradication difficult and not very successful (Megraud, 2007). New antibiotics and 
alternative eradication therapies are being investigated (Kihira et al., 1996) because of the 
association of diseases like MALT lymphoma with the persistence of H. pylori infections. 
Another approach that could shed light on the development of disease associated with H. 
pylori is the understanding of the bacteria, their molecular mechanisms that leads to survival 
within the human population, as well as their pathogenesis and virulence factors. 
1.3.4 Pathogenesis and virulence factors 
As biological organism, H. pylori requires an environment where it can survive and thrive. 
This environment is the human stomach. It will be easy to think that it has evolved to live 
there in order to avoid competition with other bacteria. After all, very few bacterial species 
are reported to establish a niche in the stomach. Nevertheless, this cannot exclude that the 
stomach could have proven to be a good place to enter the body’s inner tissues. Whatever the 
bacteria’s reasons, H. pylori has developed survival techniques to deal with the physical 
conditions found here and to deal with the immune system. These survival techniques are 
known as virulence and pathogenicity factors. 
Urease is one of the first survival measures that H. pylori applies to conquer the stomach 
physical topography. Urease is an enzyme capable of converting the acid environment (~ pH 
2) around the bacteria to more basic and tolerable surroundings through hydrolysis of urea 
into carbon dioxide and ammonia (Ferrero et al., 1992). Urease has been recently associated 
as well with a role in the evasion of the immune system. In this case, as interaction with 
macrophages occurs, the enzyme seems to confer the bacterium the ability of survival by 
formation of megasomes and inhibiting phagocytosis (Schwartz and Allen, 2006). Another 
mechanism of survival is H. pylori’s flagella. In H. pylori, expression and assembly of 
flagella have been predicted to involve more than 50 putative proteins of which the two 
subunits encoded by flaA and flaB genes have been extensively characterized (Tomb et al, 
1997). During experiments carried out on gerbil stomachs, the polar flagella help the bacteria 
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to keep its ground amid the mucosa, overcoming the constant mucus secretion and 
maintaining a “territory” that ranges from 0 - 25 µm area of the mucus layer above the 
epithelia. The same studies established that the bacterium manages to orientate in the stomach 
mucosa using a movement towards certain pH gradients and carbonate concentrations 
(Schreiber et al., 2004; Schreiber et al., 2005). Movement towards a gradient can indicate 
tropism towards the epithelia in order to bind to it. In these experiments, only a small 
percentage of the bacteria are localized on the epithelia cells, being the majority in the mucosa 
layer per se.  
This data uncovers a controversial and complex system required for colonization. In studies 
by Kavermann (Kavermann et al., 2003), genes were found to be required for a successful 
colonization. Schreiber et al confirmed the mutagenesis effects on these genes. Some of these 
data were not surprising as for genes encoding for motility components like the flagella 
associated proteins. The same results were expected from genes encoding for acid survival as 
the urease genes. However, the impact of other genes on colonization, as a collagenase protein 
or Outer Membrane Proteins (OMPs), was startling. Adhesion onto the epithelia cells is not a 
common observation made in gerbils during colonization. The necessity of adhesion related 
proteins for a successful colonization could be explained by the fact that adhesion seems to be 
triggered by changes in the tissue’s pH and, in some conditions, it might lead to invasion 
(Schreiber, S; personal communication). If the observations made in the gerbil model are 
comparable to the situation in the human stomach, adhesion of H. pylori can be essential for 
the survival of the bacterium in the stomach under pH changing conditions. 
In general, it is known that adhesion of H. pylori can be mediated by adhesins and OMPs 
present in it, for which 32 paralogous genes are predicted (Alm et al., 2000; Alm and Trust, 
1999; Tomb et al., 1997). These OMPs are grouped in two families termed hop and hor genes. 
From these families the best-known members are BabA, SabA, AlpA, AlpB, and OipA. The 
BabA (Blood group antigen-binding adhesin) binds to fucosylated Lewis B (Leb) blood group 
antigen found in MUC5A on gastric cells (Aspholm-Hurtig et al., 2004; Ilver et al., 1998). 
SabA (Sialic acid-binding adhesin) binds to Lewis X (Lex) antigens present in inflamed tissue 
(Mahdavi et al., 2002), neutrophils (Unemo et al., 2005) and erythrocytes (Aspholm et al., 
2006). OipA (Outer inflammatory protein) plays an important role as adhesion/colonization 
factor. AlpA, and AlpB (Adherence-associated lipoprotein) are essential colonization factors 
presumably binding to receptors on the cells surface (Odenbreit et al., 1999). 
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With the adhesion onto the epithelial cells, the thin line between colonization and invasion 
can be easily crossed. The invasion of the tissue could indicate the progress of disease. 
Therefore, factors for evasion or modulation of the immune response are necessary.  
Within these factors, it can be named the HP-NAP (H. pylori Neutrophil-associated Protein) 
which has been described as an oligomeric protein consisting of 10-12 monomers of a 17-kDa 
polypeptide with homology to iron proteins (Tonello et al., 1999). HP-NAP is able to induce 
neutrophils to produce oxygen radicals (Satin et al., 2000), and it has been described to act as 
an adhesin (Namavar et al., 1998; Teneberg et al., 1997). 
VacA toxin (Vacuolating Cytotoxin A) and the Type IV Secretion Systems (T4SS), Cag and 
ComB, are as well part of the virulence factors. VacA is an AB type toxin encoded by the 
vacA gene. It presents a precursor of ~140 kDa, which is processed to an approximately 95-
kDa protein that is release in the media. Bybeing a secreted soluble toxin, VacA has the 
remarkable capacity of reaching areas of the stomach mucosa that bacteria cannot reach. In 
this way, its immuno-modulatory effect can be successfully achieved. By disrupting the 
phosphatase activity of Calcineurin, VacA prevents the translocation of NFAT into the 
nucleus and therefore inhibits the IL-2 synthesis and secretion by T-cells. By doing so, it 
inhibits T-cell proliferation (Gebert et al., 2003). This effect on proliferation occurs after 
VacA binds to a receptor on T-cells, the integrin β2 subunit (Sewald et al., 2008). Another 
phenotype related to VacA activity is the formation of vacuoles expressing markers for late 
endosomes (Rab7) and lysosomes (Lamp1). This property has been linked with the disruption 
of the normal proteolytic activity of the endocytic pathway, giving an advantage to the 
bacterium in case of phagocytosis (Montecucco et al., 2001). Additionally, VacA has the 
ability to increase the permeability of polarized epithelia, thereby possibly increasing the 
supplement of nutrients available to the bacterium in the mucosa (Pelicic et al., 1999). 
Two T4SS in H. pylori are to date associated with pathogenicity, the ComB and the Cag 
systems. Their relevance for pathogenicity involves different aspects. The ComB system 
allows the bacterium to take up DNA from the outside and integrating it in the genome, 
giving the bacteria great versatility for adaptations (Hofreuter et al., 2001). In the case of the 
Cag system, its relationship to pathogenicity has been extrapolated from epidemiological data. 
These data show a higher incidence of gastric tissue pathologies in cases where its effector 
protein, CagA, is present. Further description of both T4SSs and some of their cellular effects 
will follow. 
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1.3.4.1 Type IV secretion systems 
To date, there are six types of secretion systems described. They are used by gram-negative 
bacteria to transport cargo proteins across the inner and outer membranes. The best described 
secretion systems are the Type III Secretions Systems (T3SS) and its injectisome (Mueller et 
al., 2008) and the Type IV Secretions Systems (T4SS) because of their common association 
with pathogenicity. 
T4SS are common transporters used by pathogenic bacteria. The first of them described was 
the VirB system from Agrobacterium tumefaciens, which contains at least 12 genes involved 
in the transfer of the Ti plasmid into the host plant cell causing modifications that give origin 
to the Crown Gall disease. With the discovery of the VirB system 30 years ago, a 
translocation system was identified by which an interkindom DNA transfer was possible. 
Furthermore, with the identification and sequencing of its components, new secretion systems 
began to be discovered in other pathogenic Gram-negative bacteria by sequence homology. 
Today they are found in several bacteria, e.g. Bordetella pertussis (Ptl System), Brucella spp. 
(VirB system), Bartonella henselae (Trw System and VirB-homologue (vbh)), Legionella 
pneumophila (Dot/Icm system, Lvh system (Bandyopadhyay et al., 2007)) and Helicobacter 
pylori (ComB and Cag system) (Fischer et al., 2002). The purpose of translocating proteins 
across membranes works in different ways. Some of them do not require host cell contact, 
releasing the effector protein to the outside, as is the case of B. pertussis and its pertussis 
toxin. Pertussis toxin is assembled in the bacteria and exported by the T4SS into the 
extracellular milieu to find its target cells. The other systems seem to need a bactera cell- host 
cell contact to deliver the effector proteins into the target cell, as it occurs for H. pylori (Cag 
system), Legionella and Rickettsia T4SS (Fischer et al., 2002).  
In the case of Helicobacter pylori, the ComB and the Cag systems are representatives of a 
Type IV Secretion System (T4SS). Recently it has been described a third T4SS in H. pylori, 
the TFS3, whose function remains to be established (Kersulyte et al., 2003).  
1.3.4.1.1 ComB system 
The ComB system was identified as a Type IV Secretion apparatus based on sequence 
homologies with the VirB system of Agrobacterium tumefaciens. It contains the ComB2 to 
ComB4 and ComB6 to ComB10 as core proteins. Other proteins that are necessary for 
transformation, but are not part of the T4SS are RecA, DprA and ComH (Hofreuter et al., 
1998; Karnholz et al., 2006; Smeets and Kusters, 2002).  
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The ComB system is responsible for natural competence of H. pylori. Nedenskov-Sorensen et 
al. discovered the uptake of free DNA by H. pylori in 1990. The process can be divided into 
the binding of DNA to the surface of the bacterium, the transport of the DNA through the 
periplasm and the degradation of one strand leaving a single strand DNA molecule. This 
single strand DNA is translocated through the inner membrane to the cytoplasm where it is 
finally incorporated in the chromosome (Dubnau, 1999). The fact that almost all strains 
contain the ComB system, leads to contemplate the possibility that it plays an important role 
in the survival of the bacteria and not only an advantage for genetic diversity. Transposon 
mutagenesis studies (Kavermann et al., 2003) revealed the relevance of the ComB system 
under in vivo situations, in which ComB4 was essential for colonization in the gerbil model. 
However, the reason for the relevance in vivo remains to be elucidated. 
1.3.4.1.2 Cag Type IV Secretion System  
The 27 to 30 ORFs (Open Reading Frames), found in the Cag pathogenicity island, encode 
the Cag Type IV secretion system. Figure 1-2 illustrates the genes found on the strain 26695 
cagPAI.  
 
Figure 1-2 Cag Pathogenicity Island genes 
Genes encoded in the Cag pathogenicity island and its homologous genes in the VirB system. Three 
denominations systems for the genes contained in the T4SS are used to date, of which only two are 
explained here. Number of the ORF based on the sequence of H. pylori 26659 strain and a single letter code 
for the genes’ names.  
Associated with the functionality of the secretion system is the capability of inducing 
chemokine secretion, such as Interleukin 8 (IL-8) and RANTES, upon interaction with the 
eukaryotic cell (Odenbreit and Haas, 2002). Equally important is the ability to translocate the 
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CagA (Cytotoxic Associated Gene A) into the eukaryotic cell (Odenbreit et al., 2000). A 
systematic mutagenesis study of the genes encoded by the cag PAI was performed (Fischer et 
al., 2001), in which phenotypic effects of the Cag apparatus, IL-8 induction and CagA 
phosphorylation (CagA-P) were analyzed, giving an insight in the functionality of the genes 
encoded. They have been classified in five groups: proteins essential for the apparatus 
functionality, support or accessory proteins, proteins essential for CagA translocation, effector 
proteins and proteins of unknown function.  
As effector protein, only CagA, encoded by gene hp0547, has been identified. Based on the 
IL-8 induction ability, 14 proteins are classified as essential proteins for the secretion 
apparatus. The proteins encoded by hp0526, hp0524 (virD4 homologue), hp0543 and hp0540 
were shown to be essential only for CagA translocation; while hp0520, hp0521, hp0534, 
hp0535 and hp0536 are not necessary neither for IL-8 induction nor for CagA translocation 
(Fischer et al., 2001). 
From the proteins essential for the functionality of the Cag apparatus are worth to mention the 
CagY (homologue to VirB10), CagT (homologue to VirB7), and CagX (homologue to 
VirB9). All have been defined as structural proteins in electron microscopy studies (Rohde et 
al., 2003; Tanaka et al., 2003). In the case of CagY, studies of its composition unveiled 
remarkable characteristics. Its homology region to VirB10 proteins is present in the C-
terminal part of the protein. Additionally, CagY contains two repeat regions. Repeat Region I 
(RRI) corresponds to the N-terminal part, while Repeat Region II (RRII) is localized in the 
middle region of the protein. Both repeat regions show no homology to any known bacterial 
protein. Between RRI and RRII, a transmembrane domain has been predicted. The same 
prediction has been made for the region found between the RRII and the VirB10 homology 
region (Liu et al., 1999). Structural studies have found other proteins related to the apparatus 
structure. This is the case for CagT (HP0532), which shares homology with the VirB7, a 
structural protein of the VirB system (Cascales and Christie, 2003). Using antibodies and 
electron microscopy studies, Sasakawa et al. were able to localize this protein on pilus-like 
extensions found only on bacteria with an intact Cag island. The same observation was made 
with the VirB9 homologue, CagX (HP0528) (Tanaka et al., 2003). Eventhough Sasakawa’s 
studies could not detect CagY on the surface of these structures, Rohde et al. could confirm 
the presence of this protein along of pilus-like structures with concentrated areas around their 
tips, as well as areas at the bacteria’s surface (Rohde et al., 2003). 
The current working model of the Cag apparatus is pictured in figure 1-3. Most of the 
interactions between the proteins shown here have been elucidated using Yeast-2-Hybrid 
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(Y2H) assays complemented by biochemical assays, which have confirmed the interactions in 
independent ways (Kutter et al., 2008; Pattis et al., 2007). 
 
Figure 1-3 Model for the CagPAI apparatus 
Actual working model of the Cag apparatus based on defined protein interactions and functionality.  
CagA is the only effector protein yet known to be translocated by the T4SS into the target 
cell. Once inside the cell’s cytoplasm, it is phosphorylated by Src and Abl family kinases on 
its EPIYA motifs. The EPIYA motifs are located in the C-terminal region of the protein 
(Poppe et al., 2007; Selbach et al., 2002). The variations in these phosphorylation motifs 
determine the biological activity of the CagA. A closer look at these motifs revealed a 
difference between CagA+ Western Strains (Western CagA-Specific Sequence, WSS) and 
Eastern Strains (East-Asian CagA-Specific Sequence, ESS), explaining the variability in 
disease progression between infections in East Asia and Western cases (Higashi et al., 2002). 
The five amino acid sequence constitutes the EPIYA motif, which is recognized by cellular 
kinases that phosphorylate the tyrosine (Y) residue. Based on their adjacent amino acid 
sequences, the EPIYA motifs have been classified in four types: A, B, C and D. The Eastern 
Strains contain the combination ABD while Western Strains present ABC EPIYA motifs 
(Hatakeyama, 2006).  
However, not only the variations on its EPIYA motifs determine the effects of CagA on the 
target cell. CagA’s presence inside the cell and its effects vary as well depending of its 
phosphorylation status. Non-phosphorylated CagA has been associated with changes in 
transcription patterns through direct binding to E-Cadherin, which disrupts the Cadherin/β-
catenin complex, translocating β-catenin into the nucleus. Once β-catenin is translocated in 
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the nucleus, it upregulates pathways like the cdx1 pathway, which regulates intestinal 
differentiation (Murata-Kamiya et al., 2007). Through the same interaction, CagA disrupts 
tight junctions of polarized epithelia and induces invasiveness, as seen in studies with 
polarized MDCK cells (Bagnoli et al., 2005).  
In case of phosphorylated CagA, its functions include the dephosphorylation of cellular 
proteins and the inactivation of kinases essential for the normal operation of the cell. The 
dephosphorylating activity has been linked with the Shp-2 protein. Shp-2 phosphatase activity 
is stimulated by the direct binding of phosphorylated CagA to the phosphatase. (Higashi et al., 
2002). Additionally, it has been reported that the dephosphorylation is reinforced by the 
inhibition of Src-kinase by phosphorylated CagA, which results in dephosphorylation of 
Cortactin (Selbach et al., 2003). Cortactin dephosphorylation induces some of the 
cytoskeleton modifications associated with the phosphorylated form of CagA. Another way of 
altering the cytoskeleton is through Crk-dependent activation of the Arp2/3 complex (Suzuki 
et al., 2005)  and the dephosphorylation of Focal Adhesion Kinase (FAK) by Shp-2 (Tsutsumi 
et al., 2006). The cytoskeleton modifications are visible in two phenotypes presented by 
infected cells: “hummingbird” and cell scattering. The “hummingbird” phenotype is presented 
by AGS cells (Adenogastric carcinoma cells, human) as an elongation of the cells shape 
(Segal et al., 1996). Cell scattering occurs after infection of cells that have been serum starved 
previously, increasing the movement of cells. This phenotype has been associated with the 
presence of the Cag apparatus as well (Moese et al., 2004).  
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1.4 Aim of the studies 
The Type IV Secretion System (T4SS) encoded on the cagPAI and its effector protein CagA 
represents one of the most intriguing virulence mechanisms of H. pylori. In the course of this 
thesis I will try to identify the molecular mechanisms implicated in the interaction of the Cag 
apparatus with the host cell. I will describe the elements from the bacteria necessary that 
make possible the transfer and translocation of the effector protein CagA. The main objectives 
of these studies are the identification of the receptor for the Cag apparatus on the cell’s 
membrane and the signaling necessary to make this interaction a successful one for CagA 
translocation. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Cell lines 
3051/9 Human Adenogastric carcinoma cell line 
AGS Human Adenogastric carcinoma cell line (ATCC CRL-1739) 
Caco-2 Human Colon carcinoma cell line 
CHO-K1 Chinese Ovary Hamster cell line Clone K1 
CHO-K1 β1A Chinese Ovary Hamster cell line Clone K1, hITGB1A 
CHO-K1 β1com Chinese Ovary Hamster cell line Clone K1, hITGB1 com 
CHO-K1 β1TR Chinese Ovary Hamster cell line Clone K1, hITGB1A 
transmembrane and extracellular domains 
GD25 Murine Fibroblast-like embryonic cell line, ITGB1 -/- 
GD25β  Murine Fibroblast-like embryonic cell line, mITGB1 in trans 
GD25β 1A Murine Fibroblast-like embryonic cell line, ITGB1 +/+ 
GE11 Murine Epithelia-like embryonic cell line, ITGB1 -/- 
GE11β Murine Epithelia-like embryonic cell line, hITGB1 in trans 
H10 Mouse breast epithelial cell line, cMet -/- 
H10 cMet Mouse breast epithelial cell line, cMet -/-, human cMet in trans 
HEK-293 Human Embryonic Kidney Cell line 
HeLa Human Cervical carcinoma cell line (ATCC 57) 
HL-60 Human promyelocytic leukemia cell line 
J774A.1 Murine Macrophage cell line (ATCC 170) 
Jurkat EG-1 Human T-Cell line (ATCC TIB-152) 
Kato III Human epithelia cell line 
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MDCK Marby Darby Canine Kidney cell line (ATCC CCL-34) 
MKN45 Human Adenogastric carcinoma cell line 
T47D Human Breast Carcinoma cell line 
T47D Met 
Human Breast carcinoma cell line, over expressing human cMet 
receptor 
β-2-4  Murine Fibroblast-like embryonic cell line, ITGB1 -/- 
β-2-4-8  Murine Fibroblast-like embryonic cell line, mITGB1 +/+ 
2.1.2 Bacteria Strains 
2.1.2.1 Escherichia coli strains 
DH5α 
F-,φ80lacZ∆M15∆(lacZYA-argF)U169, deoR, recA 1, endA 1, 
hsdR 17(rK-,mk+), supE 44, thi -1, λ- gyrA 96, relA 1 
(GIBCO,BRL) 
2.1.2.2 Helicobacter pylori strains 
P12 
Clinical Isolate from the Department of Medicine Microbiology 
and Immunology, University of Hamburg 
P217 Clinical isolate. 
P145 ATCC 45526  
26659 Genome Sequenced Wild strain (Tomb et al., 1997) 
LJ-H1 P12∆547 KanR
LJ-H56 P12∆544 CamR
LJ-H54 P12∆527 CamR
LJ-H17 P12∆PAI, KanR
LJ-H12 P12∆547 pHel4 GFP, KanR, CamR
LJ-H10 P12 Wild type pHel4 GFP, KanR, CamR
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LJ-H15 P12∆PAI pHel4 GFP, KanR, CamR
LJ-H53 P12∆CagA ::CagA-GSK, KanR, CamR
2.1.3 Plasmids 
pLJ-2 pGEX-4T3 containing CagYc (H. PYLORI0527c) 
pJP109 pGEX-4T-3 containing CagY RRII (H. PYLORI0527b) 
pJP110 pGEX-4T-3 containing CagY RRI (H. PYLORI0527a) 
pHel4 GFP pHel4 containing GFP protein for expression in H. pylori. 
2.1.4 Oligonucleotides 
LJ-10 GGTGTCGTGTTTGTGAATGCT 
Sense primer for detection of ITGB1 mouse 
LJ-11 GGCAACTTCTCCCTGCTTTC 
Antisense primer for detection of ITGB1 mouse 
LJ-12 GCAGAATCCAAAGTAAATGTCCTG 
Sense primer. Recognizes Human ITGB1 Variant 1A 
LJ-13 GATTAGAAGAGGTGATAGAAAGCAC 
Antisense primer. Recognizes Human ITGB1 Variant 1A 
LJ-14 GACAGTTCTTCTTCTTGCCA 
Sense primer. Recognizes Human ITGB1 Variant 1B 
LJ-15 CCACAATCAAGTCATCCCAA 
Antisense primer. Recognizes Human ITGB1 Variant 1B 
LJ-16 GCTGGAATTGTTCTTATTGGCCTT 
Sense primer. Recognizes Human ITGB1 Variant 1D 
LJ-17 TTCACCGGCAATTTAGAGACCAG 
Antisense primer. Recognizes Human ITGB1 Variant 1D 
LJ-20 AAAAAGCAGGCTCCGCCAATGTTCAAGAGAGCTGAAGAC 
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Forward AttB1 sequence vWF domain integrin β1 
LJ-21 AGAAAGCTGGGTCTAAATGACTTCTGAGGAAAG 
Reverse AttB1 sequence vWF domain integrin β1 
LJ-22 AAAAAGCAGGCTCCGCCAATGTCTTACTGCAAGAACGGG 
Forward AttB1 sequence Laminin / EGF-like domain from 
integrin β1 
LJ-23 AGAAAGCTGGGTCTATTTCCTGCAGTAAGCATC 
Reverse AttB1 sequence Laminin / EGF-like domain from integrin 
β1 
LJ-24 AAAAAGCAGGCTCCGCCAATGAATTTACAACCAATTTTC 
Forward AttB1 sequence extracellular domain from integrin β1 
LJ-25 AGAAAGCTGGGTCTAGATGTCTGGACCAGTGGG 
Reverse AttB1 sequence extracellular domain from integrin β1 
LJ-38 CGTGGATCCATCATAGCTCTAGATAAACTCATAGGC 
Sense primer of hp0527 introducing BamHI site 
LJ-39 CGTAGCGGCCGCTTAATTGCCACCTTTGGGGCTTGTGGT 
Antisense primer of hp0527 introducing NotI site 
LJ-57 CGTGGATCCAATTTACAACCAATTTTCTGG 
Sense primer of PSI domain (ITGB1 Aa 1-99) introducing BamHI 
site 
LJ-58 CGTAGCGGCCGCCTATCCTTTGCTACGGTTGGTTAC 
Antisense primer of PSI domain (ITGB1 Aa 1-99) introducing 
NotI site 
LJ-59 CGTGGATCCTCAGAAGGAGTAACAATAAG 
Sense primer of EGF (1-4) domains (ITGB1 Aa 410-625) 
introducing BamHI site 
LJ-60 CGTAGCGGCCGCCTAAAACTTCGGATCTGTACAC 
Antisense primer of EGF (1-4) domains (ITGB1 Aa 410-625) 
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introducing NotI site 
LJ-61 CGTGGATCCTGTCGTGTGTGTGAGTGCAACC 
Sense primer of β-tail domain (ITGB1 Aa 575-728) introducing 
BamHI site 
LJ-62 CGTAGCGGCCGCCTAGATGTCTGGACCAGTGGGACAC 
Antisense primer of β-tail domain (ITGB1 Aa 575-728) 
introducing NotI site 
LJ-63 CGTGAATCCGTAACCAACCGTAGCAAA 
Sense primer of I-like domain (ITGB1 Aa 96-460) introducing 
BamHI site 
LJ-64 CGTAGCGGCCGCCTAATCCTTTTTTGGACACTTATTTC 
Antisense primer of I-like domain (ITGB1 Aa 96-460) introducing 
NotI site 
dsRNA ILK Sense strand 5’-GGAAGAGAUAGUUUGAUUUTT-3’ 
Antisense strand 5’-AAAUCAAACUAUCUCUUCCTG-3’ 
2.1.5 Reagents and Solutions 
2.1.5.1 Reagent  s
BBL Brucella Broth (BD Falcon), Fluoroprep (BioMeriux), Coomassie Brilliant Blue G250) 
(Biomol), Acrylamide/Methylenbisacrylamide 30% (29:1) and X-Gal(Roth), Streptomycin, 
Trimethoprim, Vancomycin, Nystatin, Ampicillyn, Phrobol-12-myristat-13-acetate  PMA, 
Cytochalasin D, Bafilomycin A1, Genistein, Cycloheximide, 5-Brom-3-chlor-3-
indolylphosphate-p-toluidinsalt BCIP, Ionomycin, Guanidine-HCL, Ethidium Bromide, 
Leupeptin, Sodium-ortho-orthovanadatee, Paraformaldehyde, Glutaraldehyde, Pepstatin, 
Triton X-100, Tween 20, DMSO, Dansylcadaverine, Methyl-β Cyclodextrin (Heptakis), 
ammonium chloride (Sigma-Aldrich); Chloramphenicol (Serva), Kanamycin, 
Phenylmethylsulfonylfluorid PMSF (Merck), GC Agar, LB Agar, LB broth (Oxoid), 
Sephadex-G-50, Glutatione Sepharose (Pharmacia), Zinc staining kit, Silver staining kit , 
Precision Plus Protein Standards All Blue (BioRad); U73211 (Calbiochem); Dynasore was a 
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kind gift from Dr. Tomas Kirchhausen. 
 
2.1.5.2 Solutions and buffers  
PBS 10X 2 g/l KCL, 80 g/l NaCl, 2 g/l KH2PO4; 14,4 g/l Na2HPO4 ( 29 
g/l Na2HPO4 . 12H2O). Autoclave if necessary and store at RT. 
2X SDS loading buffer 100 mM Tris HCl pH 6,8; 4% SDS; 0,2% Bromophenol blue, 
20% Glycerol, 10% β-Mercaptoethanol (optional) 
5X SDS loading buffer 10% SDS; 0,5 M Tris HCl (pH 6,8); 50% Glycerol, 5% 
Bromophenol blue. Store at room temperature. 
NBT detection buffer 0,1 M Tris HCl pH 9,6; 0,01% w/v NBT, 0,005% w/v BCIP, 7 
mM MgCl2
Agarose Loading buffer 6X 0,25% Bromophenolblue; 0,25% Xylene Cyanol FF, 30% 
Glycerol; in TAE buffer 
50X TAE buffer 242 g/l Tris Base, 57,1 ml/l Glacial Acetic Acid, 50 mM EDTA 
PFA 1X Paraformaldehyde 4%, PBS (+Ca2+, +Mg2+), pH 7,4 
PFA 10X Paraformaldehyde 27%, PBS 10X, pH 7,4 
2.1.6 Peptides, Proteins and enzymes 
Proteins Fetal Horse Serum (PAA Laboratories GmbH), Bovine Serum 
Albumin BSA (Sigma), Alkaline Phosphatase-Protein A 
(Sigma), purified integrin β1α5 (VLA-5) and integrin β1α1 
(Chemicon), Collagen Type I from bovine skin (Vitrogen 
100®, Nutacon, Holland). 
Peptides  RGD (Gly-Arg-Gly-Asp-Ser-Pro-Lys) peptide, RAD (Gly-
Arg-Ala-Asp-Ser-Pro-Lys) peptide (Sigma) 
Enzymes Thrombin (Calbiochem); trypsin (Pancreatic), fibronectin 
(human plasma) and proteinase K (Sigma); DNAse I and 
RNAse A (Roche). 
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2.1.7 Antibodies 
2.1.7.1 Primary antibodies 
α- Actin (H-196) Mouse monoclonal antibody against actin from different 
species (Santa Cruz Technologies) 
α- CagA (AK257) Rabbit polyclonal antibody against the C-terminal part of 
CagA from Helicobacter pylori. 
α- CagA (AK268) Rabbit polyclonal antibody against the N-terminal part of 
CagA from Helicobacter pylori. 
α- CagC (AK576) Rabbit polyclonal antibody against the C-terminal part of 
CagC from Helicobacter pylori. 
α- CagC (AK577) Rabbit polyclonal antibody against the C-terminal part of 
CagC from Helicobacter pylori 
α- CagY (AK273) Rabbit polyclonal antibody against the Repeat Region II of 
CagY from Helicobacter pylori. 
α- CagY (AK280) Rabbit polyclonal antibody against the Repeat Region I of 
CagY from Helicobacter pylori. 
α- CD18 PE Mouse monoclonal antibody against human CD18 (integrin 
β2) Clone 6.7. R-Phycoerithrin (PE) conjugated. (BD 
Biosciences) 
α- CD29 FITC Hamster monoclonal antibody against extracellular part of 
ITGB1 from different species. Clone Ha2/5. FITC conjugated. 
(BD Biosciences) 
α- Clathrin  Mouse monoclonal antibody against the heavy chain of 
clathrin (Pharmacia) 
α- GST Mouse monoclonal antibody against Glutatione S-Transferase 
(GST) protein (Sigma) 
α- H. pylori (AK175) Rabbit polyclonal antibody against a soluble extract of 
Helicobacter pylori P1 strain. 
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α- IL-8 Mouse monoclonal antibody against human IL-8 (BD 
Biosciences) 
α- IL-8 biotin Mouse monoclonal antibody against human IL-8, biotin 
conjugated (BD Biosciences) 
α- ILK Mouse monoclonal antibody against human integrin-linked 
kinase (ILK). (Sigma) 
α- ITGB1  Rabbit monoclonal antibody against cytoplasmic tail of 
human integrin β1 (ITGB1). (Cat. Nr. AB1952 from 
Chemicon) 
α- ITGB1 (Clone 3S3) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA) 
α- ITGB1 (Clone 4B7) Mouse monoclonal antibody against human ITGB1. 
(Calbiochem) 
α- ITGB1 (Clone 6S6) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA) 
α- ITGB1 (Clone 8E3) Mouse monoclonal activating antibody against human ITGB1 
(Mould et al., 1995)  
α- ITGB1 (Clone 9EG7) Rat monoclonal antibody against extracellular part of human 
and mouse ITGB1 (Calbiochem) 
α- ITGB1 (Clone 12G10) Mouse monoclonal inactivating antibody against human 
ITGB1 (Mould et al., 1995) 
α- ITGB1 (Clone AIIB2) Rat monoclonal antibody against extracellular part of ITGB1. 
Inactivating antibody. Prepared from hybridoma cells. 
α- ITGB1 (Clone B3B11) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA,1996) 
α- ITGB1 (Clone B44) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA,1996) 
α- ITGB1 (Clone JB1A) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA,1996) 
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α- ITGB1 (Clone K20) Mouse monoclonal antibody against extracellular part of 
human ITGB1. (Santa Cruz Technologies) 
α- ITGB1 (LM534) Mouse monoclonal antibody against extracellular part of 
human ITGB1. (Chemicon) 
α- ITGB1 (Clone N29) Mouse monoclonal antibody against human ITGB1 (Wilkins 
JA,1996) 
α- P-tyr (4G10) Mouse monoclonal antibody against tyrosine phosphorylated 
proteins (Upstate) 
α- P-tyr (PY99) Mouse monoclonal antibody against tyrosine-phosphorylated 
proteins (Santa Cruz Technologies)  
α- Tubulin Mouse monoclonal antibody against human and mouse 
tubulin alpha subunit (Upstate) 
2.1.7.2 Secondary antibodies 
α- mouse IgG Alexa488 AlexaFluor488-conjugated goat monoclonal antibody 
(Molecular Probes) 
α- mouse IgG Alexa555 AlexaFluor555-conjugated goat monoclonal antibody 
(Molecular Probes) 
α- mouse IgG Alexa567 AlexaFluor567-conjugated goat monoclonal antibody 
(Molecular Probes) 
α- mouse IgG AP Alkaline phosphatase-conjugated goat monoclonal antibody 
(Sigma) 
α- mouse IgG Pox Peroxidase-conjugated goat monoclonal antibody (Sigma) 
α- rabbit IgG Alexa488 AlexaFluor488-conjugated goat monoclonal antibody 
(Molecular Probes) 
α- rabbit IgG Alexa555 AlexaFluor555-conjugated goat monoclonal antibody 
(Molecular Probes) 
α- rabbit IgG Pox Peroxidase-conjugated goat monoclonal antibody (Sigma) 
α- rat IgG Alexa488 AlexaFluor488-conjugated goat monoclonal antibody 
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(Molecular Probes) 
α- rat IgG Alexa555 AlexaFluor555-conjugated goat monoclonal antibody 
(Molecular Probes) 
2.1.8 Cell culture solutions and additives 
For each cell line, a different medium is necessary Here is a general description of media and 
additives used in cell culture. 
Cell Media  High Glucose DMEM, RPMI-1640, MEM, F12 and 
DMEM:F12. (Invitrogen/GIBCO BRL), 10X MEM 
Antibiotic Penicillin/Streptomycin and Gentamicin (Invitrogen/GIBCO 
BRL) 
Selective G418 (Geniticin) and Hygromicin B (PAA laboratories), 
Puromycin (SIGMA-Aldrich) and Zeocin 
(Invitrogen/GIBCO BRL). 
Supplements Fetal Calf Serum and L-Glutamine (Invitrogen/GIBCO 
BRL). Fetal Bovine Serum Superior (Biochrom), 7,5% 
Sodium Bicarbonate (GIBCO) 
Others Trypsin-EDTA (TE), Dulbecco PBS (+Ca2+, +Mg2+) and 
Dulbecco PBS (-Ca2+, -Mg2+) (Invitrogen/GIBCO BRL), 
DMSO and EDTA (SIGMA Aldrich). 
2.1.9 Consumables and Equipment 
2.1.9.1 Consumables 
Sulphate modified latex fluorescent beads (Sigma), Carboxyl Magnetic beads (Chemicell), X-
Ray film (Fuji, A.Hastenstein), Dialysis membranes (Medicell), Dialysis membranes for small 
volumes (Pierce), ELISA Maxisorp plates (Nunc), Cell scrappers (Falcon), FACS tubes 
(Becton Dickinson), Freezing Tubes 2 ml (Nalgene), PVDF membrane (Bio-Rad), High 
Range Protein Marker (Bio-Rad), Cell culture treated plates (Corning), 0,2µm- Sterile filters 
(Millipore), Cell culture treated bottles (75 cm2 and 175 cm2) (BD Falcon), Filter paper 
(Whatman), Cell culture inserts 3 µm pores (Corning). Paraffin pellets (Fluka). 
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2.1.9.2 Equipment  
PAGE-Mini Gel System and Voltage Units Power Pac 300 and Power Pac 1000 (Bio-Rad), 
Incubator (Binder), Incubator Ultima (Revco), Microincubator MI22C (Scholzen), 
Geldocumentation System (Bio-Rad), Absorbance Reader Sunrise (TECAN systems), FACS 
EPICS ® XL-MCL (Coulter), Spectrophotometer DR/2000 (Hach), Multichannel Pipette 
(MATRIX Corporation), Agarose Gel Electrophoresis chamber (Bio-Rad), Centrifuge 
Biofuge 15R and Megafuge 3.0 R(Heraeus), Centrifuge Mikro 20 (Hettich), Developing 
Cassette for X-Ray films (Rego), Magnetic Stirrer MR 3001 (Heidolph), Medical Film 
Processor FPM-100A (Fuji film), Microscope DM IRB (Leica), Confocal Microscope (Leica) 
and TCS Software (Leica), PCR Thermocycler (ThermoHybaid), PCR Thermocycler 
Microcycler Personal (Eppendorf), Pipette Transferpette-8 (20-200µl and 0,5-10 µl)(Brand), 
Scales (Fischer Biotech), pH Meter (WTW), Semi-dry Blotting Chamber (Fischer Biotech), 
Sterile Hood (BDK), Vacuum Centrifuge Speed-Vac DNA 110 (Savant), Vortex Gene 2 
(Scientific Industries), Water Bath (GFL). 
2.2 Methods 
The methods here described are the general protocol for the work with bacteria, DNA and cell 
culture as well as the methods developed and/or used in frame of this work. 
2.2.1 Working with bacteria 
2.2.1.1 Culture  
Helicobacter pylori strains were passed from a 3-day culture after defrosting. Usually the 
bacteria would have grown on a GC agar plate for 24 hours before passed or used for 
experiments. The conditions of growth were at 37°C in an atmosphere composed of 85% N2, 
10% CO2 and 5% O2. In the case of growth in serum-free media, bacteria were grown 
minimum two passages before using them in the experiments. 
For the growth of Escherichia coli strains, it was used LB-agar for the selection of 
transfomants, LB media for growth of bacteria producing fusion proteins and Terrific Broth 
(TB) for plasmid isolation. All growth media were complemented with their respective 
antibiotic and/or inducer. 
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GC Agar serum 36 g/l GC agar, 8% Horse Serum, 1% Vitamin mix, 1 mg/l 
Nystatin, 5 mg/l Trimethoprin, 10 mg/l Vancomycin 
GC Agar serum-free 36 g/l GC agar, 1X Cholesterol (GIBCO), 1% Vitamin mix, 1 
mg/l Nystatin, 5 mg/l Trimethoprin, 10 mg/l Vancomycin 
LB Agar 32 g/l Lennox-L Agar 
LB Media 20 g/l Lennox-L Medium 
Vitamin Mix 100 g/l a D-Glucose, 10 g/l L-Glutamine, 26 g/l L-Cystein, 0,1 
g/l Cocarboxylase, 20 mg/l Fe(III)-Nitrat, 3 mg/l Thiamin, 13 
mg/l p-Aminobenzin acid, 250 mg/l Nicotinamid-adenine 
dinucleotide (NAD), 10 mg/l Vitamine B12, 1,1 g/l L-Cystine, 
1 g/l Adenine, 30 mg/l Guanine, 0,15 g/l L-Arginine, 0,5% 
Uracil. 
TB Solution 1 12 g/l Tryptone, 24 g/l Yeast Extract, 0,4% Glycerol 
10X TB Solution 2 0,17 M KH2PO4; 0,72 M K2HPO4
Antibiotics were used in the following concentrations,  
Ampicillyn    100 mg/l 
Chloramphenicol  30 mg/l (LB Medium, TB medium and LB agar) 
    6 mg/l (GC Agar) 
Kanamycin   50 mg/l (LB Medium, TB medium and LB agar) 
    8 mg/l (GC Agar) 
2.2.1.2 Freezing of E.coli 
From an overnight liquid-grown culture, 350 µl from the culture were mixed with 350 µl of a 
sterile 70% (v/v) Glycerol solution, and frozen directly by storage at -70°C. 
2.2.1.3 Freezing of H. pylori 
Bacteria grown on plates were resuspended in 1 ml Freezing Media for H. pylori and frozen 
directly by storage at -70°C. 
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Freezing Media H. pylori 10% FCS, 20% Glycerol, 70% Brucella Broth, sterile 
filtrated. 
2.2.1.4 Transformation of chemical competent cells 
For the transformation of E.coli bacteria, chemical competent cells were prepared after 
Hannahan’s method. The prepared bacteria suspension was aliquoted in 50 µl aliquots and 
store at -70°C. Shortly before transformation, an aliquot was defrosted slowly in ice. Plasmid 
DNA (between 20 ng and 500 ng) was added to the bacteria and incubated for 30 minutes in 
ice. The bacteria were then exposed to 42°C for 45 seconds and immediately cooled in ice. 
After the temperature shock, 1 ml warm LB media was added to the bacteria and incubated 
for one hour at 37°C. The suspension was pulse-centrifuged , the supernatant discarded and 
the bacteria pellet resuspended in 50 µl LB media. The resuspended pellet wasplated on LB 
agar plates containing the antibiotic necessary for the selection of transformants. 
2.2.1.5 Transformation of H. pylori 
H. pylori bacteria were grown on GC serum plates overnight to form a very thin film, which 
was collected and resuspended in 1 ml Brucella Broth containing 1% FCS to a final OD550 
0,1. Bacteria were left for one hour at 37°C with 10% CO2, after which DNA was added. 
After 4 hours of incubation at 37°C with 10% CO2, bacteria were collected, pulse-centrifuged 
and resuspended in 50 µl Brucella broth. The suspension was plated onto GC agar plates 
containing the antibiotic in the concentrations needed. 
2.2.1.6 Integrin β1α5 staining of H. pylori 
GFP expressing bacteria were grown on serum-free or serum complemented GC agar plates. 
For serum-free media, two passages were necessary to reduce the serum proteins still adherent 
on the bacteria. Thin grown bacteria were collected with a sterile cotton swab and 
resuspended in cold PBS (-Ca2+, -Mg2+). OD550 was measured and a 1 ml suspension OD550 
0,1 was created. In each well of a 24-well plate, cover glass slides were added. Per well 250µl 
of ice cold PBS (-Ca2+, -Mg2+) was added followed by 250 µl of the OD550 0,1 bacteria 
suspension. The bacteria were adhered to the glass slide present on the wells through 
centrifugation for 10 minutes at 4000 rpm at 4°C. Not attached bacteria were removed and 
washed with 1 ml cold PBS (+Ca2+, +Mg2+). To each well 500 µl PBS (+Ca2+, +Mg2+) were 
added as well as 3 µl of fluorescent conjugated integrinβ1α5-Alexa555. The protein and 
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bacteria were incubated in darkness one hour at 4°C. Unbound integrin and bacteria were 
removed with three washing steps using 500 µl of cold PBS . Finally, samples were fixed in 
500 µl 1X PFA solution for one hour in darkness at 4°C. Cover glass slides were washed two 
times with PBS (-Ca2+, -Mg2+) and mounted on as glass slide containing a drop of mounting 
medium (FluoprepTM). Solidification of mounting media took place at 4°C overnight. After 
sealing of the cover slides with nail polish, they were stored in darkness at 4°C until imaging 
with a Leica Confocal microscope. 
2.2.1.7 Binding of H. pylori to integrin β1α5 coated beads 
Thin growing bacteria on GC serum plates were collected in serum-free DMEM media, its 
absorbance at wavelength 550 (OD550) was measured and suspensions of 1 ml in cold serum-
free DMEM with a final OD550 0,1 were done. To each solution, 10 µg of RGD containing 
peptide were added to inhibit unspecific binding of integrin to bacteria. After addition of 5 µl 
of coated magnetic beads, the solution was shortly vortexed and placed in a magnetic field for 
five minutes. To wash unspecific binding, three wash steps were done with 1 ml serum-free 
DMEM. After the third washing, beads were resuspended in 100 µl of serum-free DMEM. 
Serial dilutions were made and plated to count the amount of bacteria adhered to the beads. 
As control for the viability of the bacteria originally used, serial dilutions were as well made 
from the original OD550 0,1 suspension. Plated samples grew at 37°C in an atmosphere 
composed of 85% N2, 10% CO2 and 5% O2. After 3-4 days, colonies were counted. Three 
colonies from each strain were chosen to grow them for further binding assays to integrin 
β1α5 coated beads. 
2.2.1.8 Induction of Cag apparatus expression for Cryo-EM 
studies 
Bacteria grown on serum GC agar plates were collected in PBS (-Ca2+, -Mg2+) and their 
OD550 estimated. Bacteria were then added to 250µl AGS cell exudates (see 2.2.3.18) to a 
final OD550 of 0,3 per ml in a 24-well and incubated for 60 to 105 minutes at 37°C with 5% 
CO2. 10 µl of the suspension were carefully taken for EM studies, keeping the rest of the 
samples for biochemical studies. 
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2.2.2  General DNA work 
2.2.2.1 DNA extraction 
Plasmid DNA was prepared depending on their following use with two different methods: the 
method from Holmes and Quigley was used for rapid screening of transformants. Qiagen prep 
kits were used for isolation of plasmids that were to be used in PCR reactions or to transfect 
eukaryotic cells. 
2.2.2.1.1 Isolation of plasmid DNA after Holmes and Quigley (Holmes and Quigley, 
1981) 
Suspected positive clones for selection were grown overnight on 1/6 of LB plates at 37°C, 
collected using a cotton swab and resuspended in 300 µl STET buffer. After adding 10 µl of a 
lysozyme solution, the samples were mixed gently by inversion and incubated in ice for no 
more than 5 minutes. To lysate the cells completely, cells were exposed one minute to 100°C. 
The cell debris, as well chromosomal DNA, was separated from the solution containing the 
plasmid DNA by centrifugation at 13000 rpm for 15 minutes. After removing the pellet with a 
sterile toothpick, 200 µl of isopropanol was added to the supernatant, mixed by inversion and 
incubated for 10 minutes at -20°C. The plasmid DNA was collected in a pellet after a 10-
minute centrifugation at 13000 rpm. To eliminate any traces of isopropanol, awashind step 
with 500 µl of a 70% Ethanol solution followed. The solution was centrifuged at 13000 rpm 
for 1 minute and all the ethanol removed. After drying the DNA pellet, it was resuspended in 
distilled water or TE buffer. 
STET 8% Sucrose, 5% Triton X-100, 50 mM EDTA, 50 mM Tris HCl 
pH 8,0. 
Lysozyme solution  10 mg/ml lysozyme in STET buffer. 
2.2.2.1.2 QIAGEN preps 
For the preparation of plasmid DNA, transformed bacteria grew for 16-20 hours at 37°C in 
TB media under constant shaking. TB components were sterile mixed shortly before 
inoculation in a proportion 1:10 (Solution 2: Solution 1). After growth, bacteria were 
centrifuged at 4000 rpm for 20 minutes at 4°C, and the supernatant discarded. Extraction of 
DNA was achieved using the mini (midi or maxi) prep kit from QIAGEN with some 
modifications. For 250 ml cultures, the Maxi-prep kit (QIAGEN) was used. The bacterial 
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culture was centrifuged at 4000 rpm for 20 minutes at 4°C. The supernatant was carefully 
discarded and the pellet resuspended in 10 ml buffer P1. Lysis was achieved adding 10 ml of 
buffer P2. The lysis reaction was neutralized with 13 ml of buffer N3. To separate bacterial 
debris from DNA suspension, the solution was centrifuged at 4000 rpm for 40 minutes 
followed by the collection of supernatant. The supernatant was added onto a pre-equilibrated 
column with QBT buffer. After the supernant has runned through the column, the column was 
washed three times with 15 ml of wash buffer. To eluate the DNA from the column, 2 ml of 
Elution buffer was added onto the column and collected.. DNA concentrations were estimated 
at OD260. 
P1 Buffer   50 mM Tris HCl pH 8, 10 mM EDTA, 100 µg/ml RNAse 
P2 Buffer   200 mM NaOH, 1% SDS 
N3 Buffer 3 M Potassium Acetate. Adjust pH with Glacial Acetic Acid to 
pH 5,5 
QBT Buffer 750 mM NaCl, 50 mM MOPS pH 7, 15% Isopropanol, 0,15% 
Triton X-100 
Wash Buffer   1 M NaCl, 50 mM MOPS pH 7, 15 % v/v Isopropanol 
Elution buffer   Tris 10 mM pH 8, 10 mM EDTA 
2.2.2.2 DNA purification and concentration 
Plasmid DNA that was used for transfection experiments was concentrated and purified using 
phenol:chlorophorm. The solution containing plasmid DNA was mixed in a proportion 1:1 
with phenol:chlorophorm solution (1:1) and vortexed (only for plasmids smaller than 10 kb). 
After centrifugation at 13000 rpm for 10 minutes at room temperature, the upper phase was 
collected and mixed with 3M sodium acetate (1/10 Volume). 9-Volumes Ethanol 100% were 
added and then mix by inversion. The resulting solution was centrifuged at 13000 rpm, 4°C 
for one minute and the supernatant discarded. The pellet was washed once with 500 µl ethanol 
90%, centrifuged again at 13000 rpm for one minute, and the ethanol discarded. The DNA 
pellet was dried and resuspended in 50 µl TE buffer. The DNA concentration was estimated 
and the DNA solution was stored at -20°C until needed. 
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2.2.3 Work with cell culture 
In general, cells grew in the optimal media and physical conditions described in previous 
publications or recommended by the ATCC (American Type Culture Collection). If not 
explained otherwise, all cells were splitted once they reached a maximum of 90% confluency. 
2.2.3.1 Cell synchronization 
Cells that were used for synchronization experiments were splitted using the PBS/EDTA 
method (see 2.2.3.2). For synchronization, 70% confluent cells were washed once with 
serum-containing media (complete media, CM). The CM was removed and cell culture media 
lacking serum (serum-free media) was added. Cells were incubated at 37°C with 5% CO2 
overnight. In the case that cells showed extreme susceptibility to this treatment, they were 
synchronized using media containing 0,1% serum for 18 hours. 
2.2.3.2 PBS /EDTA suspension of adherent cells 
To avoid extra stress on the cells or the lost of a possible receptor / interaction partner from 
the surface of the cells, adherent cells were splitted using a PBS (-Ca2+, -Mg2+) solution with 
2 mM EDTA (sterile filtrated). For a 75 cm2 bottle, cells were washed once with 10 ml of 
PBS (-Ca2+, -Mg2+), and after removal of the PBS (-Ca2+, -Mg2+), 3 ml of the PBS/EDTA 
solution was added. Cells were incubated for 10 minutes or until detachment of the cells and 
mixed with 13 ml cell media, which stopped the EDTA effect on the cells. Cells were finally 
collected by centrifugation for further work.  
PBS/EDTA   PBS (-Ca2+, -Mg2+), 2 mM EDTA 
2.2.3.3 Estimation of viable cells 
Using cells in solution, a dilution 1:10 was done in Trypan Blue solution (10 µl cell 
suspension, 90 µl Trypan blue) and 10 µl were loaded onto a Neubauer Chamber. Only cells 
in the chambers external quadrants that possessed no blue color were counted. The total 
number of cells counted was divided by 4, multiplied by the dilution factor and by the 
chamber’s factor (104) to obtain the final amount of viable cells per milliliter of suspension. 
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2.2.3.4 Fixation of cells using the “in flagrante” method 
Because of the fast fixation effect observed using this protocol, it has being named “in 
flagrante” method. Using a 10X Paraformaldehyde solution pre-warmed at 37°C, 1/10th of the 
solution was added to the samples to be fixed. Incubation for 20 minutes at room temperature 
followed. Cells were then washed with PBS (-Ca2+, -Mg2+) once and samples stored in a 1% 
PFA solution at 4°C until immunostaining. 
2.2.3.5 General proto ol for the detection of proteins on cell’s
surface using flow cytometry 
c  
Adherent cells were detached from wells using the PBS/ EDTA method and collected by 
centrifugation. For non-adherent cells, they were collected and centrifuged at maximum 300g 
for 5 minutes and the media removed. After collecting cells, pellets were resuspended gently 
using PBS (-Ca2+,-Mg2+) and washed two times to remove any traces from EDTA in the 
solution. After counting and resuspending cells to a concentration 1x106 cells/ml, the 
detection followed. In the case of detection using fluorescent-labeled primary antibodies, the 
manufacturer’s recommended concentrations were used and incubation followed for one hour 
at 4°C. If the use of a non-labeled primary antibody was necessary, it was diluted 1:1000 and 
incubated one hour at 4°C or 20°C. After washing three times, a secondary fluorescent-
labeled antibody was added using a 1:1000 dilution followed by one-hour incubation at 4°C. 
Two wash steps with PBS removed the unbound antibody. After the cells were fluorescent 
labeled, they were resuspended in 1 ml of PBS or FACS buffer and stored in ice and darkness 
until measurement. 
2.2.3.6 FACS quantification of integrin β1 levels on the 
membrane  
AGS cells were splitted in 60 mm plates using the PBS/EDTA method in a dilution 1:4 
calculating that 48 hours later they will be 100% confluent. After approx. 30 hours, cells were 
synchronized overnight. One well was fixed using the “in flagrante” method (see 2.2.3.4). 
This well represents the initial amount of integrin β1 on the surface after the synchronization. 
Media containing serum was added, and at the following time points, the same fixation 
method was used: t = 0 (2min), 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 and 120 minutes. Each 
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fixation was for one hour at 4°C store before the addition of antibody. Cells were blocked 
with an IP blocking buffer overnight at 4°C. Next day cells were washed two times with PBS 
(+Ca2+, +Mg2+) and supernatant containing primary antibody AIIB2 was added in a 
concentration 1:100 in blocking buffer for minimum 6 hours at 4°C. Antibody was removed 
and washed twice with PBS, leaving the reaction in PBS overnight at 4°C for increased 
specificity. Next day, the washing step was repeated four times, and Alexa488 conjugated anti-
Rat antibody was added in a concentration of 1:2500 for one hour at 4°C. Excess antibody 
was removed with four washing steps and cells were scrapped from the plate’s surface in 1 ml 
PBS. The cells were collected and measure their fluorescence intensity in an EPICS® XL-
MCL cell sorter (Coulter). Data obtained was analyzed using WinMDI software. By using the 
mean fluorescence from the population, curves were graphed that describe the amount of 
integrin β1 present on exposed side of the membrane at the time of fixation in a time 
dependent way. 
Blocking buffer  10% FCS (v/v) in PBS (+Ca2+, +Mg2+). 
2.2.3.7 General protocol for Immunostaining 
After the fixation of the samples by the “in flagrante” method (see 2.2.3.4), samples on glass 
coverslides were blocked overnight using 500 µl sterile blocking solution at 4°C. To remove 
the blocking solution, coverslides were washed three times with 1 ml PBS, each time for 10 
minutes. 250 µl of the blocking buffer with primary antibody (1:1000) were added for one 
hour at 37°C. To remove unbound antibody, five washing steps were repeated. After the 
primary antibody was removed, 250 µl of blocking solution containing the secondary 
antibody (1:1000) were added for one hour at 37°C. After one wash step, samples were stored 
overnight in 500 µl PBS at 4°C. Next morning two washing steps were repeated,  and the 
coverslides were mounted on glass slides using ProLong ® Gold mounting media 
(Invitrogen). After 24 hours drying at room temperature in darkness, imaging started and/or 
slides were stored at 4°C. 
Blocking solution  PBS with 10% FCS 
2.2.3.8 HL-60 differentiation 
HL-60 cells were counted, and for differentiation 1x106 cells were added to 15 ml RPMI 
media (Biochrom AG) containing 10% FCS superior (PAA), and 190 µl DMSO. After 6 days 
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of incubation at 37°C,5% CO2, cells were collected by centrifuging at 300g for five minutes, 
then resuspended in media and counted for further work. 
2.2.3.9 General Phosphotyrosine assay 
Cells were grown to a density of 70-90% depending of the cell type. Bacteria were grown 20-
24 hours on agar plates, resuspended and their OD550 measured. Knowing that a suspension of 
H. pylori bacteria OD550 0,1 represents approx. 3 x107 cfu/ml, cells were infected using a 
Multiplicity Of Infection (MOI) of 60 ( approx. 60 bacteria per cell). In case of pre-treatment 
of cells with inhibitors, media was changed and inhibitors added 30 minutes before infection 
started. Infection was done for one, two or four hours at 37°C and 5% CO2, and stopped by 
cold temperature. Supernatants were collected and stored at -20°C for later ELISA detection. 
Cells were collected in 1 ml ice cold fresh prepared PBS* using a cell scrapper and 
centrifuged at 500g and 4°C for 10 minutes. Pellets were resuspended in ice-cold RIPA buffer 
with freshly added protease inhibitors and DNAse I. To prepare the sample for detection of 
proteins, 2X SDS loading buffer was added and samples boiled in a water bath at 95°C for 10 
minutes. Proteins in the samples were separated in a 6% or 8% gel and immunoblotting was 
done using a mouse polyclonal antibody against phosphorylated proteins PY99 (1:1000) or a 
mouse monoclonal anti-Phosphotyrosine 4G10 (1:10000). Detection followed using 
peroxidase conjugated anti-mouse antibodies in a dilution 1:10000. 
PBS* PBS (+Ca2+, +Mg2+), 1 µM Sodium- Orthovanadate, 1 µM 
PMSF, 1 µM Leupeptin, 1 µM Pepstatin, 10µg/ml DNAse I 
RIPA buffer 150 mM NaCl, 1 mM EDTA, 1% (v/v) NP-40, 0,25% (w/v) 
Sodium deoxycholate, 50 mM Tris HCl pH 7,4, 1 µM Sodium- 
Orthovanadate, 1 µM PMSF, 1 µM Leupeptin, 1 µM Pepstatin, 
10 µg/ml DNAse I.  
2.2.3.10 Assay for CagA phosphorylation inhibition by integrin 
antibodies 
For this test, the general phosphorylation assay protocol was followed with some 
modifications. Cells were synchronized overnight, serum-free media removed and 1 ml CM 
added. After 30 minutes, 30 µg of antibody was added and left to bind for 30 minutes at 37°C 
in 5% CO2 conditions. Bacteria were added for a MOI 60 for one or three hours. At the end of 
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the infections, cell were collected as described before. For the evaluation of IL-8 secretion, 
only supernatants of the three hour infections were analized. 
2.2.3.11 Chemotaxis quantification through Boyden Chamber 
Assay 
Differentiated HL-60 cells (dHL-60) were infected with an MOI 5 for one hour. Cells were 
collected and 1x106 cells were added to the upper chamber of a cell culture insert with a 
membrane with 3 µm pores. After adding the chemoattractant in the lower chamber of the 
insert, incubation followed for one hour at 37°C with 5% CO2 (see figure 3-1). Cells that 
migrated were found on the bottom well and were counted using a Neubauer Chamber. To 
avoid loss of cells, since they tend to bind to the bottom surface of the well, each well was 
mixed thoroughly and carefully before each counting event. Each well was counted two 
times.  
2.2.3.12 Agarose Gel-based 2D migration Assay 
A 1,5% agarose suspension in previously CO2-saturated Buffered media was heated and 
poured onto a fibronectin-coated MatTek plate. After solidification, three wells were drilled in 
the agarose gel using capillary tubes. Plates were left for 30 minutes at 37°C with 5% CO2 for 
CO2 saturation. Differentiated HL-60 cells (dHL-60) were infected with an MOI 5 for one 
hour. Cells were collected and 5x105 cells were added to a well in the agarose gel. In the other 
wells, chemoattractants were added. Imaging was started after 15 minutes for the lapse of one 
hour. 
Buffered Media   RPMI, 10% FCS, 25 mM Hepes pH 7,4. 
2.2.3.13 Collagen Matrix 3D migration Assay 
For the formation of the 3D collagen matrix, protocol originated from P. Friedl (Friedl et al., 
1993) was followed. Differentiated HL-60 cells (dHL-60) were infected with an MOI 5 for 
one hour. Once the chamber walls were solid, the collagen matrix containing the cells was 
added and left to solidify for 30 minutes at 37°C. A second layer was added, solidified and the 
solution with chemoattractant was added. The chamber was immediately sealed and life 
imaging was done for the lapse of one hour with 20 seconds intervals at 37°C. 
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2.2.3.14 IL-8 production curves 
AGS cells were splitted in 96 well plates, each with 200 µl media. Once they reached 80% 
confluency, their media was exchanged for media alone or for media containing the bacteria 
for a final MOI of 60.Supernatants were collected at the time points indicated and stored at -
20°C until ELISA analysis. 
2.2.3.15 siRNA transfection 
Low passage AGS cells were splitted in a way that after 24 h they would have a maximum of 
20% confluency in 6-well plates. After this time, a suspension of 50 nM dsRNA coding for 
the protein target was transfected using Lipofectamine RNAi-Max. As transfection control, 
siRNA-GFP oligonucleotides (Invitrogen) were used, as well as a standard RNA 
oligonucleotide with a sequence with similar GC content to the target sequence (dsRNA GC-
Medium, Invitrogen). After two to three hours transfection, media was changed and 
transfection efficiency estimated by observation of fluorescent vesicles and/or nuclei in the 
cells. Only when the transfection efficiency was above 80%, cells were kept for the following 
experiments. After 48 hours, cells from a 6-well with same treatment were carefully detached 
using PBS/EDTA method, mixed and splitted 1:2 in 6 well plates. 60 hours after the 
transfection, cells were used for the experiments. 
2.2.3.16 Binding Protocol for integrin activation status 
In order to test the activation status of the integrins on the surface of the cells, the adhesion 
capacity to pre-coated plates was tested using the protocol of Mould et al (Mould et al., 1995) 
with some modifications. Cells grown in 75 cm2 bottles to 70-80% confluency were detached 
with 3 ml trypsin-EDTA. After cells were in suspension, 10 ml media containing 10% FCS 
was added and then transferred to a tube for centrifugation at 300g for 5 minutes. The pellet 
was washed two times with 10 ml Hepes buffer. Cells were finally resuspended in the same 
buffer and counted. 1x105 cells were used per treatment and exposed to Calcein AM for 
detection. In the case of infection, bacteria were given for a final MOI 30 or100. After 
exposure to treatments for 10 to 30 minutes at room temperature, cells were given to the pre-
warmed BSA saturated wells and left binding at 37°C for 20 to 60 minutes in 5% CO2. 
Unbound cells were washed three times and measurement done by fluorescence detection.  
Hepes Buffer  Hepes 25 mM pH 7,4 150 mM NaCl. 
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2.2.3.17 GST-fusion proteins binding to cells 
Cells with 70% - 90% confluency in a 75 cm2 bottle were detached using 2 ml trypsin EDTA, 
and collected in 10 ml RPMI serum-free media. To collect the cells, the suspension was 
centrifuged at 200g for 10 minutes, washed two times with 10 ml PBS (-Ca2+, -Mg2+), 
followed by a washing step with 5 ml of FACS buffer freshly prepared. Cells were finally 
resuspended in 1 ml FACS buffer. Viable cells were counted and 3x105 cells added to a well 
from a 96-well plate with round bottom. Cells in the 96-well plates were centrifuged at 210g 
for five minutes, their supernatant was removed and 200 µl of a FACS solution with PMSF (1 
mM, used as proteinase inhibitor to stabilize the fusion proteins during the incubation) 
containing 5-10 µg (per 1x106 cells) of the fusion protein to be tested were added per well. 
Cells were incubated at 4°C for one hour and washed four times with FACS buffer with 
PMSF, 200 µl per well. Anti-GST primary antibody was added in a dilution of 1:1000 in 
FACS buffer with PMSF and incubated for 60 minutes at 4°C. To remove unbound antibody, 
two wash steps were repeated followed by addition of anti-mouse Alexa488 secondary 
antibody (1:1000) in FACS buffer with PMSF and incubation in darkness for 45 minutes at 
room temperature. Cells were washed two times in FACS buffer with PMSF and collected in 
500 µl of FACS buffer with PMSF to be analyzed by flow cytometry. 
FACS buffer 27 mM Tris-HCl pH 7,4 , 137 mM NaCl, 2,4 mM KCl 
2.2.3.18 Production of AGS exudates 
AGS cells grown to a 70% - 90% confluency on 12-transwell membranes with 3 µm pores or 
on 75 cm2 cell culture flask were washed two to three times with PBS (-Ca2+, -Mg2+) and left 
in 500 µl or 2 ml PBS (-Ca2+, -Mg2+) for 60 minutes at 37°C with 5% CO2. The ideal time 
point to collect the exudate was determined by evaluating thechange of the PBS viscousity. 
The 2 ml exudates from the 75 cm2 flasks were collected and filtrated though a 0,22 µm pore 
membrane. The filtrated solution was used to induce the expression of the Cag apparatus for 
EM studies. 
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2.2.4  Protein work 
2.2.4.1 Protein concentration estimation 
A BSA 100 mg/ml start solution was used as standard protein concentration. 10 µl of the 
protein solution and the standards in different concentrations (0,5 – 400 µg/ml), were added to 
90 µl PBS and mixed. To this suspension, 1000 µl of Bradford solution was added, mixed and 
incubated 15 minutes at room temperature in darkness. The protein concentration was 
measured (OD595) in combination with the standard curve, to determine the concentration of 
the samples. 
Bradford Solution  0,01 % Coomassie Brilliant Blue G250, 5% Ethanol, 8,5% 
Phosphoric Acid 
2.2.4.2 Separation of proteins and blotting 
For the detection of proteins, separation of proteins based on their molecular weight was 
achieved using a SDS-Acrylamide gel.For immunodetection, the function of certain 
antibodies depends on the condition of the protein preparations. Therefore, most of the 
samples were prepared with 2X SDS buffer without β-mercaptoethanol. SDS gels (separation 
layer) containing concentrations of 6%, 8% and 12% acrylamide were prepared and left 
overnight at 4°C for full polymerization. Shortly before they were used, the 5% acrylamide 
upper gel (collection layer) was added. Samples were loaded and gels immersed in SDS 
running buffer, runned first for 10 minutes with 100V (~ 30 mA per gel), followed by 75-90 
minutes at 130V. Proteins were transfered from SDS-acrylamide gels to a PVDF membrane 
using a semidry electric transfer chamber, with a 1,2 mA/cm2 for 75 minutes, using anode I, 
anode II and cathode buffer as transfer buffers. For some gels zinc staining was done using 
the Zinc Staining kit from BioRad following the manufacturer’s instructions. Once the 
transfer to the membrane was complete, membranes were dryed and stored at 4°C or -20°C 
until immunodetection. 
SDS running buffer  250 mM Glycin, 0,1% SDS, 25 mM Tris HCl pH 8,3 
Anode buffer I  0,3 M Tris pH 10,4; 10% Methanol 
Anode buffer II   25 mM Tris pH 10,4; 10% Methanol 
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Cathode Buffer 25 mM Tris, 40 mM 6-Amino-n-Caproic acid (or glycin), 10% 
Methanol, final pH 9,4 
2.2.4.3 Immunodetection by Western Blot 
For the immunodetection, dryed membranes containing the separated proteins were immersed 
in 100% methanol for no less than 15 seconds. Once wet, the membranes were blocked with 5 
ml blocking buffer for one hour. The buffer was then exchanged for 5 ml reaction buffer 
containing the primary antibody. Incubation of the antibody followed for one to two hours at 
room temperature. The excess and unbound antibody was washed five times with wash buffer 
every 10 minutes. 5 ml of reaction buffer containing conjugated secondary antibodies 
(alkaline phosphatase or peroxidase conjugated) were added to the membrane for 45 minutes 
at room temperature. Washing steps were repeated three times followed by detection of the 
secondary antibody. In many cases, re-evaluation of results by detection of other proteins was 
necessary. For this purpose, PVDF membranes were exposed to 5 ml of 50 mM NaOH for 1-2 
hours in order to remove the antibodies. After the stripping of the membrane with the NaOH 
solution, the rest of NaOH was removed with distilled water and the immunoblot was started 
again with 5 ml of blocking buffer. A maximum of four stripping processes could be done 
without observing any damage on the proteins or membrane. 
Blocking buffer PBS, 5% Fat-free milk (powder). 
Reaction buffer 0,9% NaCl, 10 mM Tris HCl pH 7,4; 0,75% Tween 20, 1% fat-
free milk (powder) 
Wash buffer  0,9% NaCl, 10 mM Tris HCl pH 7,4; 0,75% Tween 20 
2.2.4.4 Fluorescent staining of proteins 
Proteins which were to be stained using an AlexaFluor compound, were dialyzed previously 
in 2 liters PBS (+Ca+2, +Mg+2) at 4°C minimum for two hours in order to eliminate any traces 
of Tris contained in the storage buffer. After dialysis, staining was made following the 
manufacture’s protocol (Invitrogen / Molecular probes). Conjugated proteins were store at -
20°C until their use. 
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2.2.4.5 Production of AIIB2 antibody from hybridoma cells 
Hybridoma cells were defrosted and cultivated for two days in 5 ml of DMEM media 
containing 10% FCS and glutamine (10 cm2 cell culture bottles, 5% CO2 at 37°C). All cells 
were then transferred to a 75 cm2 cell culture bottles with a final volume of 15 ml. After 3 to 4 
days, 5 ml from the cell culture were transferred to 175 cm2 bottles with a final volume of 25 
ml and left to grow until 80% of cells were non-adherent (Phenol red in media should have 
turned yellow). 20 ml of the cultures were then collected in tubes and centrifuged for 5 
minutes at 300g. The supernatant was sterile filtrated through a 0,22 µm filter and stored until 
the detection of the antibody’s production was done by Acrylamide-SDS separation and 
Coomassie Staining. For further production of antibody,  5 ml of cells resting in the bottle of 
the collected antibody were kept in culture by addition of, 20 to maximum 50 ml of media. 
The culture was incubated and the supernatant was harvested again when cells  lost adherence 
(about 7 to 10 days later). Supernatants containing the antibody were store at -20°C for long 
term and for up to 6 months on 4°C. 
2.2.4.6 Production and purification of GST fusion proteins  
Strains containing the inducible plasmid were cultivated in 10 ml LB media at 37°C 
overnight.6 ml of the overnight culture was used to inoculate a 600 ml culture, which was 
incubated for approx. 3 hours at 37°C and constant agitation at 200 rpm.. Once the bacteria 
culture reached an OD550 of 0,5,  induction was started with a final 1 µM concentration of 
IPTG. Further incubation was done at 27°C overnight under constant rotation for GST, GST-
CagYa and GST-CagYb. For the production of GST-CagA, GST-CagYc and GST-CagI 
fusion proteins only 5 hours incubation could be done, before the proteins were degraded. 
Bacteria were collected by centrifugation at 6000 rpm for 15 minutes at 4°C. The pellet was 
resuspended in cold Buffer 1. Bacteria cells were lysed using an ultrasonicator with five times 
30 pulses at 40% Output intensity, duty cycle 40% (Branson Sonifier 250) in ice-cold 
conditions. Bacteria fragments were separated from supernatant by centrifugation at 12000 
rpm for 50 minutes at 4°C. After collecting the supernatant, equilibrated glutathione-
sepharose beads were added for 20 minutes at room temperature or two hours at 4°C. Four 
washing steps followed. For this, Buffer 2 was used, with a volume corresponding to10 times 
the original beads volume. The elution buffer was added in the same volume as the original 
beads, 20 minutes incubated at room temperature, and beads separated from supernatant by 
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centrifugation for 5 minutes at 500g and 4°C. Eluted proteins were aliquoted and stored at -
20°C until their use. 
Buffer 1 PBS containing 10 mg/ml lysozyme, 2 mM EDTA, 1 mg/ml 
DNAse I, CompleteTM protease inhibitor (Roche), 1 mM PMSF.  
Buffer 2 PBS containing CompleteTM protease inhibitor (Roche), 1 mM 
PMSF.  
Elution Buffer 50 mM Tris HCl pH 8,2 – 8,7; CompleteTM, 0,1 M NaCl, 10 
mM Glutatione. 
2.2.4.7 Detection of proteins by Coomassie Staining 
After separating the proteins in the samples using Acrylamide-SDS gel, the gels were 
immersed in 40 ml of Coomassie staining solution per gel (50 cm2 gel) for 60 minutes. After 
this time, the solution was exchanged for 40 ml of Coomassie distaining solution. Exchange 
of the distaining solution occurred three times every 30 minutes until the bands were 
distinguishable from the background. Once the gels were ready, they were store in distilled 
water until they were dried for 30 minutes at 80°C in a Gel drying chamber. 
Staining Solution 0,5% (w/v) Coomassie Brilliant Blue R250, 50%(v/v) 
Methanol, 7% (v/v) Acetic Acid 
Distaining Solution 20% (v/v) Methanol, 7% (v/v) Acetic Acid  
2.2.4.8 Coating of Fluorescent Beads 
The sulphate-modified Red Fluorescent Beads (Sigma), were used following the 
manufacturer’s directions. Beads were centrifuged at 500g for 15 minutes, washed using PBS 
and resuspended in PBS 1% BSA for saturation of the beads for one hour at room temperature 
in darkness. After that time, beads were washed two times to remove excess of BSA and 
resuspended in a buffer which pH was adjusted to the calculated Isoelectric Point (IP) of the 
protein in order to be bound (Repeat I pI 4,4; and Repeat II pI 8,8). For a 25 µl original bead 
suspension, 2 µg of protein was added into 500 µl of the IP coating buffer. Incubation was 
required for one hour at room temperature in constant rotation and darkness. Unbound 
proteins were eliminated by washing the beads with the IP buffer and resuspended in the 
original volume of beads taken in IP buffer with a 0,05% of Sodium Azide. 
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IP Buffer 8,8   150 mM Tris HCl pH 8,8 
IP Buffer 4,4   50 mM  Sodium acetate pH 4,4 
2.2.4.9 Coating of Magnetic Beads 
Carboxyl modified magnetic beads from Chemicell (Berlin) were coated using the 
manufacturer’s protocol with some modifications. 10 mg particles of magnetic beads were 
washed three times with MES buffer and resuspended in 250 µl of MES buffer containing 
freshly resuspended 10 mg of CMC (1-cyclohexyl-3(2-morpholinoethyl) carbodiimide metho-
p toluensulfonate) to activate the beads. Activation took place for 10 minutes at room 
temperature under constant agitation. Beads were washed two times in MES buffer and the 
proteins intended to bind were added in a concentration of 50 µg Tris-free protein per 10 mg 
magnetic particles. A two hour incubation at room temperature was followed by two washing 
steps in 500 µl PBS and a final addition of blocking buffer with 0,05% Sodium Azide for 
storage. 
MES Buffer   0,1 M 2-(N-Morpholino)ethanesufonic acid pH 5,0 
Tris Blocking buffer  0,1 M Tris HCl pH 7,4 
BSA blocking buffer  0,1% BSA in PBS 
Tris Storage buffer  25 mM Tris HCl pH 7,4, 0,05% Sodium Azide 
BSA Storage buffer  0,1% BSA in PBS, 0,05% Sodium Azide 
2.2.4.10 In vitro phosphorylation assay 
In order to test if cells are able to phosphorylate the CagA, an in vitro phosphorylation of the 
CagA was was done using total cell lysate. The cells to be tested were grown in a 75 cm2 
bottle until they reached 90% confluency. They were collected and lysed in 50 µl of RIPA 
buffer. At the same time, a bacteria suspension of OD550 0,1 was centrifuged, concentrated 
and resuspended in 50 µl NP-40 buffer. Both lysates were mixed in proportion 1:1. To the 
mixed lysates 100 µl of phosphorylation buffer was added for a final volume of 150 µl. The 
mixture was incubated at 37°C for 30 minutes and 5X SDS loading buffer was added. The 
samples were boiled and stored at -20°C until the protein separation and immunodetection of 
phosphorylated proteins could be done. 
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RIPA buffer 150 mM NaCl, 1 mM EDTA, 1% (v/v) NP-40, 0,25% (w/v) 
Sodium deoxycholate, 50 mM Tris HCl pH 7,4, 1 µM Sodium- 
Orthovanadate, 1 µM PMSF, 1 µM Leupeptin, 1 µM Pepstatin, 
10µg/ml DNAse I.  
NP-40 Buffer 20 mM Tris HCl pH 7,5; 150 mM NaCl, 1mM Sodium 
Orthovanadate, 1% NP-40 
Phosphorylation buffer 25 mM Tris HCl pH 7,2; 40 µM ATP, 6,25 mM MnCl2, 31,25 
mM MgCl2, 62,5 µM Sodium Orthovanadate 
2.2.4.11 Extra tion of Cag apparatus proteins for integrin pull 
downs 
c
Bacteria were grown overnight on GC plates and resuspended in PBS* including 10µg/ml 
DNAse I to an OD 2. This suspension was frozen overnight. Next day it was treated with a 10 
mg/ml lysozyme solution and 4 mM EDTA for 20 minutes at room temperature. After the 20 
minutes incubation, the suspension was ultrasonicated five times with 30 pulses at 40% output 
intensity, duty cycle 40% (Branson Sonifier 250) in ice. In 2 ml aliquots, samples were 
centrifugated at 45000 rpm for 75 minutes at 4°C, acquiring the Soluble I and Pellet I. Pellet I 
was resuspended thoroughly in 1 ml cold HSL buffer with protease inhibitors and once more 
ultrasonicated until an uniform suspension was observed. This suspension was centrifuged at 
13000 rpm for 60 sec to eliminate non-resuspended particles and the supernatant (Soluble II) 
was taken for the pull downs, the pellet loading control for the immunoblot. 
PBS* PBS (+Ca+2, +Mg+2), 1 µM Sodium Orthovanadate, 1 mM 
PMSF, 1 µM Leupeptin, 1 µM Pepstatin.  
2.2.4.12 Integrin β1 interacting proteins pull downs  
In this experiments, the Soluble I and II (resulting from the protocol 2.2.4.11) were tested 
using the integrin β1α5 or integrin β1α1 coated magnetic beads. To each 2 ml initial Soluble I 
or II solutions prepared, 5 µl of the magnetic coated beads were added at 4°C for 45-60 
minutes. To remove the unspecific binding proteins, three washes followed using 500 µl HSL 
300/400, each time recovering the beads by use of a magnet. After the third washing step, all 
washing buffer was carefully removed. Magnetic beads were resuspended in 12 µl of 
Resuspension Buffer, and a equal volume of 2X SDS loading buffer was added. Samples were 
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boiled for 10 minutes at 95°C. For analysis of the interacting proteins, the samples were 
loaded onto 8% and 12% Acrylamide-SDS gels using the protocols described before.  
HSL buffer 25mM Tris HCl pH 7,4; 0,05% Triton X-100, 4 mM MgCl2, 3 
mM MnCl2, 150 mM NaCl, 1 mM PMSF. 
HSL 300 buffer 25mM Tris HCl pH 7,4; 0,05% Triton X-100, 4 mM MgCl2, 3 
mM MnCl2, 300 mM NaCl  1mM PMSF 
HSL 400 buffer 25mM Tris HCl pH 7,4; 0,05% Triton X-100, 4 mM MgCl2, 3 
mM MnCl2, 400 mM NaCl, 1 mM PMSF 
2.2.4.13 Detection of IL-8 production 
Using an Enzyme-linked Immunosorbent Assay (ELISA) as immunodetection system, 
concentrations of IL-8 produced by AGS cells during infection assays were detected. 
Immunoadsorbent 96-well plates (Nunc) were coated overnight with 30 µl of anti-IL-8 
coating antibody (0,5 mg/ml) in 5 ml coating buffer, with 50 µl per well, at 4°C. Excess of 
antibody was washed three times using 200 µl wash buffer. Surfaces were blocked using 100 
µl of blocking buffer for one hour at 37°C. Two washing steps were repeated. Standards and 
samples were added for a final volume of 100 µl per well and incubated for minimum three 
hours at 37°C. To remove unbound antigen, six wash steps were done. To detect the bound 
IL-8, 100 µl per well of a solution containing the monoclonal anti IL-8 biotinylated antibody 
(0,5 mg/ml) in wash buffer with 10% FCS were added. The biotynilated antibody (detection 
antibody) was incubated one hour at room temperature, washed six times and a streptavidin-
peroxidase complex in ELISA buffer was added for one hour at room temperature. After six 
washes, TMB substrate for detection of peroxidase activity was added and the reaction was 
stopped after 30 minutes with 50 µl of the stop solution. The colorimetric reaction was 
measured using a wavelength of 450 nm with subtraction of a 570 nm wavelength in a Tecan 
Sunrise ELISA plate reader. Data analysis was done using Magellan 3 Software. 
Coating buffer  50 mM Sodium Carbonate pH 9,6 
Wash buffer   PBS (+Ca2+, +Mg2+), 0,05% Tween 20 
Blocking buffer  PBS (+Ca2+, +Mg2+) 10% FCS 
ELISA buffer   50 mM Tris HCl pH 7,6 
Stop solution   1M H2SO4 
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3 Results 
3.1 Cag T4SS interaction with Eukaryotic cells 
Helicobacter pylori (H. pylori) presents a Type IV Secretion System (T4SS) denominated 
Cag that translocates the CagA protein into eukaryotic cells. The CagA protein contains 
EPIYA motifs at its C-terminal half that are phosphorylated at their tyrosine (Y) aminoacids 
upon entrance in the cytoplasmic compartment of the eukaryotic cell. The phosphorylation is 
catalyzed by members of the Src kinase family. Using this characteristic of CagA, the 
function of the T4SS is measured in assays were tyrosine phosphorylated proteins are 
detected by immunoblotting. In this way, the phosphorylated CagA is visualized and an 
effective CagA translocation confirmed. The following experiments detect the proper Cag 
T4SS operation through the detection of the phosphorylated CagA protein. 
3.1.1 Effects of CagA on migration of dHL-60 cells 
HL-60 cells are a pro-myelocytic leukemia cancer cell line, which has been extensively 
studied and used in laboratories since 1990. These cells are known to possess the capacity to 
differentiate in cells similar to the monocytic or the granulocytic cell lines depending on the 
stimuli used. In the presence of 1,3% DMSO for 5 to 6 days, HL-60 cells turn into cells 
showing characteristics typical for neutrophils, including the ability to migrate towards a 
chemoattractant.This ability is termed chemotaxis. 
In the immune system, the ability of the cells to respond to a stimulus and, therefore, migrate 
towards a chemoattractant is essential for their proper operation. Here it was examined if H. 
pylori CagA or the Cag apparatus have an effect on migration of immune cells.As model cell 
line, the dHL-60 were used as neutrophil-like cells. 
3.1.1.1 CagA inhibits the dHL-60 response to chemoattractants 
(Chemotaxis) 
DMSO differentiated HL-60 (dHL-60) cells are defined as the closest cell culture model to 
study and to define the characteristics and requirements of neutrophils motility as a response 
to chemoattractants. In order to evaluate an effect of the Cag apparatus and its effector protein 
CagA on chemotaxis, infections were carried out using the H. pylori P12 strain and its mutant 
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strains, P12∆cagA and P12∆PAI. The effect of the Cag apparatus and/or CagA on the cells 
was measured by the capacity of the cells to migrate through a membrane towards a 
chemoattractant. As chemoattractant fMLP (formyl-Methionine-Leucine-Phenylalanine) was 
used. fMLP is a by-product of protein synthesis in prokaryotic cells. Its presence is detected 
by immune cells through the fMLP-receptor (Fechheimer and Zigmond, 1983). For the 
evaluation of possible effects on migration, cells were infected for one hour with an MOI 
(Multiplicity of Infection) of 5 (approx. 5 bacteria per eukaryotic cell) and placed on the top 
compartment of a Boyden Chamber containing a basal membrane with 3 µm pores. Their 
ability to move through the membrane for one hour as a response to the chemoattractant 
found on the lower chamber was measured by counting the number of cells found on the 
bottom compartment using a Neubauer chamber (Figure 3-1). 
 
Figure 3-1 Boyden Chamber Migration assay 
Schematic of Boyden Chamber used to calculate the migration capacity of differentiated HL-60 cells (dHL-
60) toward a chemoattactant after 1-hour infection with Helicobacter pylori P12 wild strains and mutants 
As seen in figure 3-2A, only for those infections where CagA protein was present, there was a 
reduction in the number of cells that were able to cross the membrane and migrate towards the 
lower chamber containing the chemoattractant. To ensure that the effect seen here is 
independent of the fMLP chemoattractant and its receptor, IL-8 was used next as 
chemoattractant. Here the same effect of the CagA is present (Figure 3-2B). Cytochalasin D, 
as Actin cytoskeleton inhibitor, served as control for migration. From the results of these 
experiments, it can be concluded that motility of dHL-60 cells is significantly reduced by the 
presence of the CagA protein, but no significant effect seems to be caused by other proteins 
from the apparatus. 
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Figure 3-2 Effects of CagA and Cag apparatus on motility 
Migration of dHL-60 cells after one hour infection with P12 wild type strains, P12∆cagA, and P12 ∆PAI 
(MOI 5), towards (A) fMLP (formyl-Methionine-Leucine-Phenylalanine, 20 pM) and (B) IL-8 (8 µg/ml). 
CytD, Cytochalasin D. The graphics represent the percentage of migrated cells relative to uninfected dHL-
60 cells (Control). Statistical analysis using t Test. * P<0.05, ** P<0,01, ***P< 0,005. NS, no significance 
3.1.1.2 Migration deficiency caused by CagA 
The CagA protein has an effect on migration of the dHL-60 cells, by reducing their capacity 
to move across a membrane. Since the motility of cells is the result of several synchronized 
processes tightly interacting with each other, more information can be gathered to assess the 
CagA’s mechanism of action by evaluating themotility related changes of the cell caused by 
CagA. 
To date the morphology of cells that takes place during motion in direction to a stimulus has 
been very well described (Gomez-Mouton et al., 2001; Heit et al., 2002; Meili and Firtel, 
2003; Muller, 2003; Srinivasan et al., 2003; Van Haastert and Devreotes, 2004; Xu et al., 
2003). Previously, a reduction of motility was quantified. A better definition of the effect 
caused by CagA on the cells can be evaluated by observing the characteristics of movement 
with help of live cell imaging. For this purpose, the movements of the cells in two different 
systems were compared. The first one, using an agarose test, simulates the 2D movement 
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described already for dHL-60 chemotactic motility. The second one, using a collagen matrix, 
evaluates their morphology and movement simulating a 3D system, similar to the conditions 
found in the animal tissue. 
3.1.1.2.1  “2D” migration (Agarose Assay) 
In the agarose assay, the cells must migrate between fibronectin covered glass and an agarose 
layer towards a chemoattractant, in this case fMLP. Cells do not show any affinity or binding 
capacity to agarose. Therefore, they are forced to move using only the fibronectin as 
anchoring point and by doing so, migrating on a two-dimensional system. After the glass 
surface of the MatTek plates was covered with human fibronectin, a 1,5% (w/v) solution of 
agarose was poured onto the plate and left to solidify. Once solid, by use of capillary tubes, 
small wells were perforated into the agarose gel. In one well fMLP was added and in the 
others the cells (uninfected or infected), which started moving once they sensed the 
chemoattractant. In order to allow cells to enter the space between glass and agarose, the 
imaging was started after 15 minutes after the addition in the wells and continued exposures 
with 20 s delays for 60 to 120 minutes in phase contrast were taken. In all experiments the H. 
pylori P12 wild type (w+) strains and their ∆cagA mutant were used, a “barrier” of bacteria 
was seen between dHL-60 and chemoattractant, as if the bacteria were attracted to it and they 
moved faster towards it. This barrier presented itself as a problem since it restricted the 
movement of dHL-60 cells as a response to the chemoattractant gradient (data not shown). 
 
Figure 3-3 Effect of Cag on migration of cells in a 2D system 
Phase contrast images of dHL-60 cells uninfected (control) and infected with P12 Wild type (MOI 5) 
migrating towards fMLP in an agarose system. Lower picture defines the morphology of typical leukocyte-
like migrating cells. 
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However, in the transition between well and agarose, it was observed that dHL-60 cells were 
able to enter space between agarose and fibronectin coated glass independent of the treatment. 
As seen in figure 3-3, control cells and cells infected with P12 wild type produced a migration 
front, or lamellipodia, and a migration tail, or Uropod. Even though there seems to be some 
morphology differences, the Cag apparatus or CagA does not inhibit the polarization of the 
cells that is normally displayed by cells during migration.  
3.1.1.2.2 3D migration (Collagen Matrix Assay) 
Immune cells can find the place where they are needed by migration toward a stimulus. This 
migration includes getting out of the circulatory system through or between the endothelial 
cells of the veins, arteries and capillaries (called diapedesis). Once on the other side of the 
endothelial cells, migration occurs through the space between cells and tissues (interstitial 
space). In 1993, Friedl et al published a new design of an in vitro system in which the cells 
were suspended in a Collagen matrix, having the possibility to move through it in a three 
dimensional system. In these experiments, new phenotypes were described for cells during 
their migration through the 3D-Collagen matrix. Because of the limitations encountered using 
the 2D agarose system, the collagen matrix offered a possibility to observe the motility of the 
cells and the effects of CagA on it. 
For the collagen matrix assay, dHL-60 cells were collected and infected as described for the 
experiments in 2D Agarose system. From this suspension, cells were added to the Collagen 
matrix mix and left to solidify followed by an addition of a chemoattractant, sealing of the 
chamber and taking pictures in the microscope (Microscope DM IRB, Leica), at 37°C for a  
minimum of one hour with 20 seconds intervals. Because the matrix is between 2-3 mm thick, 
only planes were imaged where cells showed any migration characteristic (Lamellipodia and 
uropod). Control cells (Figure 3-4A) showed a defined movement with a migration front and 
uropod retraction. Contrary to these results, H. pylori P12 wild type infected cells were not 
able to form neither front nor uropod, maintaining a spherical form (Figure 3-4B). In the case 
of P12 ∆cagA infections, some of the cells were not able to form an active migration front or 
lamellipodia, but the majority had a similar morphology seen in the control cells. However, 
their movements seemed slow and erratic (Figure 3-4C). P12 ∆cagPAI infected cells showed 
a morphology and movement similar to uninfected cells (Figure 3-4D). 
These results confirm the inhibitory effect on migration when cells are infected with P12 Wild 
type. The presence of CagA in 3D collagen matrix conditions shows that inhibition does not 
act on the coordination between processes of formation of lamellipodia and retraction of 
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uropod, it shows that a previous event is blocked, since cells are not able to even adhere to the 
collagen fibers. Using CagA (-) strains only slowed down the migration of the cells in the 
collagen matrix but did not inhibit neither the formation of lamellipodia nor the uropod 
formation and retraction.  
 
Figure 3-4 Migration of dHL-60 in a collagen matrix (next pages) 
Images from Live Imaging experiments recording the movement of dHL-60 cells (A) uninfected (Control) 
or (B) infected with P12 wild type strains, or mutants lacking  (C) cagA (P12∆cagA) or  (D) the entire 
CagPAI (P12 ∆PAI). Time lapse between each picture is 2 minute 40 seconds (160 seconds). 
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3.1.2 Integrin β1 is essential for CagA translocation 
In the previous motility studies, differences were observed between the parental cell line HL-
60 and the DMSO differentiated HL-60 (dHL-60) in their capacity to phosphorylate CagA 
(CagA-P) (data not shown). To confirm that this effect was not strain specific, two other H. 
pylori wild type strains, which contain a functional Cag apparatus, P217 and P145, were 
tested as well. In these experiments, the same results were observed: massive reduction of the 
CagA-P when bacteria infected dHL-60 cells in comparison to the HL-60 cells (Figure 3-5A). 
By an in vitro phosphorylation assay, in which bacteria and cell lysates are mixed, it could be 
confirmed that both cell lines contained the kinases necessary to phosphorylate CagA (data 
not shown). This suggested that the inability of dHL-60 cells for CagA phosphorylation might 
be a result of the interaction of the Cag T4SS with the host cell membrane. 
 
Figure 3-5 HL-60 and dHL-60 differences and integrin relations to CagA translocation 
(A) Differences in CagA phosphorylation (CagA-P) in HL-60 and DMSO differentiated HL-60 (dHL-60) 
cells. Western blot detecting phosphorylated CagA (CagA-P) using antibody anti-phosphotyrosine (PY99) 
and anti-CagA antibody (AK257) after a 4-hour infection with MOI 60. (B) Effect of integrin β2 on CagA 
phosphorylation. Western blot detection of CagA-P in cells with integrin β2 (SK W3) and their integrin β2 
knockout form (SKβ 2.7) after a 4-hour infection with MOI 60 (strains P217, P12 and P145). Jurkat cells 
were included as control for lymphocyte lineage. (C) Expression levels of integrin β1 and integrin β2 on 
HL-60 and dHL-60 (dHL-60). Flow cytometry from HL-60 and dHL-60 cells labeled with anti-integrin β2 
(αCD18-PE) and anti-integrin β1 (αCD29 FITC). For each cell line, a control background was evaluated. 
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Taking advantage of the great amount of genomic and proteomic data available for these cells, 
a specific search for differences in membrane proteins that appear after the differentiation was 
performed (Hauert et al., 2002; Itoh et al., 1998; Okubo et al., 1995; Yanagida et al., 2007). 
Expression differences were found on two members of the integrin family, integrin β1 (CD29, 
ITGB1) and integrin β2 (CD18, ITGB2). The first step was to confirm the expression levels 
of both integrin proteins on the different cells using immunofluorescence and flow cytometry. 
By flow cytometry analysis it was confirmed that integrin β2 is absent in HL-60, but present 
in dHL-60. This correlates with already published data (Collins et al., 1979; Itoh et al., 1998). 
In the case of integrin β1, a higher level was observed on the surface of the non-differentiated 
cells compared to the differentiated ones (Figure 3-5C). 
The possibility that the presence of the integrin β2 subunit could have a negative effect on the 
translocation and phosphorylation of CagA was tested using the T-lymphocytic cell line 
SKW3 and their corresponding integrin β2 knockout part, SKβ 2.7. Jurkat cells were used 
here as positive control cell line of lymphoid origin. After infection of these cells, their 
tyrosine-phosphorylated proteins were detected using immunoblots. As seen in Figure 3-5B, 
there is no difference in CagA-P levels in knockout cells compared with the ones expressing 
integrin β2. With this result, any involvement or negative effect of integrin β2 in CagA 
translocation could be excluded.  
In HL-60 cells higher levels of CagA-P correlate with higher amounts of integrin β1 present 
on the surface of these cells. To confirm the relevance of integrin β1, a different approach was 
necessary. For this, integrin β1 knockout (KO) cell lines GD25 and GE11 were tested, using 
as control the corresponding integrin β1 complemented cells, GD25β (mouse integrin β1) and 
GE11β (human integrin β1), respectively. After infection of the cells under standard 
conditions (MOI 60, 4 hours, 37°C, 5% CO2) using the P217 strain, CagA-PP217 was detected 
using the same procedure as described before. The immunodetection of tyrosine-
phosphorylated proteins shows that CagA-P from strain P217 is present only in infections of 
integrin β1 complemented cells but not on the knockout counterparts (Figure 3-6A). 
As explained before, phosphorylation of translocated CagA is catalyzed by Src kinase family 
members. Since integrins are important for membrane signalling processes in the cell, the 
possibility existed that knockout cells had a deficit in the recruitment of Src kinases to the 
translocation site producing a false negative result. To rule this out, a P12 strain expressing a 
CagA protein containing a N-terminal GSK tag was used for infection of the integrin β1 
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knockout cell lines (GD25 and GE11) and their integrin complemented versions (GD25β and 
GE11β). The function of a GSK tag is to confirm the translocation of proteins into the 
cytoplasm by using a threonine/serine phosphorylation of the tag as read out (Pattis et al., 
2007). This method gives an alternative phosphorylation site on the protein that is Src-kinase 
independent. Using the GSK-tagged CagA (GSK-CagA), infections were done and the 
phosphorylated tag was detected using an antibody against phospho-GSK in immunoblots. It 
was confirmed that GSK-CagA was GSK-phosphorylated only in infections where the cells 
expressed integrin β1. It was verified that the data previously observed with the normal CagA 
tyrosine phosphorylation (Figure 3-6B) were not a consequence of a defective recruitment or 
function of Src kinases related to the integrin β1 knockout condition of the cells. Any possible 
false negative results were discarded. 
 
Figure 3-6 Integrin β1 dependent CagA phosphorylation in different cell lines 
(A) CagA translocation and tyrosine phosphorylation in integrin β1 knockout cells (GE11 and GD25) and 
their integrin β1 complemented forms (GE11β and GD25β). Western blots detecting CagA-P from strain 
P217 after 4 hours infection with a MOI 60. Full arrowhead shows phosphorylated form of CagA detected 
using anti-phosphotyrosine antibody (PY99). Empty arrowhead shows bands corresponding to CagA 
detected using anti-CagA antibody (AK257). (B) Phosphorylation of GSK-CagA protein in integrin 
knockout cells and their integrin β1 complemented forms. Detection of phospho-GSK tag after 4-hour 
infections of AGS, GE11, GE11β, GD25 and GD25β cells with a P12 strain expressing a CagA-GSK 
protein at MOI 60. 
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In all these different experiments, the relevance of the integrin β1 for the CagA translocation 
was recognized, concluding that integrin β1 plays an essential role for the translocation of 
CagA into the cells. Additionally, they show that this role appears to be independent of mouse 
or human origin of the integrin β1.  
3.1.3 CagA translocation efficiency correlates with the presence of 
integrin β1 on the surface 
3.1.3.1 Integrin β1 is expressed on the surface of AGS cells in a 
cyclic manner 
With the intent to confirm the connection of integrin β1 expression on the membrane of cells 
and the capacity of the bacteria to translocate CagA, the amount of integrin β1 expressed on 
the surface of synchronized adherent AGS cells was measured. The purpose of 
synchronization is to arrest all cells in G0 of the cell cycle, start the experiments at a known 
time point of the cells’ metabolism and analyze them as a uniform population. For 
synchronization, cells grown to 70% confluency were left in serum-free media overnight. To 
these cells, CO2 saturated warm media containing serum (Complete Media, CM) was added. 
After the addition of CM media, cells were fixed at the time points indicated (0, 2, 10, 20, 30, 
40, 50, 60, 70, 80, 90, 100 minutes) using the “in flagrante” method, in which cells are fixed 
instantly by addition of a pre-warmed concentrated form of paraformaldehyde. Fixation was 
followed by detection with primary antibodies against integrin β1 (Clone AIIB2). The 
labeling of the primary antibody was achieved by use of an anti-rat IgG Alexa488 secondary 
antibody for flow cytometry analysis. By labeling directly on the original growth surface of 
the well, only the exposed integrin β1 on the surface of the cells was detected. Before cells 
were analyzed by flow cytometry, they were carefully scrapped and collected in 1 ml PBS. 
The acquired data was evaluated using WinMDI software. The mean peak of fluorescence of 
the cell population for each time point was determined. In figure 3-7A an example curve is 
illustrated. In this figure includes as well an overview of the protocol followed. As depicted in 
the curve, approximately two minutes after addition of serum containing media, integrin β1 
levels on the membrane were slightly reduced. After that, the integrin β1 levels on the surface 
were relatively stable until 40 minutes after the addition of the serum-media. At this time 
point, an exponential increase of integrin β1 on the surface takes place, reaching a peak at 
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approximately 60 minutes. Between time points 60 and 80 minutes, these levels are again 
reduced until a baseline point similar (or sometimes lower) as the one found on cells after 
synchronization (time point 0). This process repeats itself with a periodicity of about 60 
minutes for cells in low passage, and it shortens as the cells accelerate their reproduction time 
at high passage number (data not shown). 
 
Figure 3-7 Dynamics of integrin β1 surface location and effect on H. pylori CagA translocation 
(A) Integrin β1 cycle on AGS cells. Scheme of protocol used to determine integrin β1 presence on AGS 
cells’ surface in relation with time. Curve represents the variations on integrin β1 surface presence after 
synchronization and addition of serum containing media. Antibody clone AIIB2 was used for the detection 
of whole integrin β1 population. Analysis using flow cytometry detection and calculated the mean 
fluorescence for each time point. Curve here is representative of three independent experiments. (B) Time 
points of infection of AGS cells with first and/or second strain. All infections took place for one hour after 
addition of the second strain. (C) Western blots detecting levels of CagA phosphorylation at time point 0 and 
60 after serum addition. Strains used were P12 and P217 with an MOI 60. Phosphorylated CagA (CagA-P) 
detected using anti-phosphotyrosine antibody PY99, CagA levels using anti-CagA (CagA) antibody AK257 
and to confirm comparable amount of cellular proteins an anti-integrin β1 (β1) antibody (Clone LM534) was 
used. 
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By establishing that the integrin β1 expression on the surface of the AGS cells is cyclic and 
can be coordinated for a maximum expression on the surface of the cells, it makes possible to 
determine the ideal time point for an evaluation of the relation of integrin β1 on CagA 
phosphorylation. 
3.1.3.2 CagA translocation and phosphorylation in relation to 
integrin β1 membrane expression levels 
Knowing the time points where to expect the maximum or minimum amount of integrin β1 on 
the surface of AGS cells, infections were done using two wild type strains, P12 and P217. 
Since both contain CagA proteins of different size, co-infections were made to evaluate a 
strain independent effect. Figures 3-7B explains the infection protocol. The results of the 
infection seen on figure 3-7C give an idea about the connection of the integrin β1 presence on 
the surface and the CagA-P levelsAt time point zero cells were infected for one hour with the 
two strains. In this time lapse (0-60 minutes), the cells express their minimum amount of 
integrin β1 on the surface for the time of infection. As seen in the immunoblots detecting 
phosphorylated CagA, the amount of CagA-P is lower as compared to infections of cells 
expressing the highest amounts of integrin β1 on the surface at the initial time point of 
infection (time 60). The effect is independent of the bacterial strains and the co-infection 
conditions (Figure 3-6 C, lanes 2 vs. 6, and 3, 4 vs. 8, 9). For infections where the initial time 
point was 0, it is necessary that approx. 120 minutes passed to obtain similar CagA-P levels as 
obtained after 60 minutes in infections were the initial time point was 60 (Figure 3-6 C lanes 
4, 5 vs. lanes 8, 9). This data supports a direct connection between the amount of integrin β1 
on the cellular surface of AGS and the efficiency of CagA translocation/phosphorylation. 
3.1.4 Relevance of integrin β1 extracellular activation and its 
cytoplasmic domain for CagA translocation 
3.1.4.1 Only the extracellular part of integrin β1 is necessary 
for CagA translocation 
The principal characteristic of integrins is their inside-out signaling, achieved by the 
connection between their extracellular domain and cytoplasmic domain (Arnaout et al., 2005). 
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In order to elucidate if this property of the integrins is relevant for the CagA translocation, 
cells expressing full human integrin β1 (Isoform A) as well as its truncated forms in its 
cytoplasmic tail were tested. CHO-K1 cells, which are Chinese Hamster Ovary cells, were 
shown to be negative for CagA translocation. Therefore, expression from the different forms 
of human integrin β1 in these cells was used to evaluate their relevance in CagA 
translocation. As described in figure 3-8A, CHO-β1A contained the full version of human 
integrin β1 (Isoform A). CHO β1com expresses the integrin β1 form containing only the 
domain denominated “integrin common region” (com) found in the cytoplasmic part. CHO-
β1TR does not present any part of the cytoplasmic tail. It contains only the transmembrane 
and extracellular domain (Retta et al., 1998). For the infections, P12 and P217 wild type 
strains were used under standard infection conditions. 
 
Figure 3-8 Effect of integrin β1 cytoplasmic tail and integrin β1 signaling on CagA translocation 
(A) Immunodetection of phosphorylated CagA after infection with strains P12 and P217 of AGS cells 
(Positive Control), CHO-K1 (Negative control) and cells expressing the full integrin β1A protein, and cells 
expressing the cytoplasmic truncated forms β1com and integrin β1TR. The variations on cytoplasmic 
domain of the integrin β1 proteins are illustrated. Full arrowheads shows phosphorylated CagA form 
detected using Anti-phosphotyrosine (PY99) antibody. Empty arrowhead shows bands corresponding to 
CagA detected using antibody AK257. (B) ILK role in CagA translocation and phosphorylation. 
Immunoblots detecting levels of ILK on normal AGS cells and AGS cells transfected with siRNA against 
ILK mRNA. Strains used for a 3-hour infection were P12, P217 and P145. Full arrowheads shows 
phosphorylated CagA and empty arrowheads shows phosphorylated cellular proteins. Tubulin detection was 
used as marker to compare the total amount of cellular proteins. 
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After infection of the different CHO cell lines, the immunodetection of their phosphorylated 
CagA proteins revealed that both strains were able to translocate CagA in CHO expressing the 
complete version of human integrin β1A (CHO-β1A). Surprisingly the same result was 
obtained in cells expressing the truncated forms of integrin β1: β1A COM and β1 TR, both of 
them missing parts of their cytoplasmic domain but presenting the extracellular part of the 
integrin β1 on the surface of the cells (see Figure 3-8A). These results indicate that the 
cytoplasmic domain of the human integrin β1 is not essential for CagA translocation. The 
extracellular and transmembrane domains are enough for the Cag apparatus to translocate 
CagA into eukaryotic cells. 
3.1.4.2 Integrin β1 cytoplasmic signaling is not required for 
CagA phosphorylation 
After having shown that the cytoplasmic part of the integrin β1 does not play a role in CagA 
translocation, it can be expected that integrin β1 signaling will show no relevance on the 
efficiency of CagA translocation. Part of the integrin signaling occurs through changes 
transmitted from the extracellular part to the intracellular part causing modifications that 
induce the interaction of the cytoplasmic tail of integrin β1 with other cytoplasmic proteins. 
Some of the proteins known to be part of this intracellular signaling are the Focal Adhesion 
Kinase (FAK) and the Integrin-linked Kinase (ILK) (Hsia et al., 2003; Legate et al., 2006). 
FAK is a protein tyrosine kinase involved in the formation of focal adhesions that link the 
integrin β1 with the cytoskeleton (Delon and Brown, 2007; Liu et al., 2000). The 
serine/threonine kinase ILK interacts directly with the cytoplasmic region of the integrin β1 
regulating integrin β1-mediated signal transduction (Wang et al., 2006). An indirect approach 
was taken to confirm the previous results. In our first approach, AGS cells were transiently 
transfected with a construct for expression of the dominant negative (DN) form, green 
fluorescent fusion protein (GFP), of FAK (FRNK-GFP). The expression of the protein was 
confirmed after 24 hours by fluorescence microscopy. However, transfected cells were not 
able to survive after 36 hours of transfection, which is the time recommended for an 
evaluation of the FAK. This cytotoxic effect left not enough material for a reliable 
phosphorylation assay. Since ILK is involved with the integrin β1 as well, a reduction of ILK 
expression levels was achieved using siRNA in AGS cells. With an approx. 99% transfection 
efficiency of the siRNA sequence, cells were grown 60 hours. Their ILK levels were reduced 
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between 71-76% as measured on immunoblots using a densitometer software analysis. Lower 
levels of ILK expression were reached around 72 hours after the transfection, were 
accompanied with high lethality as well. Therefore, infections were done after 60 hours of 
transfection for four hours with H. pylori strain P12. As seen in figure 3-8B, even though the 
levels of ILK were reduced almost to 20% of its original levels, CagA-P levels were not 
affected by this reduction. In agreement with the results previously discussed, CagA 
translocation needs only the extracellular part of the integrin β1, neither its cytoplasmic 
domain, nor its pathway linked to the ILK activity. 
3.1.4.3 The activation status of the integrin β1 alters the CagA 
translocation efficiency 
3.1.4.3.1 Bivalent cations effect 
The activation status of integrins can be altered by extracellular changes on the concentration 
of divalent cations such as calcium or magnesium. It has been published that high 
concentrations of calcium work as antagonist of the adhesion properties, and magnesium as 
agonist (Mould et al., 1995). Because the effect caused by Mg2+ can be drastically magnified 
by use of Mn2+ at very low concentrations, Mn2+ was preferred. To test the effects of the 
activation status in the CagA translocation, 80% confluent cells were washed three times with 
PBS (-Ca+2, -Mg+2) and media containing serum and glutamine (Complete Media, CM) was 
added. 10 mM CaCl2 or 1 mM MnCl2 concentrations were added to the cells for 30 minutes 
pre-incubation. Infection with P12 wild strains followed for one, three and four hours. After 
detecting the CagA-P levels through immunoblotting of the infected cells lysates, CagA 
phosphorylation did not change with Mn2+ after four-hour infections (data not shown). 
However, it increased the CagA translocation after one-hour infections (Figure 3-9B). 
Calcium behaved differently. It decreased the levels of CagA-P after four hours (data not 
shown).  
To rule out a direct effect of calcium on the bacteria, suspensions in warm RPMI complete 
media saturated with CO2 of P12 and P12 mutant lacking the cagE gene of the Cag apparatus 
(P12 ∆cagE) were exposed to 5 mM and 10 mM concentrations of CaCl2 for four hours in 
10% CO2. After collecting the bacteria by centrifugation, they were lysed and their proteins 
separated in an SDS-Acrylamide gel and blotted for immunoanalysis by detection of the 
CagA protein using anti-CagA (AK257) antibody. As seen in figure 3-9A, an inverse effect 
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on CagA concentrations in the lysate was detected in relation to the concentration of 
calcium.Therefore,  an inhibitory effect of calcium on the CagA concentrations in the bacteria 
cell took place. Because of these results, the initial experiments to evaluate the calcium effect 
on phosphorylation of CagA were repeated with an one-hour infection only. In this case, no 
difference was seen in the levels of CagA-P (data not shown). By using the extracellular bi- 
and trivalent metal ions chelator EDTA at final concentrations of 2 mM, no effect was 
observed on the CagA-P levels. However in experiments where cells were pre-incubated with 
BAPTA, a cell permeable calcium-specific chelator, and infected for one or three hours with 
three wild type strains ( P12, P217 and P145), a strong reduction of CagA-P levels was 
observed in a strain specific manner (Figure 3-9C and Table 3-1). Thus, activation of integrins 
by MnCl2 at 1 mM concentration increases the CagA translocation and phosphorylation after 
one-hour infection. In the case of calcium, it seems to alter the efficiency of CagA 
translocation only when it is sequestered from the intracellular compartments. However no 
effects on CagA translocation were visible by low levels in the extracellular milieu. 
 
Figure 3-9 Effect of bivalent cations on CagA levels and CagA phosphorylation 
(A) P12 wild type and P12∆cagE OD 0,1 in RPMI media incubated 4 hours with different concentrations of 
calcium chloride. CagA levels detected using antibody AK257. (B) Effect of MnCl2 in CagA 
phosphorylation. AGS cells with 1 mM MnCl2 were infected for one hour with strain P12. Western blots 
indicate CagA-P levels with or without MnCl2. Full arrowheads show phosphorylated form of CagA 
detected using anti-phosphotyrosine antibody PY99. Empty arrowhead show bands corresponding to CagA 
detected using anti-CagA antibody AK257. (C) Effects of BAPTA on CagA phosphorylation. AGS cells 
pre-incubated 30 minutes in a 60µM solution with BAPTA and infected with P12, P217 and P145. Full 
arrowheads show phosphorylated form of CagA detected using anti-phosphotyrosine antibody PY99. Empty 
arrowheads show bands corresponding to CagA detected using anti-CagA antibody AK257. Infections with 
MOI 60. 
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Table 3-1 Ligands or inhibitors of cell’s cytoskeleton or integrin signaling and their effect on CagA 
translocation. 
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3.1.4.3.2 Integrin β1 specific antibodies involved in activation or deactivation status 
of integrins  
In other studies, antibodies that activated or inactivated the integrin β1 subunit were described 
(Bazzoni et al., 1995; Favre et al., 1992; Lenter et al., 1993; Mould et al., 1997). Antibodies 
showing these regulatory effects are able to bind to a region on the integrin β1 denominated I-
like domain. Two antibodies that bind to this region were tested in our infection conditions. 
These antibodies are 12G10, which binds to activated integrin β1, as well as AIIB2, that 
inactivates the integrin β1. Once the antibodies were added to the cells for 30 minutes at 
37°C, the infection took place with an MOI 60. In these experiments, no effect was seen in the 
levels of CagA-P after four hours. Since membrane proteins, including integrins, are 
constantly recycled; thepossibility that these processes could remove most of the antibodies 
from the membrane before the infection occurred were very high. In order to diminish 
membrane recycling, incubation of cells with antibodies was done under 4°C conditions for 
one hour or at room temperature for 30 minutes with 30 µg of antibodies, followed by 
infection at 37°C with 5% CO2 for one or three hours. Again, no effect was seen in the CagA-
P levels (data not shown). However, after long exposure of the AGS cells to the AIIB2 
antibody, the cells were not able to adhere anymore to the surface of the well, which 
corresponds to the inactivating effect associated with this antibody, confirm its functionality. 
The fact that none of these antibodies affected the levels of CagA translocation (see Table 3-
1) indicates that the activation status of integrin β1 affected by these antibodies is not relevant 
for CagA translocation. 
3.1.4.3.3 Competition for the integrin β1α5 RGD binding domain 
Many proteins are described to interact with integrin heterodimers. Two of them are 
fibronectin, an extracellular matrix (ECM) component protein, and invasin (Inv), a protein 
that allows Yersinia spp. to adhere and to invade eukaryotic cells in an integrin β1α5 specific 
way (Dersch and Isberg, 1999). Fibronectin contains an RGD motif, which allows it to bind 
the I-domain of the α5 subunit of the integrin β1α5 (Mould et al., 1997). invasin (Inv) contains 
no RGD motif but an aspartate in position 911 (D911) that presumably functions as the 
aspartate of the RGD motif of fibronectin (Leong et al., 1995). With the same principle, a 
RGD-containing peptide and its control (RAD) have been used to establish competition for 
this domain, inhibiting binding of RGD motifs (and invasin) to the integrin β1α5 heterodimer. 
To learn if the I-domain found on the alpha subunit of integrin heterodimer is relevant for the 
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Cag apparatus–integrin interaction, fibronectin, invasin and the RGD and RAD peptides were 
used in competition experiments. Their effect on CagA phosphorylation was measured. As 
described in table 3-1, none of them had an effect on the CagA-P levels independent of the 
infection time (one, two or four hours), the protein concentration (5-100 µg /ml) or the 
binding conditions (37°C or 4°C). These data can be correlated with the results obtained by 
the earlier use of inactivating antibodies, which targeted the I-like domain of the β subunit 
and inactivated the I-domain’s capacity of the alpha subunit to bind to RGD containing 
peptides. It can be concluded from these experiments that the RGD binding domain of the 
alpha subunit is not relevant for the CagA translocation. 
3.2 Integrin β1 interacts with the Cag apparatus. 
3.2.1 Integrin β1 interaction with Helicobacter pylori is Cag dependent. 
3.2.1.1 Integrin β1α5 fluorescence assay 
In order to determine if the Cag apparatus interacts directly with integrin β1, a localization of 
the apparatus on the bacteria was attempted by using a purified, soluble fluorescent labeled 
integrin β1α5 protein complex (integrin β1α5 Alexa555 conjugated). Green Fluorescent Protein 
(GFP)-expressing H. pylori were grown overnight on plates, resuspended and exposed to the 
integrin β1α5, before they were fixed and analyzed by confocal microscopy. This procedure 
was performed with bacteria growing on serum plates, as well as with bacteria growing 
serum-free plates especially developed for these studies. For both cases, with or without 
serum, integrin β1α5 bound to P12 wild type and P12∆cagA intact bacteria, but not to 
P12∆PAI. However, only when bacteria grew on serum-free media, the binding to the 
recombinant proteins was more specific than to those bacteria that grew on serum plates, as 
shown for the wild type P12 in figure 3-10. This could be explained by the existence of ECM 
proteins like fibronectin in the serum plates that adhered to the bacteria while growing. The 
staining of bacteria using integrin β1α5-Alexa555 did show a conserved localization on the 
bacteria concentrated on spots around the bacterial cell. This concentration was observed only 
on Cag positive strains and not on the Cag mutant, thus confirming a dependent interaction 
between the integrin proteins and the Cag apparatus components. Furthermore, ECM proteins 
are not serving as bridging molecules in this interaction, as serum-free grown bacteria showed 
a better and defined interaction of the apparatus proteins to integrin β1 protein. 
RESULTS 
 
 
Figure 3-10 Integrin β1α5 binding to P12 CagPAI-dependent 
Bacteria expressing GFP (green) were grown on serum or serum-free media, resuspended to OD 0,025 in 
1ml of DMEM and exposed to purified integrin β1α5- Alexa555 ( red). Bacteria were centrifuged, fixed and 
imaged using a Leica Confocal microscope. Z-stacks with 0,24 µm distance were merged into a single 
picture. Raw pictures were edited using Metamorph software.  
3.2.1.2 Selection of bacteria expressing the Cag apparatus 
Not all H. pylori bacteria grown on GC–Serum agar plates present the Cag T4SS (Rohde et 
al., 2003). Under the hypothesis that only H. pylori expressing the Cag apparatus were able to 
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bind integrin β1α5, and taking advantage of the commercial availability of integrin β1α5, a 
selection of bacteria presenting the Cag apparatus was attempted using integrin β1α5 
heterodimer coupled to magnetic beads. The binding of Cag apparatus expressing bacteria 
with the integrin heterodimer took place under the presence of 10 µg of RGD peptides, to 
minimize any cross-reaction with the fibronectin that bacteria could have on their surface. 
 
Figure 3-11 Selection of Cag apparatus expressing bacteria using magnetic beads 
(A) Scheme of experimental design using integrin β1α5 recombinant protein covalently linked to magnetic 
beads to select and quantify bacteria expressing the Cag apparatus. wt; wild type. ∆PAI; Mutant lacking the 
cagPAI. (B) Percentage of bacteria recovered using the magnetic beads with recombinant protein. 
Percentage is relative to wild type strains. Statistical analysis was done using a t-test, n=7. *** P<0.005, ** 
P<0.01 and *P<0,05. (C) Percentage of recovered wild type strains containing Cag apparatus with magnetic 
beads in comparison to the initial amount of bacteria in suspension. 
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After the bacteria were exposed to the coated magnetic beads, the bound bacteria were 
recovered using a magnet. They were washed, plated and grown for three days in 
microaerophilic conditions at 37°C in order to quantify the colony forming units (cfu) (see 
scheme, Figure 3-11A). This procedure was repeated ten times. The results are graphed in 
figure 3-11B. The interaction of the bacteria with the integrin-coated beads was entirely 
dependent on the presence of the Cag components, as demonstrated for both strains P12 and 
P217. As well, it could be estimated that between 2% and 5% of the total amount of bacteria 
growing on serum plates carry a functional Cag apparatus (Figure 3-11C). Therefore, it can be 
speculated that the Cag apparati present on bacteria allows them to interact with integrin β1 
heterodimers. 
3.2.1.3 Integrin β1 co-lo alizes with H. pylori Cag dependent 
under infection condition  in vitro 
c
s
The Cag T4SS binds to the purified integrin β1α5. However, it is necessary to know if the 
binding happens during in vitro infections as well. Using live imaging, a neutral antibody 
against integrin β1 (Clone 4B7) conjugated to AlexaFluor555 was used to label the integrin β1 
present on the membrane of living AGS cells. GFP-expressing bacteria, grown on serum-free 
media, were added at a MOI of 30. By evaluation of life imaging data, co-localization was 
observed and measured. 
 
Figure 3-12 Co-localization of integrin β1 with cagPAI containing strains during infection of AGS cells 
(A) Using an Alexa555-conjugated anti-integrin β1 antibody (Clone 4B7), integrin β1 (green) expressed on 
AGS cells were labeled and observed its co-localization with P12 wild type and P12 ∆cagPAI GFP 
expressing bacteria (red). (B) Co-localization events were counted and graphed in percentage relative to total 
amount of bacteria counted. 
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As seen in figure 3-12, only bacteria containing the Cag apparatus components co-localized 
with the integrin β1 present on the cell. In this way, the relevance of the interaction of integrin 
β1 with bacteria on a Cag dependent manner under infection conditions was proven. 
3.2.2 Integrin β1 interacts directly with CagA, CagY and CagI proteins 
from the Cag apparatus 
The Cag pathogenicity island (cagPAI) encodes a T4SS. It is composed of 29 genes, of which 
most products are essential for the proper functioning of the apparatus. Given the fact that the 
Cag apparatus interacts with integrin β1, it is important to know which of the proteins 
encoded in the cagPAI are involved in a direct interaction. Two methods were applied in 
order to find the interaction partners: Yeast two hybrid assay (Y2H) and protein pull down 
assays using the purified integrin heterodimers proteins (β1α5 and β1α1) covalently attached to 
magnetic beads. 
3.2.2.1 Yeast two hybrid assay (Y2H) (Together with S. Kutter, 
LMU, Munich) 
Until this point, the relevance of integrin β1 has been confirmed by infection of cells from 
different cell origin: Epithelia (AGS), embryonic epithelial-like (GE11β), embryonic 
fibroblast-like (GD25β) and hematopoietic (HL-60, Jurkat) cells. Because of their different 
origin, different sets of alpha subunits are present and interact with the integrin β1 subunit 
(Boelens et al., 2007; Brakebusch et al., 1997; Hoffmann et al., 2005; Schweighoffer et al., 
1994; Sixt et al., 2006). Since the only common factor is the β1 subunit, in frame of the PhD 
work of Stefan Kutter (Max-von-Pettenkofer Institute, LMU Munich, Germany), a Yeast Two 
Hybrid (Y2H) assay was performed using the full size extracellular integrin β1 subunit versus 
all proteins present on the Cag PAI.  In figure 3-13, the proteins that gave a positive 
interaction with integrin β1 are represented. 
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Figure 3-13 Proteins used in Y2H assay 
Representation of proteins or protein fragments used in the Y2H assay with integrin β1 extracellular 
fragment as bait and Cag apparatus proteins as prey. CagA N-terminal and C-terminal halves were expressed 
independent. The same in the CagY case, with CagYa (HP0527a) being the Repeat Region (RP) I, CagYb 
(HP0527b) the RPII and CagYc (HP0527c) the region after the second putative transmembrane region. 
Green segments represent those showing a positive interaction with human integrin β1 extracellular part. 
pGBKT7, plasmid from bait yeast strain; pGADT7, plasmid from prey yeast strain. 
Since CagA and CagY are very large proteins, they were screened in fragments that are 
considered relevant for the function of the T4SS. For the CagA analysis, it was evaluated in 
two fragments: the N-terminal part of CagA (547a, Aa 1-613) and the C-terminal part 
containing the EPIYA motifs (547b, Aa 565-1186). CagY contains three fragments of 
interest: 527a or CagYa (Aa 1-345), which contain the Repeat Region I (RPI) of the protein; 
the 527b or CagYb (Aa 363-1799) containing the Repeat Region II (RPII); and the 527c or 
CagYc (Aa 1815- 1927) with the area of the CagY homologue to the VirB10 protein of 
Agrobacterium tumefaciens. CagI sequence (540, Aa 21-381) was not fragmented, but its 
signal sequence removed. As seen in figure 3-14, the extracellular domain of integrin β1 
showed interactions with only three proteins from the Cag PAI: CagA, CagY and CagI. The 
results specifically revealed an interaction between the CagA N-terminal and CagY virB10 
homology section (CagYc), and the whole CagI sequence with the integrin β1. 
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Figure 3-14 Interactions detected in Y2H assay 
The growth of yeast shows the interaction between proteins at different dilutions. Control growth of yeast is 
visualized on SD-Trp-Leu media. Only yeast presenting proteins with a positive interaction, are able to grow 
in media lacking histidine (SD Trp-Leu-His). Dilutions are to confirm the strength of the interaction. Only 
CagA N-terminal part (547a), Cag I (540) and CagY C-terminal (527c) shown interaction with integrin β1 
With the Y2H assay, it could be shown that only three proteins from the Cag apparatus, CagA 
N-terminal half, Cag I protein and C-terminal region of CagY, act as interacting partners with 
the extracellular domain of integrin β1 protein.  
3.2.2.2 Validation of Y2H data interaction . s
3.2.2.2.1 Protein pull down assays 
In order to verify the first data obtained in the Y2H assay, which showed an interaction of 
CagA, CagY and CagI with the extracellular domains of integrin β1, pull downs were carried 
out using purified integrin heterodimers integrin α1β1 and α5β1, attached to magnetic beads. 
With the purpose of obtaining the proteins from the Cag apparatus present on the surface of 
the bacteria minimizing cross reactions and high background, a new extraction protocol was 
developed. In this protocol the use of certain detergents was avoided, since they could damage 
the heterodimer conformation of the integrins. An overview of this protocol can be seen in 
figure 3-15. 
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Figure 3-15 Pull down assay using integrin β1 proteins 
Scheme of protocol developed to extract Cag apparatus proteins present on the surface of the membrane 
used to detect those proteins interacting with integrin β1α5 and integrin β1α1 coupled to magnetic beads. 
HSL, High Salt Lysis Buffer. WB, Western Blot. IP, immunoprecipitation or pull down. 
The bacteria were lysed with ultrasonication and the membrane components separated from 
the cytoplasmic ones. The membrane fraction was exposed to ultrasonication and high salt 
conditions in an attempt to obtain the proteins attached to the membrane fraction in a soluble 
form and therefore being able to carry out the pull downs. Once the proteins were solubilized, 
they were exposed to the integrin proteins on the magnetic beads, and after several highly 
astringent washing steps, loaded on a gel and immunoblotted to identify which proteins were 
interacting with the heterodimer. 
As observed in figure 3-16, the interaction already seen in the Y2H system of integrin β1 with 
CagA and CagY was confirmed. Unfortunately, the lack of antibody against CagI did not 
allow confirming this interaction. However, it was possible to confirm that CagA is able to 
interact directly with the integrin β1 independently of other proteins of the apparatus, since in 
P12 the strain lacking the complete island, but expressing CagA in trans, CagA showed 
interaction with the integrin β1. 
In these experiments, it has been shown that the alpha subunit does not seem to influence the 
interaction of the Cag proteins and the β subunit of the integrin. At the same time, it could be 
confirmed that CagA and CagY are interacting partners with the integrin β1. In the case of 
CagI, the lack of antibody against it, made it impossible to detect an interaction with integrin 
β1 through this experiment.  
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Figure 3-16 Western blot analysis of proteins interacting with integrin β1 
Immunoblots detecting CagA and CagY after pull downs using two integrin heterodimers (α1β1 and α5β1) 
coupled to magnetic beads. Antibodies used to recognize the CagA and CagY were AK257 and AK273 
respectively. Initial extract prepared from P12 wild strain and P12 ∆PAI expressing CagA26695 protein in 
trans encoded by a plasmid. 
3.2.2.2.2 Specific binding of CagA protein to integrin β1 
An assay to confirm the importance of the N-terminal half of CagA was attemptedusing 
antibodies directed against both halves of CagA and testing their capability to inhibit CagA 
translocation. The purified antibodies were AK268, which is directed against the N-terminal 
half of CagA, and AK257, which was produced against the C-terminal half of CagA. Result 
observed during live imaging using bacteria pre-exposed to one of both antibodies revealed a 
decline in co-localization events with integrin β1 (Figure 3-17B). As seen in figure 3-17A, 
neither the antibody against the N-terminal region (AK280) nor AK257, which recognizes the 
C-terminal region, were able to inhibit CagA translocation/ phosphorylation in thestrains 
tested. Even though a reduction of co-localization of the antibody pre-treated bacteria was 
seen, it can be concluded that there is no effect on the CagA translocation when the CagA 
does not colocalize with integrin β1. 
It was also necessary to confirm that the interaction between CagA and integrin β1 occurs as 
well with integrins in their natural form, which is found on the surface of cells. With this 
intention, a GST fusion protein containing the full size CagA was purified and its binding 
capacity to cells containing integrin β1 evaluated by flow cytometry. The cells GE11 and a 
murine fibroblast-like cell line, β1-2-8 (Cells (-)), are cells that do not express integrin β1. 
Their integrin β1 complemented forms, GE11β and β1-2-8-4 (Cells (+)), were used to define 
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the integrin β1 specific binding of CagA. In figure 3-17C an evaluation of the CagA binding 
to integrin β1 containing cells versus their KO forms revealed a specific interaction only with 
the human form presented by the GE11β cell line, and not with the mouse integrin β1 on the 
β1-2-8-4 cells (Cells (-)). These results confirm that there is a specific interaction of CagA 
with the integrin β1 present on cells and it is dependent of the species sequence. It is shown 
that the effect by the antibodies in live experiments does not correlate with an inhibition of 
CagA-P in infection conditions as well. 
 
Figure 3-17 CagA Antibody effect on CagA translocation and CagA binding to integrin β1 
(A) Effect of antibodies recognizing N- and C-terminal regions of CagA on CagA translocation. Bacteria 
were exposed to 12 µg antibody before infection.(B) Co-localization of antibody-labeled CagA on bacteria 
with antibody-labeled integrin β1 on AGS cells during infection (C) Specific binding of GST-CagA to cells 
in an integrin β1 dependent manner. Binding tested on cells KO integrin (GE11 and Cells (-)) and 
complemented forms (GE11β and Cells (+)). GST-CagA binding was evaluated through 
immunofluorescence and flow cytometry after immunodetection of the GST tag. Statistical significance was 
evaluated using a t-Test, n = 8, *P<0,05, *** P<0,005, ns, no significance. 
3.2.2.2.3 The C-terminal fragment of CagY (CagYc) interacts with integrin β1 
Since in the Y2H assay a specific interaction of C-terminal fragment of CagY (CagYc) was 
shown, and at the same time integrin β1 pull downs confirmed an interaction with CagY, it 
was necessary to confirm the specificity of this interaction with the CagYc using a GST-
fusion protein. Using GST proteins coupled to beads as control, pull downs were done using 
the GST-CagYc protein and the purified integrin heterodimer. As can be observed in figure 3-
18A, only beads containing CagYc showed a binding to integrin β1. 
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Figure 3-18 CagYc interaction with integrin β1 
(A) Immunodetection of fusion protein and its interaction with integrin β1 by Western blot. First three lanes 
show the GST and GST-CagYc proteins using, anti-GST antibody, and the detection of integrin β1 with the 
antibody LM534. Last two lanes shows the immunodetection of the integrin β1 precipitated with the GST 
and GST-CagY. All samples were prepared in non-reducing conditions. (B) Binding of GST-CagYc fusion 
proteins to cells with or without integrin β1 expression. Binding tested on cells KO integrin (GE11 and Cells 
(-)) and complemented forms (GE11β and Cells (+)). Fold induction of the mean fluorescence detected by 
flow cytometry. Alexa488 conjugated anti-mouse antibodies detected the anti-GST antibody attached to the 
GST-CagYc bound to cells. Fold induction is relative to the mean fluorescence of the cells treated with 
primary and secondary antibodies only. Statistical significance was evaluated using a t-Test. n = 8. * P<0,05. 
Similar to the binding of CagA to cells in an integrin β1 dependent manner, also binding of 
GST-CagYc fusion protein to cells in an integrin β1 dependent manner was measured using 
flow cytometry analysis. As shown in figure 3-18B, GST-CagYc protein shows binding to the 
cells in an integrin β1-dependent way. The GST-CagYc fusion protein shows a preference in 
binding to the human form of the integrin β1 as well. These data confirm that the interaction 
of CagY with integrin β1 takes place in the C-terminal region of CagY. 
3.2.2.2.4 CagI protein interacts with integrin β1 
The Y2H assays showed a positive interaction between integrin β1 and CagI. During 
experiments using integrin β1 for pull down assays, CagI’s presence could not be proven 
because of the lack of an antibody against it. Therefore, a GST fusion protein with the same 
sequence of CagI as used for the Y2H assays was produced. The GST tag is N-terminal 
attached, and it was used to detect the binding of CagI to cells only when these expressed 
integrin β1 on the surface. Using the same method as with the GST-CagA and GST-CagYc, 
GST-CagI was exposed to cells with or without integrin β1: GE11, GE11β, β1-2-8 (Cells (-)) 
and β1-2-8-4 (Cells (+)). Using antibodies to detect the GST tagbinding of the CagI was 
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determined by flow cytometry. As seen in figure 3-19B, CagI binds to cells in an integrin β1 
dependent manner GST-CagI showed a higher specificity and affinity to cells expressing the 
human form (GE11β) of the integrin β1 in comparison to the mouse form present in cell line 
β1-2-8-4 (Cells (+)) to which CagI bonds independent of integrin β1. 
 
Figure 3-19 GST-CagI binding to integrin β1 cells. 
(A) Binding of GST-CagI protein (red bars) to cells without integrin β1 (GE11 and Cells (-) (β1-2-8)) and 
with it (GE11β and Cells (+) (β1-2-8-4)). For both graphics, the mean fluorescence fold induction is in 
comparison to the fluorescence of control cells without a GST fusion protein but exposed to primary (anti-
GST) and secondary (Anti-Mouse Alexa488) antibodies. Data represent the average and standard deviation 
from three independent experiments. Statistical significance was evaluated using a t-Test, n = 3. *P<0,05, ** 
P<0,01; ns, no significance. 
3.2.2.3 Position of CagA on the tip of the apparatus correlates 
with its relevance as interacting partner with integrin β1 
Given the fact that CagY has already been identified on the surface of the Cag apparatus in 
infection conditions, it was decided to look at the position of CagA on the Cag apparatus 
using immunofluorescence with AlexaFluor555 labeled AK257 antibodies, and 
immunodetection in electron microscopy (collaboration with Dr. Manfred Rohde, Helmholtz 
Center for Infection Research (HZI) Braunschweig). As seen in figure 3-20, data in 
immunofluorescence shows that CagA can be found on the surface of the bacteria. In the case 
of electron microscopy, it was confirmed that CagA is localized at the tip of the Cag 
apparatus, putting it in the right place for an interaction with the integrin β1. 
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Figure 3-20 Localization of CagA on the apparatus 
(A) Immunodetection of CagA in infection conditions. CagA (green) was detected using a fluorescent-
labeled anti-CagA antibody (AK257-Alexa647). Bacteria (red) produce GFP protein encoded in a pHel4 
plasmid. (B) EM pictures showing immunogold detected CagA positioned on the tip of the apparatus. 
3.2.3 Relevant integrin β1 domains for the interaction with CagA, CagY 
and CagI proteins 
The integrin β1 subunit has been studied extensively. Its crystal structure and functional 
domains are well known, and some of the domains functions have been elucidated by the use 
of specific anti-integrin β1 antibodies (Calderwood, 2004; Takagi and Springer, 2002; 
Wegener et al., 2007). A better evaluation of the relevant domains of the integrin β1 
interacting with the Cag proteins can give a better understanding of the mechanisms involved 
in CagA translocation.  
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3.2.3.1 Yeast-two-Hybrid Data (In colaboration with C. Ertl, 
LMU, Munich) 
Since the amount of possible interacting partners of the T4SS with integrin β1 was restricted 
to the CagA N-terminal half (CagAa), the CagY C-terminal part (CagYc) and CagI, an exact 
evaluation of which domains from the integrin β1 are interacting with these Cag proteins was 
important. This information can give an idea of how this interaction takes place for the CagA 
translocation into the cytoplasm of the eukaryotic cell.  
 
Figure 3-21 Y2H data for interaction of CagPAI proteins with integrin β1 domains 
Fragments of integrin β1 used in the Y2H screen. They were used to evaluate the binding specificity of 
CagA (N-terminal, CagAa), CagYc and CagI to the integrin β1. Results of the screen are described here. 
Positive reactions and their intensity are represented by (+). Negative interactions by (-), and Auto represents 
autoreactivity or unspecific growth of the yeast in the assay. 
The screen was made in collaboration with Claudia Ertl (Max-von-Pettenkofer Institute, 
LMU, Munich). The fragments used in this screen contained the integrin β1 domains PSI (Aa 
1-99), I-like domain (Aa 96-460), EGF domain (1-4) (Aa 410-625), β tail domain (βTD) (Aa 
575-728) and a EGF (1-4)-βTD (Aa 410 -728). All of these domains were screened for 
interactions with CagA (N-terminal), CagYc and CagI protein in the Y2H assay. 
From this screen, interaction between CagYc and PSI was established. CagA (N-terminal) 
gave a weak interaction with EGF (1-4) and strong interaction with the EGF (1-4)-βTD 
fragment. In the case of CagI, its interaction was related to the βTD domain fragment (See 
Figure 3-21). 
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3.2.3.2 Validation of Y2H interactions 
The previous results had to be confirmed with other methods and their relevance in the Cag 
apparatus functionality had to be evaluated. This was approached by evaluation of effects of 
specific antibodies targeting the integrin β1 domains in CagA translocation, as well as 
through binding assays under different conditions. 
3.2.3.2.1 EGF repeat domain involved in CagA translocation 
Knowing that CagA possibly interacts with a region between the EGF (1-4) domain and the 
βTD of integrin β1, and CagI with the βTD, antibodies directed against these regions were 
used to inhibit CagA translocation and phosphorylation. As shown in figure 3-22B, CagA 
phosphorylation is blocked only with the antibody 9EG7. 9EG7 is an antibody that binds to 
human integrin β1 at a domain made accessible in the presence of Mn2+ (Bazzoni et al., 
1995). The effect on blocking the translocation is directly proportional to its capacity to bind 
to the integrin β1, as seen after a one-hour infection in conditions with and without Mn2+. 
None of the antibodies K20 and LM534 affected the CagA phosphorylation (Figure 3-22B), 
even though they partially overlap the binding epitope recognized by 9EG7 (Figure 3-22A). 
As seen here, the AIIB2 antibody does not have an effect on CagA phosphorylation. This data 
is in agreement with the fact that the I-like domain of the β1 integrin showed no interaction 
with any of the Cag proteins tested. All antibodies were able to bind to the AGS cells (Figure 
3-22C), and the already described effect of Mn2+ for 9EG7 was observed as well. 
These results lead to the possibility that competition between the apparatus proteins (CagA 
and CagI) and the antibody could be the cause of the inhibition. To assess this hypothesis, 
binding assays using 9EG7 to inhibit GST-CagA, GST-CagI and GST-CagYc binding to 
integrin β1 expressing cells (AGS) were analyzed using flow cytometry. As shown in figure 
3-23A, the binding of 9EG7 did not reduce the binding of any of the fusion proteins to the 
AGS cells. These results are independent from the presence of Mn2+ in the binding assays. 
Thus, 9EG7 antibody does not inhibit the binding of GST-CagA, GST-CagYc or GST-CagI to 
integrin β1. 
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Figure 3-22 Evaluation of integrin β1 domains relevance in CagA phosphorylation 
(A) Localization of epitopes recognized by antibodies used to evaluate the relevance of integrin β1 domains 
in CagA translocation. (B) Immunodetection of CagA phosphorylation after 1 and 3 hours of infection of 
cells pre-exposed for 30 minutes to anti-integrin β1 antibodies (30 µg/ml). The CagA protein and integrin β1 
were detected using antibodies AK257 and LM534, respectively. (C) Evaluation of binding capacity of 
antibodies to AGS cells during the pre-incubation period before infection was done using 
immunofluorescence and analysis through flow cytometry.
3.2.3.2.2 CagYc could be interacting with the PSI domain 
Since binding of CagYc was mapped to the PSI domain, and structural studies from integrins 
show that the PSI domain is exposed when integrins are activated, binding assays to evaluate 
the binding of CagY in activated conformation were set. To achieve an activated form of the 
integrin β1 on the cells, Mn2+ was used. The results are illustrated in figures 3-23B and 3-
23C. The binding of the fusion proteins was evaluated under free bivalent cations conditions. 
The amount of MnCl2 used to activate integrin β1 was 1- 2 mM. Cells were exposed to fusion 
protein and left to bind under protease inhibitor solution for one hour at 4°C. Binding of the 
proteins was detected by immunodetection of the GST fusion protein moiety and analyzed by 
flow cytometry. Only GST-CagYc, not GST-CagA or GST-CagI, showed an increased 
tendency to bind in presence of MnCl2, which supports the idea that the binding of the CagY 
through its C-terminal part to the integrin β1 occurs in the PSI domain.  
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Figure 3-23 Effect of 9EG7 antibody and MnCl2 on binding fusion proteins 
(A) After pre-incubation of AGS cells with 9EG7 antibody for 30 minutes, GST-CagA, GST-CagYc and 
GST-CagI protein binding was evaluated by immunostaining and flow cytometry. (B) Effect of 1mM MnCl2 
on binding of GST-CagY and (C) GST-CagA protein. Dark bars indicate the binding of the fusion protein 
without MnCl2, red bars indicate the binding of fusion proteins in presence of 2 mM MnCl2. The mean 
fluorescence fold induction is relative to the control cells exposed to anti-GST and anti-mouse Alexa488 
antibodies. Statistical data analysis using t-Test. ** P< 0,01; ns, No significance 
3.2.3.3 Relevance of integrin β1 domains in CagA translo ation 
using antibodies 
c
Using antibodies binding to different regions of the integrin β1 proteins, it was expected to 
elucidate in detail other essential mechanism involved in the CagA translocation. As depicted 
in figure 3-24, no other epitopes, recognized by the set of monoclonal antibodies, are relevant 
in CagA translocation, as no changes on the CagA phosphorylation levels were observed after 
infection of synchronized AGS cells pre-incubated with different antibodies. The data 
relevant to the antibodies’ activity on the binding capacity of integrin refer to published data 
by Wilkins, JA (Wilkins et al., 1996; Clones N29, B2B11, B44), Mould, AP (Mould et al., 
1997; Clones 8E3, 12G10), Stupack, DG  (Wilkins et al., 1991; Clone JB1A), Hall, D.E. (Hall 
et al., 1990; Clone AIIB2), Ni, H. (Ni et al., 1998; Ni and Wilkins, 1998; Clone K20), 
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Bazzoni, G. (Bazzoni et al., 1995; Clone 9EG7), Takada, Y. (Takada and Puzon, 1993; Clone 
LM534), Gao, J.X. (Gao et al., 1995; Gao and Issekutz, 1995; Clone 3S3) and Gonzales, 
A.M. (Gonzalez et al., 2002; Clone 6S6).  
 
Figure 3-24 Summary of effect of antibodies against integrin β1 on CagA phosphorylation 
Antibodies tested to evaluate their effect on CagA phosphorylation. Recognized antibodies’ epitopes are 
described here. A linear epitope has not been defined for all antibodies. Conform, for those antibodies 
recognizing epitopes known to be available under a certain activation status of the integrin heterodimer. 
Neutral defined as not observed any effect on binding capacity of the integrins. Inhibitory defines antibodies 
that diminish the binding capacity of the integrin heterodimers. Stimulatory are antibodies that enhance the 
binding to their substrate. Positive or negative representation of phosphorylated CagA refers to 
phosphorylation of P12 CagA. Antibodies used in a concentration of 30 µg/ml to pre-treat synchronized 
cells for 30 minutes, after 30 minutes from the addition of serum containing media. Infection was done for 
one hour with MOI 60. Data summarizes the results of at least two independent experiments 
 95 
RESULTS 
 
 96 
3.3 Integrin β1 and the induction of IL-8 production via Cag 
The Cag apparatus does not only translocate the CagA protein into the cell cytoplasm. It is as 
well responsible for the induction of cytokine production by human cells, like Interleukin 8 
(IL-8) and RANTES (Innocenti et al., 2002; Nozawa et al., 2004). This effect is not seen in 
mouse cells (personal observation and Ferrero et al., 2008). In the previous part of this thesis, 
it has been shown that the integrin β1 is essential for the CagA translocation and 
phosphorylation. At the same time that CagA phosphorylation was assessed, the effects on IL-
8 induction were measured and analyzed. 
3.3.1 Dynamics of IL-8 production 
In order to establish if the IL-8 induction produced by the T4SS of H. pylori is possible 
through a receptor interaction, the dynamics of IL-8 secretion inAGS were studied using two 
different stimuli. Tumor Necrosis Factor alpha (TNFα) and Phorbol Myristate Acetate 
(PMA). TNFα induces IL-8 production by binding to its receptor, the TNFR. PMA is a cell 
membrane permeable PKC activator that can induce IL-8 production. The TNFα was used as 
an example for IL-8 induction via a receptor, while PMA’s effect on IL-8 represents a 
receptor independent stimulus. The experiments were done with cells that have not been 
synchronized. Two different concentrations were tested for TNFα (50 and 100 pg) and PMA 
(50 and 5 ng/ml). Supernatants were collected in time intervals of 10 minutes and IL-8 was 
measured through a sandwich ELISA. As seen in figure 3-25, both stimuli show an increment 
on IL-8 production at 50 minutes, TNFα stimulated cells being the first ones to increase 
exponentially (Figure 3-25A). In the case of PMA, which does not need a receptor for IL-8 
induction, the IL-8 induction presents a small plateau of production between the first 
measurement at 50 minutes and the exponential increment at 90 minutes. It seems that the IL-
8 production after the receptor activation mediated by TNFα leads to this plateau for a shorter 
time (between the 70 to 90 minute time points, 20 minutes) as seen in the IL-8 dynamics of 
PMA. In the case of a higher concentration of TNFα, this plateau did almost not exist. 
RESULTS 
 
 
Figure 3-25 IL-8 dynamics with TNFα and PMA 
IL-8 concentrations (pg/ml) at different time points after stimulation of AGS cells with Tumor Necrosis 
Factor α (TNFα, 50 and 100 pg) and Phorbol Myristate Acetate (PMA, 5 and 50 ng/ml). Arrows indicate 
time points where differences on release of IL-8 were noticed. (A) Time lapse 0 - 60 minutes. (B) Time 
lapse 0 - 110 minutes. Curves represent data from at least two independent experiments 
 
Figure 3-26 IL-8 dynamics of AGS cells induced by the Cag apparatus of Helicobacter pylori 
IL-8 concentrations (pg/ml) were determined at different time points after stimulation of AGS cells with (A) 
Three different wild type strains containing a functional Cag apparatus, and (B) P12 wild type and mutants 
of the Cag apparatus, P12∆cagA and P12∆PAI. All infections were done using an MOI 60. Curves are 
representative from at least two independent experiments 
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IL-8 induction dynamics via Cag apparatus, were evaluated using four different strains in 
infections with MOI 60 of AGS cells. In figure 3-26A, it can be appreciated that IL-8 
induction dynamics are dependent of the strain used. Not shown here is that the IL-8 
induction was also dependent of the fitness of the bacteria. In general, it can be said that the 
IL-8 production induced by H. pylori in a CagPAI-dependent manner starts approx. 60 to 90 
minutes after infection (Figure 3-26B). In the case of IL-8 induction via Cag, no pronounced 
plateau was observed even in the cases were CagA was not present.  
3.3.2 Effect of divalent cations on IL-8 induction via Cag apparatus. 
Since the activation of integrin β1 through Mn2+ does increase the CagA translocation levels, 
the effects of CaCl2 and MnCl2 on IL-8 induction were evaluated. Non-synchronized cells 
were pre-incubated with normal RPMI media, or additionally 2 mM MnCl2 or 3 mM CaCl2 
media. The infection took place in standard conditions and the supernatants were collected to 
measure its IL-8 content using an sandwich ELISA. H. pylori P12 strains containing 
mutations lacking the cagA and the entire cagPAI were used. It has been shown that CagA 
alone is responsible for part of the IL-8 induction associated with the Cag T4SS (Fischer et 
al., 2001). As seen in figure 3-27A, MnCl2 reduces the IL-8 induction effect up to 50% in the 
case of the wild type. This reduction can be assumed not to have an effect on the CagA 
translocation, since CagA is translocated and phosphorylated in 1 mM MnCl2 solution. The 
difference already seen in IL-8 induction for the wild type is as well observed during 
infections with P12∆cagA in presence of MnCl2. In the case of CaCl2, there is no effect 
caused by its presence on the IL-8 production.  
Consequently, only activation of MnCl2 affects the IL-8 induction via the Cag apparatus in 
infection of AGS cells. Additionally, this effect is not CagA dependent but Cag apparatus 
dependent. For calcium, no effect can be concluded from the inactivation of integrins by 
calcium on the extracellular environment. However, in the case of intracellular calcium, 
BAPTA inhibits IL-8 induction making it undetectable with our assay (depicted later in figure 
3-35), consistent with the inhibition of CagA phosphorylation seen before. 
3.3.3 Relevance of RGD binding domain in IL-8 induction 
The RGD binding domain of the integrin heterodimers showed not to be relevant for CagA 
translocation. At the same time, their effect on IL-8 was measured and evaluated. The pre-
treatment of cells for 30 minutes with fibronectin, invasin, RGD peptide and its RAD 
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counterpart, did not show a significant change on the IL-8 induction, as graphed in figure 3-
27B and summarized in Table 3-1. 
 
Figure 3-27 Effects of bivalent cations and RGD binding domain competition on IL-8 induction 
(A) Effect of calcium (Ca) and manganese (Mn) in the IL-8 induction in a Cag apparatus dependent manner. 
IL-8 concentrations in pg/ml. (B) Evaluation of integrin α5β1 ligands in IL-8 induction via Cag apparatus. 
Fold induction is relative to control infections. Strains used were P12, P217 and P145 for 4-hour infections 
with a MOI 60. Statistical analysis using t-Test. * P<0.05, ** P<0,01, ***P< 0,005. ns, no significance 
3.3.4 Effects of ILK signaling in IL-8 induction 
In order to determine if integrin β1 signaling is involved in the IL-8 production, the effects of 
knocking down ILK protein through siRNA were measured during induction of IL-8 by 
bacteria containing the Cag apparatus. The integrin-linked kinase (ILK) has been described to 
interact directly with the integrin β1 cytoplasmic domain upon activation of the integrin β1. 
As shown before, reduction to up to 70% of the ILK levels in the cell are not disturbing the 
levels of phosphorylated CagA. In the same conditions, IL-8 induction differences were 
analyzed using H. pylori P12 wild type, P12∆cagA and P12 ∆PAI. These mutants were used 
in order to differentiate between IL-8 induction by the Cag apparatus from the one induced by 
CagA alone. CagA alone is responsible for part of the IL-8 induction by the Cag apparatus. 
No change was expected in the induction on IL-8 in cells were ILK protein was reduced, 
since CagA could be successfully translocated/phosphorylated in these cells regardless of low 
ILK- levels. As shown in figure 3-28, reduction of ILK levels in AGS cells caused a lost of 
their sensitivity to induction of IL-8 via the Cag apparatus. As expected, in control cells there 
is a significant difference between the IL-8 induced by P12 wild type and P12 ∆cagPAI, as 
well as between P12 ∆cagA and P12 ∆cagPAI. 
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Thus, ILK signaling is not required for CagA translocation, but it is necessary for IL-8 
induction via the Cag apparatus. These results in conjunction with the effects of the bivalent 
cations Mn2+ on IL-8, indicate a possible role of integrin β1 on the IL-8 induction  
 
Figure 3-28 Effects of ILK on IL-8 induction via Cag apparatus 
IL-8 production by AGS cells during infection with P12 wild type and mutants lacking cagA (∆cagA) and 
the cagPAI (∆PAI). Percentage relative to control infection with wild type strain for each treatment. siRNA 
control transfected siRNA with a non-sense sequence with similar GC content as the ILK siRNA sequence. 
Statistical analysis using t Test. * P<0.05, ** P<0,01, ***P< 0,005. ns, no significance. 
3.3.5 Effects of integrin β1 antibodies in IL-8 induction via Cag 
apparatus 
As the integrin β1 plays a role in CagA translocation, the IL-8 induction levels via Cag were 
evaluated in infection conditions were cells were exposed to antibodies against the different 
domains of the integrin β1 subunit. In the case of IL-8, the effect is summarized in figure 3-
28. Only two antibodies showed an effect on IL-8 induction. The AIIB2 increased the IL-8 
induction up to five times as compared to the control infection. On the other hand, antibody 
LM534 not only reduced the IL-8 induction via Cag, but also could induce up to three times 
the normal amount of IL-8 produced by the cells. It is worth to mention that antibodies K20, 
9EG7, B3B11 were able to induce IL-8 per se although not in such magnitude as antibody 
clone LM534 (data not shown). 
It seems that not only the binding of the integrin antibodies can alter the CagA translocation, 
as it was the case with 9EG7, but the binding of the LM534 antibody reduced the IL-8 
induction by the Cag apparatus, even though it proved not to affect the CagA translocation.  
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Figure 3-29 Effects of integrin antibodies on IL-8 induction by the Cag apparatus 
Summary of IL-8 induction via CagPAI apparatus by AGS cells pre-treated with antibodies against integrin 
β1. Antibodies’ names and linear epitopes are described here for each clone. Conform, for those antibodies 
recognizing epitopes known to be available under certain activation status of the integrin heterodimer. 
Neutral defined as not observed any effect on binding capacity of the integrins. Inhibitory defines antibodies 
that diminish the binding capacity of the integrin heterodimers. Stimulatory are antibodies that enhance the 
binding to their substrate. (++++) defines the normal IL-8 induction during infection with P12 wild type of 
AGS during 3 hours. The data is representative for two independent experiments. 30 µg of antibody was 
used on synchronized AGS cells. 
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3.4 Cellular processes involved with the functionality of the Cag 
apparatus 
3.4.1 Evaluation of CagA translocation and phosphorylation 
In order to elucidate the mechanisms involved in the CagA translocation into the eukaryotic 
cells, cellular processes that involved directly or indirectly integrin β1 signaling pathways 
were manipulated or disrupted using inhibitors. The effects of this inhibitors were analyzed in 
relation with the capacity of the Cag T4SS to translocate CagA (by CagA phosphorylation) 
and induce IL-8. AGS cells were used as standard cell line because of their optimal CagA-P 
and their known IL-8 dynamics. All results are summarized in table 3-1.  Each inhibitor was 
initially tested with 30 minutes pre-incubation and a four-hour infection. If after these 
conditions a change in the levels of CagA phosphorylation was detected, experiments with 
different pre-incubation times (minimum 30 minutes and maximum 60 minutes) and one, two 
or three hour infections were repeated. The levels of CagA phosphorylation were detected 
through Western blot detecting tyrosine-phosphorylated proteins using the antibodies PY99 
and 4G10. The CagA-P levels were analyzed qualitatively in comparison with the AGS 
control infection. In the case of IL-8, the induction took place for three hours. IL-8 levels 
were measured and analyzed taking as control the IL-8 levels induced by the inhibitors alone. 
3.4.1.1 Membrane composition, protein  integrity, signaling 
and clustering 
s
The first interaction of the Cag apparatus with the host cells takes place with the cell 
membrane and its components. To learn more about this interaction, normal processes 
associated with the cell membrane’s function were disrupted by altering the lipid 
composition, by changing the protein topography of the cell membrane’s surface or by 
disrupting some of the first signaling molecules on the cytoplasmic part of the cells. The 
effects of these changes on the CagA translocation and IL-8 induction were analyzed to better 
understand the translocation process. 
3.4.1.1.1 Effects on CagA phosphorylation 
In order to disrupt several membrane processes that could have an indirect effect on the 
function of the integrin, normal lipid composition was disrupted by the use of Methyl-β-
RESULTS 
 
Cyclodextrin (MBC). MBC is reported to have high affinity for cholesterol, sequestering it 
from the membrane of the cells and, thus, disrupting microdomains present in the membrane 
known as lipid rafts (Rodal et al., 1999). Cells were pre-incubated in presence of MBC for 
one hour and then infected for four hours. CagA phosphorylation was strongly diminished 
after the depletion of cholesterol, as seen in figure 3-30A. This effect is stronger in infections 
with H. pylori strain 26695 and weaker on H. pylori strain P217 (data not shown). However, 
the effect is present on all these three strains tested.  
 
Figure 3-30 Effects of inhibitors on CagA phosphorylation 
Immunodetection of phosphorylated CagA (CagA-P). Full head arrow shows phosphorylated form of CagA 
detected using anti-phosphotyrosine antibody PY99. Empty arrow head shows bands corresponding to CagA 
detected using anti-CagA AK257. (A) Effect of Cytochalasin D (CytD, 1 µg/ml)) and cholesterol depletion 
by Methyl-β-Cyclodextrin (MBC, 0,1 g/ml). (B) Effect of Wortmannin (10 nM) and (C) Calpeptin (CP, 280 
µM). Infection time 3 hours with MOI 60 
Another aspect evaluated was the protein composition on the surface of the cells by altering it 
through a pre-digestion using trypsin (10 µg/1x106 cells) and thrombin (4 U/1x106 cells). 
These two proteases are known to digest some proteins on the surface of the cell without 
entering into the cytoplasm. In both cases, the changes of the membrane topology by the pre-
digestion of membrane proteins on the cells did not change the levels of CagA 
phosphorylation measured by immunoblot (data summarized in table 3-1). 
In the membrane signaling, PI3-K and PLC are considered important signaling molecules 
that, through their kinase and phospholipase activity, transport signals from the membrane 
into de interior of the cell. Their function is reported to be disrupted by Wortmannin (PI3-K) 
and U73122 (PLC). In both cases, no changes on CagA phosphorylation were observed (see 
figure 3-30B and table 3-1). 
By disrupting in several ways the membrane function (composition of the proteins on the 
membrane surface, lipid composition and intracellular signaling) it was discovered that only a 
massive depletion of cholesterol had an effect on CagA-P, being directly correlated with the 
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exposure time of the cells to MBC. Since lipid rafts have been associated with the capability 
of clustering of the integrins (McDowall et al., 2003), it is possible that the inhibition of such 
clustering damages the translocation capability of CagA. To confirm this hypothesis, the 
effect of calpeptin, a Calpain inhibitor that reportedly causes inhibition of clustering of the 
integrins, was studied. In accordance with the results obtained by disruption of lipid rafts 
function, the use of calpeptin inhibited as well the CagA-P (Figure 3-30C). 
3.4.1.1.2 Relevance of membrane processes on IL-8 induction 
By disturbing lipid rafts with the use of Methyl-β-Cyclodextrin (MβC), CagA-P was reduced. 
However, in the case of IL-8, only in infections with H. pylori strain 26695 was the IL-8 
induction strongly reduced. In infections with P12 strain, the IL-8 induction increased almost 
15% in a statistical significant way (Student t Test P=0,02) as seen in figure 3-31. 
 
Figure 3-31 Effect of Cholesterol depletion on IL-8 induction via Cag apparatus 
Depletion of cholesterol achieved after 1-hour pre-treatment of AGS cells with Methyl-β-Cyclodextrin 0,1 
g/ml. IL-8 concentration in pg/ml after a 3-hour infection of AGS cells with strains P12 and 26695, MOI 60. 
Statistical analysis using t Test. * P<0.05 
By pre-treating cells with trypsin and thrombin, some of the extracellular proteins were 
digested. At the same time, trypsin in PBS causes the detachement of the cells. To analyze the 
effect of the detachment, cells were pre-incubated in media:PBS solution in a 1:3 proportion 
and added trypsin 10 µg/ml. This treatment does not cause detachment of cells but conserves 
the trypsin activity. By analyzing the IL-8 induction, the induction levels were higher in cells 
treated with trypsin compared with the control cells (see figure 3-32). However, there is also a 
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statistically significant increment of IL-8 induction if cells are detached from the substrate by 
the trypsin. 
 
Figure 3-32 Effect of trypsin pretreatment of AGS cells in IL-8 induction via Cag apparatus 
IL-8 fold induction relative to –pretreated AGS cells not infected. trypsin (20 µg/ml) exposure of cells 30 
minutes before a 4-hour infection with wild type strains P12, P217, 26659 and P145. Statistical analysis 
using t Test. * P<0.05, ** P<0,01, ***P< 0,005. 
3.4.1.2 Endocytosis involvement in Cag functionality 
Until today, the process by which the Cag apparatus can translocate CagA into the cell’s 
cytoplasm is not well understood. Since most of the molecules enter the eukaryotic cell by an 
endocytic process, the effect of disturbing the endocytic system was evaluated on CagA 
translocation as well as on IL-8 induction. 
3.4.1.2.1 CagA phosphorylation requires some endocytic components  
Integrin β1 has been linked with endocytic processes, as it has been described for the 
interaction between invasin (Inv) protein and integrin β1α5. The effects on CagA translocation 
by the disruption of cytoskeleton using  Cytochalasin D, Latrunculin A and Jasplakinoline, as 
well as by the disruption of the microtubule system by Nocodazole, were evaluated. Cells 
were pre-treated with these inhibitors for 30 minutes before infection followed for one, three 
or four hours with an MOI 60. No effect was observed in the CagA-P levels with the 
inhibitors in comparison to control cells. This shows that the cytoskeleton and microtubule 
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system are no relevant cellular processes for the CagA translocation/phosphorylation (data 
summarized in table 3-1). 
 
Figure 3-33 Clathrin and CagA phosphorylation 
Immunodetection by western blots of phosphorylated CagA after infection of AGS cells pretreated with 
Mono-dansylcadaverine (MDC, 0,3 mM) or Dynasore (20µM. Full head arrow shows phosphorylated form -
detected using anti-phosphotyrosine antibody PY99and 4G10. Empty arrow head shows bands 
corresponding to CagA detected using anti-CagA antibody AK257. (A) and (B) show CagA-P levels after 30 
minutes pretreatment of AGS cells with inhibitors and 1-hour infection MOI60. α-ITGB1, detection of 
integrin β1 using clone LM534 in no reducing conditions. (C) and (D) show data testing effect of inhibitors 
on bacteria 
Clathrin is a protein involved in endocytosis processes and until today, there are controversial 
reports of its association with the cytoskeleton (Cupers et al., 1998; Kirchhausen, 1999; 
Mousavi et al., 2004; Owen et al., 2004; Puertollano, 2004; Rappoport et al., 2006; Wu et al., 
2001; Yarar et al., 2005). Mono-dansylcadaverine (MDC) and Dynasore are specific 
inhibitors of the clathrin pathway. The first one seems to inhibit the recycling of the clathrin 
chains by stabilizing nascent clathrin-coated vesicles (CCV) and preventing the uncoating of 
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already formed CCVs (Phonphok and Rosenthal, 1991). Dynasore has been described to 
inhibit directly the ATPase dynamin, which is required in different steps of the formation of 
clathrin-coated pits (CCP) and CCV (Macia et al., 2006; Nankoe and Sever, 2006). In the case 
of MDC, a 30 minutes pre-treatment of cells with 0,3 mM concentration, was able to abolish 
the CagA translocation and phosphorylation, both for four hour experiments as well as for one 
hour (Figure 3-33A). 
The effect of dynasore was evaluated with H. pylori strains grown on serum-free plates for at 
least two passages to remove all serum present on them, because of dynasore sensitivity to 
serum proteins. Shortly before infection, cells were washed three times with PBS (-Ca+2, -
Mg+2) and once with serum-free RPMI. Then in serum-free media, 80 µM dynasore was given 
30 minutes before a one hour infection with bacteria previously resuspended in serum-free 
media. The same effect seen with MDC was present with dynasore. CagA phosphorylation 
was completely abolished (Figure 3-33B). 
The effect of both compounds on H. pylori were unknown. Therefore, their effect on the 
functionality of the Cag apparatus was tested in time experiments. In the case of MDC, AGS 
cells were synchronized and exposed to the MDC from time point 0. Then, cells were infected 
for one hour at the time points 20, 40, 60 and 80 minutes. The experimental setup garanties 
that all bacteria are exposed only one hour to the chemical and any effect seen would be 
associated to an effect of the inhibitor on the clathrin pathways in the cell. As seen in figure 3-
33C, there are diminished levels of CagA-P in a time dependent manner, indicating that MDC 
is not disturbing the Cag apparatus, but its way of action is localized on the eukaryotic cell’s 
side. 
To examine the effect of dynasore on the bacteria,  a time experiment was not possible since 
dynasore enters quickly into the eukaryotic cells and its effects are almost immediately seen. 
However, to evaluate its effects on the bacteria, the bacteria suspension was exposed directly 
to 80 µM concentrations of dynasore for 45 minutes and washed two times to eliminate any 
excess. These bacteria were used to infect AGS cells for one hour in CM at 37°C with 5% 
CO2. The translocation was not affected (Figure 3-33D), indicating a non toxic effect of the 
dynasore on the H. pylori ability to translocate CagA during the infection. 
In view of the fact that proper function of the clathrin pathway is clearly necessary for the 
CagA translocation, one can assume that clathrin-dependent endocytic processes are essential 
for it. If this is the case, it is necessesary to explain the way CagA escapes the lumen of the 
endosome into the cytoplasm to be exposed to the Src kinase to be phosphorylated. Taking as 
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example virus and hormones, who seem to have discovered how to be released from the 
endocytic lumen into the cytoplasm, experiments were designed to disturb these mechanisms. 
They involve acidification of endosomal compartments in the case of viruses; or changes in 
the membrane potential of the endosome with or without involvement of chaperone proteins 
as Hsp90, as it was described for FGF-1 (Fibroblast Growth Factor -1) (Wesche J, 2006). For 
each of these processes, inhibitors were used. To inhibit acidification, the inhibitors 
Bafilomycin A, Concanamycin A and ammonium chloride (NH4Cl) were tested. Monensin A 
disrupts the membrane potential and Geldanamycin inhibits the Hsp90. Their effects were 
evaluated with a pre-incubation of cells for 30 and 60 minutes followed by a one-hour 
infection. As shown in Table 3-1, none of them had an effect on the CagA-P levels in 
comparison to control cells (immunoblots in figure 3-34). However, these results cannot rule 
out a mechanism for the apparatus that requires the formation of clathrin coated vesicles and a 
system to escape from their lumen into the cytoplasm. Further studies are required in order to 
answer this important question. 
 
Figure 3-34 Involvement of endocytosis processes in CagA phosphorylation 
Immunodetection of phosphorylated CagA. Full head arrow shows phosphorylated form detected using 
PY99 antibody. Empty arrowhead shows bands corresponding to CagA detected using AK257. Effect of 
ammonium chloride (NH4Cl, 20 mM), Geldanamycin (50 nM) and Bafilomycin 1A (1 ng/ml). Infection 
time: one hour. MOI 60 using wild type strains P12, P217 and P145. 
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3.4.1.2.2 Involvement of endocytic processes in IL-8 induction 
In the case of endocytosis processes, all inhibitors tested for CagA phosphorylation were also 
tested in their effect on Cag dependent IL-8 induction. Some of the data are shown in figure 
3-35 and all effects are summarized in table 3-1. This data has to be interpreted carefully since 
the inhibitors can as well disturb the production of IL-8 and/or is released into the media. 
There is only a drastic inhibition of IL-8 Cag-dependent induction in pre-treatments with 
Mono-dansylcadaverine (MDC), and a less but also significant reduction with ammonium 
chloride (NH4Cl), Concanamycin A, Monensin A and Bafilomycin A. No significant changes 
are observed with Nocodazole or Wortmannin. 
 
Figure 3-35 Effect of endosome processes inhibitors on IL-8 induction via Cag apparatus 
IL-8 fold induction relative to pre-treated AGS cells not infected. IL-8 induction by wild type strains P12, 
P217 and P145 on pre-treated cells after 3 hours infection MOI 60. Control, AGS cells with no inhibitor, 
infected. MDC, Mono-dansylcadaverine. Data correspond to at least two independent experiments. 
3.4.1.2.3 Cag apparatus and clathrin 
As already observed using inhibitors for clathrin and dynamin, clathrin seems to play an 
important role in the function of the Cag apparatus. To confirm this visually, 
immunofluorescence was done where co localization of GFP wild type bacteria and 
immunodetected clathrin was revealed (see figure 3-36A). Given the fact that only 5-9% of 
bacteria present the Cag apparatus at the infection time, we tried to confirm that it is a Cag 
dependent event. The apparatus was detected using antibodies against the CagY RRII and 
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looked for co-localization with clathrin. As exposed in figure 3-36B, there was co-localization 
of CagY with clathrin. 
 
Figure 3-36 Co-localizations of CagPAI containing bacteria and its CagY with clathrin 
(A) AGS infected with GFP-expressing P12 wild type strains or P12∆PAI for one hour were fixed and 
permeabilized in order to immunodetect clathrin heavy chain (red). Z-stack sections were taken with 0,2µM 
and merged to one slide. Only P12 wild type co localizes with clathrin molecules. (B) P12 GFP expressing 
bacteria (green) after 30 minutes infection of AGS cells were fixed and CagY as marker for apparatus (blue) 
was immunodetected using a Alexa647-conjugated antibody (AK273) and clathrin heavy chain using a 
secondary antibody Alexa555 conjugated (Red). Arrows point at co-localization places of CagY and clathrin 
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3.5 EM studies of the Cag apparatus 
3.5.1 Structure of the Cag apparatus 
The structure of a Type IV Secretion apparatus is unknown until today. In collaboration with 
Dr. Valério Matias, from the Max Planck Institute for Biochemistry, in Martinsried, Germany; 
aproject was started with the purpose to elucidate the structure of the Cag apparatus using 
Cryo Electron Microscopy Tomography (Cryo-EM). The first step was to solve a problem 
noticed in previous Electron Microscopy (EM) studies: the low amount of Cag apparatus on 
the surface of H. pylori. Therefore, the first effort was to discover a stimulus for the formation 
of the apparatus. 
During previous experiments, different conditions were tested to obtain the best CagA 
translocation and phosphorylation in AGS cells. It was observed that infections with strains 
P12 and 26695 of AGS cells in PBS solutions without divalent cations, reduced by a factor of 
four the time normally necessary to observe a strong CagA-translocation/phosphorylation 
related phenotype called the “Humming bird” phenotype. At the same time, it was observed 
changes in the consistence of the PBS after long exposure of the cells to it. What originally 
was a fluid solution, changed to become visible viscous, without changes in turbidity.  
With these observations, a new protocol was designed to stimulate the bacteria to produce the 
Cag apparatus without the direct contact of eukaryotic cells. AGS cells were seeded and left 
24 hours to grow in normal conditions to a confluency of 70% to 80%. Cells were washed and 
exposed to PBS free of calcium and magnesium for 60 minutes in low CO2 conditions at 
37°C. The PBS was collected, sterile filtrated and named AGS exudate. Bacteria were 
resuspended in this exudate and incubated for 90 minutes in 5% CO2 at 37°C; afterwards they 
were prepared with negative staining for the EM. 
About 20% to 30% more pilus structures were observed in strains 26695 when exposed to the 
AGS exudate in comparison to the ones in PBS control solution. The structures observed are 
depicted in figure 3-37. Two forms were identified, a “naked” form and a “sheathed” form. 
The naked form has a diameter of 20-25 nm, and seems to be formed by regular subunits 
arranged in a helical macrostructure that contains an inside channel of 2-3 nm diameter. The 
sheathed form contains the “naked” form covered by a 10 nm dick “coat”, which has not been 
identified yet. The sheathed structures appear to be attached to bacteria cells as seen in figure 
3-38. 
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Figure 3-37 Cag apparatus sheathed and naked forms 
Electron microscopy pictures of the (A)“sheathed” form and the (B)”naked” form pilus like extensions after 
90 minutes stimuli of strain 26695 with AGS exudates. Preparation as negative staining. Bars indicate 50 
nm. 
 
Figure 3-38 Cag apparatus attached to bacteria 
Electron microscopy pictures of the (A)“sheathed” pilus like structure and the (B) connection part with the 
bacterium formed after 90 minutes stimuli of strain 26695 with AGS exudates. Preparation with negative 
staining. Scale bars represent 50 nm 
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3.5.2 CagY is not part of the sheath, but CagC constitutes part of the 
naked form 
It was observed that the mutant 26695∆cagY did not present any sheathed form, but only the 
naked one. Because of this observation, the first evaluation was to prove that the CagY was 
found as part of the sheath. Using the antibody AK273 that recognizes the CagY repeat region 
II (AK273), immunostaining was done from purified “pilus-like structures” from H.pylori 
strain 26695. The immunolabeling did not stain the sheathed or the naked structure (data not 
shown). 
 
Figure 3-39 Specificity of antibody against CagC in immunofluorescence 
Strain 26695 and the cagC mutant (26695∆cagC) are stained using DAPI (red) to stain their DNA. 
Antibodies against CagC, AK576 and AK577, were added in concentration 1:1000 to 1% PFA fixated 
bacteria and labeled with an anti-rabbit secondary antibody Alexa488 labeled in dilution 1:2500 (green). Bars 
represent 10µm.  
It was tried to identify the protein that composes the naked form. Based on its regularity and 
on the homologies to the VirB system, it was postulated that this protein could be CagC. For 
the detection of CagC protein two antibodies were developed, the AK576 and the AK577. In 
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immunostaining experiments, only the AK576 stained the bacteria in a specific way (Figure 
3-39). The anti-CagC antibody AK576 shows a high specific binding, with very low 
background staining in the cagC mutant, contrary to the case of AK577 antibody, which 
stains bacteria in an unspecific manner (Figure 3-39D). 
 
Figure 3-40 EM Immunogold detection of CagC on the apparatus 
After induction of formation of the pilus-like structures, the “naked” form was immunostained using an anti-
CagC antibody (AK576) as primary antibody and an anti-rabbit IgG gold labeled secondary antibody. Bars 
represent 100 nm. 
Since anti-CagC antibody AK576 is specific for CagC, 26695 strains were induced in AGS 
exudate as done before. Their pilus-like extensions were gold immunostained for EM 
pictures. As seen in figure 3-40, gold particles associate with the “naked” form seen before. 
The gold particles associate only with those subunits that have broken apart from the pilus-
like structure, and they are found in the part that forms the inner channel observed in this 
sheathed form. This data confirms that CagC protein is a component of the “naked” form of 
the apparatus. 
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4 Discussion 
4.1 Cag apparatus effect on cell migration 
The motility of cells, especially of hematopoietic cells, is essential for the correct function of 
the immune system. In the last years, there have been great progresses made in the 
understanding of the mechanisms that allow immune cells to respond to an infection, move 
towards a tissue and find their target. Molecules like fMLP or IL-8 are sensed by leucocytes, 
inducing a cascade that ends in the polarization of the cells. This polarization is essential for 
movement towards the stimulant’s source. The motility towards the attractants source is based 
on a sense of a concentration gradient (Futrelle, 1982). This allows the cells to find the place 
where they are needed. To be able to investigate an effect on the motility via the Cag 
apparatus, the motility of the cells through a membrane and towards a chemoattractant using a 
Boyden Chamber was tested. In these experiments was observed that independently from the 
chemoattractant, cells are disturbed in their capacity to cross the membrane in a CagA 
dependent manner (Figure 3-2). Even though there is a reduction of about 60% motility, it is 
not completely lost. These results left the question open in which part of the motility 
associated processes, the CagA was acting. To answer this question, imaging studies were 
necessary.  
As part of the physiological function of immune cells, leucocytes travelling in the circulatory 
system attach to the endothelial cells forming the blood vessels as a response to 
chemoattractants. They achieve this through interaction with selectins and the involvement of 
integrins. Once cells have attached, they polarized by forming a migration front or 
lamellipodia, and a migration rear or uropod (Zigmond, 1978). The formation of these two 
parts is necessary to start migrating towards the tissue between or through the endothelial 
cells (diapedesis). In this step, a movement on the surface of the endothelial cells’ membrane 
is required, and integrins have been described to play an essential role in it (Lock et al., 2008). 
Because the movement takes place over a surface, it could be considered as a 2D movement. 
This kind of movement was observed in the experiments using the agarose assay. In the “2D” 
agarose system, cells are able to form a lamellipodia and a uropod, presenting the polarization 
essential for motility (Figure 3-3). After infection with H. pylori strains expressing CagA, 
cells are still able to migrate, however in an erratic manner. They presented modified and 
bizarre forms of the uropod as well. This leads to the question, which of all effects related to 
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CagA phosphorylation is responsible for this? Phosphorylated CagA has been reported to 
disturb the function of FAK and, in this way, the connection of integrins with the cytoskeleton 
(Tsutsumi et al., 2006). If that is the case in our experimental setup, no lamellipodia could be 
formed. Lamellipodia are formed by assembly of Focal Adhesions, which support the traction 
of the cytoskeleton and move the cell forwards (Broussard et al., 2008). The fact that 
lamellipodia are still observed indicates that CagA is, in this case, not acting on the function 
of FAK. This could be the consequence of the very low MOI used in these experiments (MOI 
5) and the fact that CagA is not effectively translocated into these cells. 
What happens with leucocytes on their way into the tissue? It was assumed that integrins were 
responsible for the motility of the cells once they had crossed the endothelial barrier and they 
were in the interstitial tissue. Their function was to interact with the Extracellular matrix 
(ECM) proteins and facilitate the movement. This idea was until lately reformulated 
(Lammermann et al., 2008). Lammermann et al. have demonstrated that cells, once they are 
immersed in the interstitial compartment, need to turn off the activity of the integrins in order 
to move through it. If integrins are activated as the cells move inside the tissue, they stop the 
motility and lose the polarization. Considering this observations, a different point of view 
could be used to analyze the effect that H. pylori has on the behavior of dHL-60 cells 
migrating in a 3D collagen matrix. As seen in figure 3-4, all cells infected with wild type 
strain, lost any sign of polarization. It was not the case for infections of dHL-60 cells with the 
cagA mutant, where some cells are still able to polarize in the collagen matrix. For cells 
infected with H. pylori lacking the cagPAI, there was no difference at all with the uninfected 
cells. Based on this, it is possible that CagA is able to activate the integrins and, by doing so, 
inhibits the movement of cells into a three dimensional system.  
CagA reduces the motility of dHL-60, which are used as example for leucocytes movement 
(Figure 3-4). Future research should answer if this occurs as well in primary leucocytes, and if 
the effect on 3D motility is caused by activation of integrins in a direct or indirect way. There 
is the possibility that activation could be already caused from outside, since CagA 
translocation is reduced in these cells. It would make the CagA a very good 
immunomodulator as extracellular toxin if bacteria were able to secrete some of it in the 
environment. In this way, the toxin could interfere with the immune cells function without the 
need of physical contact between bacteria and cells. There are several bacterial proteins able 
to manipulate at least one of the two main systems associated with motility, as they are the 
cytoskeleton and the GTPases Rho, Rac and Cdc42. Some of the cytoskeleton disrupting 
bacterial proteins are ActA from Listeria monocytogenes, IcsA from Shigella flexneri and Tir 
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from E. coli EPEC. These proteins modify the cytoskeleton by manipulating the actin 
polymerization through changes that lead to modified Arp2/3 complex function (Ahmadian et 
al., 2002). On the GTPases, bacterial proteins can act as functional mimicry taking over the 
function of the eukaryotic GAPs (GTPase Activating Proteins) and GEFs (Guanine-nucleotide 
Exchange Factors). These proteins are responsible for controlling the transition state of the 
GTPases. By controlling their transition state, proteins like YopE (Yersinia spp.), ExoS ( 
Pseudomonas aeruginosa), SptP and SopE / SopE2 (Salmonella typhimurium) are able to 
alter the host phagocytic process and invade the host cells or avoid phagocytosis  (Galan, 
2001; Heesemann and Aepfelbacher, 2001; Zhou et al., 2001). At the same time, the function 
of the GTPases can be modulated by covalent modifications (Aktories and Barbieri, 2005) as 
caused by the toxins ADP-ribosyltransferase C3 from Clostridium botulinum (Wilde et al., 
2000) and E. coli cytotoxic necrotising Factor 1 (CNF1) (Fiorentini et al., 1997). Although 
many bacteria pursue the objective of getting inside the cells to survive in them, H. pylori 
remains mostly extracellular. H. pylori’s Cag T4SS has been associated with changes in the 
cytoskeleton and CagA has not been found to interefere with any of these ways until now (Al-
Ghoul et al., 2004), making a possible extracellular effect on motility a new mechanism for a 
bacterial protein to disturb the motility of cells. 
4.2 Integrin β1 as receptor of the Cag apparatus 
4.2.1 Integrin β1 is necessary for CagA translocation 
Part of the studies with dHL-60 cells revealed a difference in the CagA translocation in 
comparison to their parental cell line HL-60 (Figure 3-5). The comparison of their mRNA and 
proteome indicated the possibility that integrins could play an important role in CagA 
translocation. This necessity was further demonstrated as the integrin β1 subunit was found to 
be essential for CagA translocation (Figure 3-6). To better understand the role of integrin in 
the CagA translocation, it is important to know more about the integrin family. 
Integrins are a family of heterodimeric transmembrane proteins which to date include more 
than 28 recognized members. They are composed of an alpha (α) subunit in combination with 
a beta (β) subunit. One subunit cannot work without the other, and because of this property, 
several of the functional mutations used for their study concentrate in only one of the 
subunits. As members of the transmembrane protein category, integrins are composed of a 
cytoplasmic tail (20-60 amino acids), a short transmembrane domain and an extracellular 
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domain (700-900 amino acids) (Travis et al., 2003). Each domain possesses a function, which 
has been carefully studied over the last 25 years. The first member of the family to be 
discovered was the integrin β1, in that time called fibronectin receptor and today denominated 
CD29 or ITGB1. This protein showed an amazing capacity to resist trypsin digestion 
(Sczekan and Juliano, 1990). Their study gave a better understanding of the importance of the 
extracellular matrix (ECM) milieu in the physiology and function of cells. With the discovery 
of the interaction of ECM proteins with integrins, their remarkable property of not only 
transmitting signals from the outside of the cell to the inside, but as well to respond from the 
inside environment of the cells with changes on the outside was found. They achieve this by 
modifying their affinity capacity to ligands. This behavior has been called inside-out 
signaling. In this way they can regulate adhesion of the cells to their surroundings, initiate and 
enhance signaling cues from growth factors and mediate processes linked to the cytoskeleton 
(Pozzi and Zent, 2003). This explains their presence in all types of cells and its essentiality in 
the embryonic development in the mouse (Fassler et al., 1995). Since integrin β1 is present in 
all cells of mammals (except on erythrocytes), it makes it an excellent molecule that will 
allow access to all kind of cells, independent of their origin and function. Many pathogens 
have discovered these advantages and exploit the integrins as triggering molecule to enter the 
cells. This is the case for Yersinia spp. through their invasin protein (InvA) (Isberg and 
Leong, 1990) and its direct interaction with the integrin heterodimer, or as binding surface 
through ECM proteins as it is the case of Staphyloccocus aureus (Sinha et al., 1999).  
It is now possible to add Helicobacter pylori and its Cag T4SS to the growing list of bacteria 
that uses integrins. The essentiality of integrin β1 as receptor for the CagA translocation was 
not only confirmed but also a direct correlation was established between the amounts of 
integrin β1 found on the surface of the cells and the CagA translocation/phosphorylation 
(Figure 3-7).  
4.2.2 Integrin β1 signaling and CagA translocation 
As part of their inside-out signaling, integrin β1 (ITGB1) interacts via their cytoplasmic 
domains with proteins linked to cytoskeletal functions like Talin, Cortactin, ILK (integrin-
linked kinase) and FAK (Focal Adhesion Kinase). The function of integrins has been defined 
as being dependent on the level of activation and their capacity of aggregation within 
membrane compartments or lipid rafts (Leitinger and Hogg, 2002). They have not only been 
shown to interact with cytoskeletal proteins, but as well with other receptors, such as the 
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Epithelial Growth Factor (EGF) Receptor or EGFR. (Kuwada and Li, 2000). Considering the 
importance of the signal transfer through the membrane, it was necessary to define its 
relevance in the interaction between the eukaryotic cell and the Cag apparatus. Therefore, 
experiments followed, which evaluated the importance of the cytoplasmic domain and one of 
the signaling pathways (ILK) associated with integrin β1 on CagA translocation (Figure 3-8). 
The fact that the expression of only transmembrane and extracellular domain of integrin β1 
renders CagA-translocation non-permissible cells (CHO-K1) permissive to CagA 
translocation is remarkable. Together with the results showing that disruption of the ILK 
pathway in AGS cells does not influences the CagA translocation levels, lead to the 
conclusion that the interaction between Cag apparatus and integrin β1 requires neither the 
cytoplasmic tail nor the ILK pathway in order to translocate CagA into the eukaryotic cell 
effectively. This defines a novel form of interaction with integrin β1, since all pathogens 
described to date, which are able to interact with integrins, do so in order to exploit the 
integrin’s capacity to relay information from the extracellular environment to the cytoplasm 
of the cell, starting signaling processes that would give pathogens some kind of advantage. 
These advantages are to facilitate invasion (Yersinia spp. (Hamzaoui et al., 2004), Bordetella 
spp. (el and Skurnik, 2001), Shigella spp. (Nhieu and Sansonetti, 1999), Salmonella spp. 
(Kingsley et al., 2004), Streptococcus pyogenes (Cue et al., 2000) and Staphylococcus aureus 
(Fowler et al., 2000)) or to intensify their adherence for persistence (E. coli (Frankel et al., 
1996)). Therefore, for H. pylori there has to be an advantage in order to use integrin β1 as a 
receptor as well. The next aspects evaluated in the relation between Cag apparatus and 
Integrin β1 should help to elucidate this advantage. 
4.2.3 The role of integrin β1 in CagA translocation is through direct 
interaction of Cag apparatus components and the integrin β1 
subunit 
Many of the above mentioned bacteria are able to interact with the integrin β1 in an indirect 
way. Most of them through interaction with ECM proteins as fibronectin and fibrinogen, 
which are able to bind through their RGD motifs to the alpha subunit of the integrin 
heterodimer (Krysko et al., 2004) (Smith and Cheresh, 1990). Therefore, it was necessary to 
determine if the Cag apparatus functionality involved a direct or indirect interaction with 
integrin β1. To achieve this, experiments testing the binding of soluble integrin β1α5 (Figure 
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3-10 and 3-11) to H. pylori in a Cag dependent manner were performed. As a result, it was 
observed that the soluble integrin β1α5 was able to bind to the bacteria in a Cag dependent 
manner. There was less background binding when bacteria were grown on serum-free 
conditions and, therefore they were free of ECM proteins. This correlation between Cag 
apparatus presence and integrin β1 was observed in infection conditions as well, where 
integrin β1 on AGS cells showed a co-localization with bacteria containing Cag apparatus 
proteins (Figure 3-12). It is interesting to see that using two different experimental setups it 
was confirmed what in previous EM experiments was observed (Rohde et al., 2003). Only a 
small percentage (5% -12%) of H. pylori bacteria (wild type strain) showed a functional 
apparatus, an apparatus able to interact with the integrin β1 (Figures 3-11C and 3-12B). 
Not all these experiments can exclude the possibility that integrin interaction could take place 
with the alpha subunit through its I-domain, which binds to ECM proteins (Lee et al., 1995). 
This possibility was open since one of the proteins essential for the Cag apparatus 
functionality contained a RGD domain. The protein is CagL, encoded by the hp0539 gene in 
H.pylori strain 26695. Experiments done with the invasin (Inv) protein of Yersinia spp. 
showed that by using RGD containing peptides, the binding of Inv was inhibited, possibly 
through competition for the RGD binding domain (Van Nhieu and Isberg, 1991). Following 
the same principle, the CagA translocation was tested in presence of RGD peptides (RAD 
peptides as control), the invasin fragments Inv397 and Inv197 (minimum fragment from Inv 
binding to integrin β1α5) (Leong et al., 1995) and fibronectin. The binding of these proteins 
would compete for the I-Domain (or αA domain) binding pocket of the alpha subunit with the 
Cag apparatus proteins, possibly even with CagL, and inhibit the CagA translocation. The 
results summarized in Table 3-1 showed that there was no effect on the capacity of 
translocation of CagA under these conditions. At the same time, by testing CagA  
translocation in different cells lines, it was observed that this succeeded regardless of their 
cellular background (epithelia (AGS, GE11β), fibroblast (GD25β) or hematopoietic (HL-60, 
Jurkat). Different cellular backgrounds increased the chances that different sets of α subunits 
are expressed with the integrin β1 subunit. These data indicated that the interaction with the 
cells integrins could be limited to the β subunit.  
Assuming that this interaction is between the Cag apparatus and the integrin β1 subunit 
extracellular part, Y2H assays were performed in order to identify the interacting partners of 
the apparatus. These assays identified the Cag components CagA (N-terminal), CagY (C-
terminal) and CagI as possible interaction partners of the integrin β1 subunit. The lack of 
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interaction with CagL, suggested that CagL did not seem to be interacting with the integrin β1 
extracellular domain. These results were expected, since the RGD binding partner is not 
mainly on the β subunit, but on the A domains of the α subunit of the integrin heterodimer. 
The Y2H interactions were successfully confirmed with pull down experiments using soluble 
integrin β1α5 and integrin β1α1, as well as with GST fusion proteins of CagA (full size), 
CagYc and CagI and their specific binding to cells containing integrin β1 (Figures 3-14, 3-16, 
3-17C, 3-18B and 3-19B). After it was established in our lab that CagL does not play a role in 
the integrin β1-Cag apparatus interaction, the group of Steffen Backert (Kwok et al., 2007) 
published that CagL is essential for the functionality of the apparatus. They claimed that the 
necessity of CagL depends on its RGD motif, which allows an interaction with the integrin 
β1α5 on AGS cells. These data contradict the experimental data presented here. In order to 
clarify this situation, P12 bacteria were generated in which cagL was deleted and mutants 
were complemented with wild type cagL (cagL RGD) and CagL forms lacking partial or the 
whole RGD domain (cagL RAD and cagL∆RGD). As presented in figure 4-1, the RGD 
domain from CagL is neither necessary for CagA translocation nor for IL-8 induction. Since 
the results claiming the necessity of an RGD domain on CagL were not reproducible and the 
data obtained in the time of this thesis support that RGD does not play an essential role in 
CagA translocation, no further experiments followed in order to revalidate the published data. 
 
Figure 4-1 RGD domain from CagL is not essential for CagA translocation 
Immunodetection of CagL, CagA and phosphorylated CagA after infection of AGS cells with P12 strains 
wild type and cagL strain mutants. These mutants were complemented with cagL containing the wild type 
RGD motif, substitution of the glycine (cagL RAD) and deletion of the RGD region (cagL∆RGD). IL-8 data 
from each of the infections. The experiments were done three times. The IL-8 is represented by the 
percentage in comparison to the wild type infection. 
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As said before, Cag apparatus proteins CagA, CagI and CagY are interacting directly with the 
integrin β1 subunit. Which of the integrin β1 domains are relevant for this interaction? 
Knowing the exact domain could give an idea of how the Cag apparatus exploits the binding 
to integrin β1 to translocate CagA into the cell.  
 
Figure 4-2 General domains of integrin and their activation status 
Integrin alpha subunit contains a β propeller in which the I-domain (or αA domain) is found. They are 
followed by the Thigh domains and the Calf1 and Calf2 domains connected to the membrane through the 
transmembrane domain. The β subunit contains a PSI domain, followed by the I-like domain or the βA 
domains found between the hybrid domains. A highly cystein rich domain (EGF 1.4) attached to the hybrid 
domain connects the βTD to the rest of the extracellular part of the integrin β subunit. The three possible 
conformational states of the integrins, with different affinities and their structural movement (bottom). 
Each of the domains in the integrin β subunit is important for the function of the integrin 
heterodimers. The function of the integrin β subunit is accomplished through specific 
interactions with the α subunit. The domains are represented in figure 4-2. In the structure of 
integrins, as mentioned before, both subunits, α and β, are transmembrane proteins. On the 
integrin β subunit at the N-terminal part the PSI (Plexin, Semaphorins and integrins) domain 
can be found. This domain is usually not accessible in inactivated integrins, only in activated 
forms (see figure 4-3). Activated integrins are able to bind to their ligands though the binding 
pocket formed by the I-domain of the α subunit supported by the I-like domain of the β 
subunit. The α subunit contains a bivalent-cation-binding domain at the N-terminal part, in 
the region denominated αA domain or I-Domain (Lu et al., 1998; Oxvig and Springer, 1998). 
In the I-like domain of the β subunit, Mg2+ and Ca2+ bind and activate/inactivate the integrins. 
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The binding of integrins to their ligands is always bivalent-cation dependent. This means that 
integrins are stimulated to bind to their ligands by Mg2+, and are partially inhibited by Ca2+, as 
shown for the first time for the heterodimer integrin β1α5 (Gailit and Ruoslahti, 1988).  
Since the Y2H assays showed to be a reliable way to explore integrin β1 with Cag apparatus 
interactions, a new Y2H assay was designed, in which the different domains of integrin β1 
were scanned for interactions with the Cag proteins as mentioned before (Figure 3-21). The 
results of this assay, in conjunction with the fact that CagA translocation could be inhibited 
only by one antibody against integrin β1 (Figure 3-22), has led to the construction of the 
model presented in figure 4-4. In this model, the apparatus is able to bind to the activated 
form of integrin β1. This hypothesis is supported by the results showing higher CagA 
phosphorylation levels in conditions where integrin β1 is activated through exposure to 
MnCl2, which is reported to act similar to Mg2+, activating integrins by binding to the MIDAS 
(Metal Ion-Dependent Adhesion Site) pocket in the I-like domain of integrin β1 (Mould et al., 
2002) (Figure 3-9B). The possibility that the Cag apparatus binds to an activated form of the 
integrin β1 is supported as well by the fact that CagYc, whose interacting domain partner 
seems to be the PSI domain, is able to bind  with higher affinity to the integrin β1 expressing 
cells (Figure 3-23D) when Mn2+ is present. The presence of Mn2+ induces the extension of the 
integrins complex leaving the PSI domain of the β subunit accessible for the GST-CagYc to 
bind to the integrin β1. 
The binding of CagA to the EGF-like domains (EGF (1-4)) and the β-tail domain (βTD) 
region as well as the binding of CagI to the βTD, are based on the Y2H assays results, but 
further experimental data needs to be done to confirm these observations. CagA was 
confirmed to be located on the surface of the apparatus, on the area around the tip, putting it 
on the right place for interaction with integrin β1, as it is shown in the EM immunogold 
pictures in figure 3-20. 
In the model  here, the necessity of a “bendable” form of the integrin β1 subunit for CagA 
translocation has been derived from the results obtained with the use of the anti-integrin 
antibody clone 9EG7.In this case the antibody is able to successfully block the CagA 
translocation in a binding dependent manner (Figure 3-22B & 3-22C), without inhibiting the 
binding of CagA, CagYc or CagI (Figure 3-23A). Although 9EG7 antibody recognizes an 
overlapping region of the integrin β1 that was identified via Y2H to be the possible binding 
domain of CagA N-terminal half  to the integrin β1 (domains EGF (1-4) and part of the β-
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TD), there was no competition between both of them. The fact that competition between the 
GST-fusion proteins and 9EG7 does not take place, indicates that the inhibition of CagA 
translocation by the 9EG7 antibody could be related to a conformational blockade of integrin 
β1 caused by the antibody. The 9EG7 antibody binds to human integrin β1 under activating 
conditions, which can be induced by either Mn2+ or Dithiothreitol (DTT) (Mould et al., 1995) 
(Ni et al., 1998) and is therefore associated to be a conformational epitope (Bazzoni et al., 
1995). Several crystal structural studies, as well as EM negative staining studies, have 
revealed a bend/extended conformation change associated with the inactive/active form of the 
integrins (Arnaout et al., 2007). Most of these studies have been done on heterodimers 
containing integrin β3, but it has been accepted as a standard model for the integrin family 
members containing the same domain regions, as it is the case for integrin β1 heterodimers. In 
the “bend” or inactive form, the structure is completely bent on the “knee” region located on 
the β subunit between the EGF1 and EGF2 domains and stabilized in this bended form by 
interactions between the PSI-Hybrid-EGF and EGF (2-4)-βTD. Several contacts have been 
observed as well between the EGF (1-4) and βTD domains of the β subunit with Calf 1 and 
Calf 2 domains of the α subunits (Xiong et al., 2001), through the disulphide bridges between 
their cysteins (Kamata et al., 2004) (See Figure 4-2 for the bend and extended forms). In this 
latter region, the conformational epitope has been mapped and identified by 9EG7 antibody 
upon activation of the integrin β1. It is plausible that the binding of the antibody in these 
regions blocks the formation of the bridges and thus blocking the integrin in the extended 
form. This conclusion is supported by the PhD thesis of Michael Kristin while he was 
working with the biophysical properties of Focal Adhesions at the Georgia Institute of 
Technology (2006). If the binding of this antibody can cause a blockade of the bending of 
integrin β1, it would mean that this molecular movement is required by the Cag Type IV 
Secretion System, with the objective to get closer to the membrane. 
From all other antibodies tested, none had an effect on CagA translocation, even though some 
like AIIB2, 12G10 and 8E3 are reported to affect the affinity of the integrin β1-containing 
heterodimers to their ligands (Takada and Puzon, 1993) (Mould et al., 1995), indicating that 
the I-domain, containing the ligand binding pocket, is not essential for CagA translocation. 
This data correlates with the lack of competition between the Cag apparatus and the I-Domain 
of the alpha subunit. 
Experiments were performed as well with antibodies directed against the PSI domain, N29 
and 8E3. Both epitopes recognized by them are found on the inside of the PSI domain, which 
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faces the α subunit (Mould et al., 2005). Knowing this, it is not surprising that these 
antibodies were not able to block the CagA translocation. Considering the model proposed 
(see in Figure 4-3) the antibodies could not compete with the CagYc of the apparatus because 
they would have a different binding region. At the same time, the study of the effects of these 
antibodies by Mould et al., indicates that their efficiency to stimulate activation is present 
only when the Calf-2 domain is absent. These results can be interpreted as a hierarchy of 
activation/inactivation motifs, in which the Calf-2 domain interaction with the EGF (2-4)-
βTD has a higher control of the activation than the PSI domain. This correlates at the same 
time with our model based on the fact that only the 9EG7 antibody inhibits the CagA 
translocation. 
 
Figure 4-3 Model for Interaction of Cag apparatus with integrin β1. 
Represented are the actual models of the Cag apparatus and the interactions of CagY, CagA and possibly 
CagI with the PSI, EGF and βTD domains of integrin β1 respectively. The binding of the apparatus or the 
apparatus itself, induces the bending necessary to get the pilus-like structure closer to the membrane. The 
blocking of this bending of integrin β1 could be the mechanism of action of the 9EG7 antibody.  
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4.3 Relevance of cellular processes for CagA translocation 
Integrins function is dependent on a successful clustering (Vitte et al., 2004). Normally, 
clustering takes place in microdomains in the cell membrane named lipid rafts. Lipid rafts or 
microdomains have been defined as regions in the cell membrane rich in 
Sphingolipid:cholesterol composition, resistant to extraction in detergent conditions (1% 
Triton, 4°C) (Brown and London, 2000; Brown and Rose, 1992). The presence of cholesterol 
in these regions confers to the cell membranes special flexibility, that allows the curvature 
necessary for internalization events (Mukherjee and Maxfield, 2004). Even though 
transmembrane proteins are not usually associated with cholesterol, association of 
transmembrane proteins with lipid rafts have been found in cases where the proteins undergo 
an oligomerisation process (Cherukuri et al., 2001). In the case of integrin, binding events are 
not dependent on the cholesterol levels of the membrane, but cholesterol seems to be 
indispensable for signaling events related with the cytoskeleton as demonstrated for integrin 
LFA-1 (αLβ2) and β1α4 (Leitinger and Hogg, 2002). Since the important role of integrin β1 in 
CagA translocation has been established, it is necessary to explore cellular processes related 
with the function of integrins. During determination of the integrin functions required for 
CagA translocation, the irrelevance of the cytoplasmic domain of the integrin β1 and the 
associated ILK pathway for CagA translocation has been recognized. However, because of 
their localization imbedded in the lipid bilayer, the transmembrane region does not only play 
a role in the anchoring of the integrins to the membrane. The conformational changes, 
associated with their inside-outside and outside-inside signaling, could have an effect on their 
association with the lipids in the membrane for transmitting signals to the cytoplasm. To date, 
more research has been done to discover this relation (Arnaout et al., 2007). A direct way to 
search for the necessity of the transmembrane domain and its effect on clustering for CagA 
translocation was the disruption of the lipid content in the membrane of the cells. The result 
of cholesterol depletion by a Methyl-β-Cyclodextrin (MBC) of AGS cells, conferred the cells 
with an apparent resistance to CagA translocation (Figure 3-30A). This resistance could be 
associated with the incapability to cluster the integrins by lipid raft association. However , 
these results could be an indirect consequence on the recruitment and not on the enzymatic 
activity, of Src kinases to the membrane. Src kinases are recruited to the membrane through 
their myristoylated and palmitoylated moiety that gives these kinases a higher preference to 
the ordered lipid domains in the membrane (Buss et al., 1986; Robbins et al., 1995). Since 
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CagA seems to have a membrane preference (Higashi et al., 2005), the phosphorylation would 
not take place in cholesterol-depleted cells if the Src recruitment were as well disturbed.  
In order to confirm the relevance of clustering, calpeptin, a Calpain inhibitor, was tested 
(Figure 3-30C). Calpain is a cystein protease, and its activity has been related with the 
function of integrins on migration (Calle et al., 2006). The Calpain protein, a calcium 
dependent protease; plays an important role in the disassembly of focal contacts where 
integrins are linked to the cytoskeleton. Calpain can act by cutting the cytoplasmic tails of 
integrins, which is important for the formation of new small clusters, and create new focal 
adhesions (Huttenlocher, 2005) or by digestion of Talin, whose products had been shown to 
induce the clustering of β3 integrins (Ginsberg et al., 2001). By inhibiting the function of 
Calpain, clustering of integrins is reduced, or even blocked as demonstrated in motility effects 
on T-lymphocytes (Stewart et al., 1998). The fact that Calpain inhibition, through use of 
calpeptin, blocks CagA translocation could be associated with the necessity to cluster of 
integrin β1. The activity of Calpain is calcium dependent and it can explain the effect seen by 
the use of BAPTA, a membrane permeable calcium chelator. Pre-treatment of AGS cell with 
BAPTA can almost abolish the CagA phosphorylation (Figure 3-9). In an excellent study by 
Marlink et al., it was shown that one of the earliest events associated with a functional Cag 
apparatus was the release of intracellular calcium stocks from the Sarcoplasmic/Endoplasmic 
Reticulum, with the help of the Sarcoplasmic/endoplasmic reticulum Calcium ATPases 
(SERCA) (Marlink et al., 2003). It is possible that the first effect of Cag apparatus 
components, triggered by binding to the integrin β1, induces an elevation of calcium 
concentration in the cytoplasm to induce the activity of calpains and therefore allowing the 
clustering of the integrins. 
If clustering of integrin β1 is necessary for CagA translocation, the possible following effect 
caused by the Cag apparatus could be the initiation of internalization by endocytic processes. 
In general, cells are able to take up molecules from the environment through different 
endocytic processes. These processes include the involvement of proteins like caveolin, 
clathrin, flotillin or actin (Miaczynska and Stenmark, 2008). Their function is to support and 
allow the deformation of the membrane in order to engulf particles and take them inside the 
cells. Since all of them have been associated with a functional actin polymerization, its 
necessity for CagA translocation was evaluated. In the case of H. pylori CagA translocation, 
the exposure of cells to cytoskeleton disruptors, such as Cytochalasin D or Jaxplakinoline, 
showed no defect on the CagA translocation and phosphorylation (Figure 3-30A and Table-
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1). Since microtubules are involved in the transport of vesicles from the membrane towards 
the inside of the cells, microtubule disruptor Nocodazole was tested as well, giving the same 
results (Table 3-1). Based on these results, it was assumed that endocytic processes do not 
take part in the CagA translocation. However, reports claiming that the cytoskeleton is not 
essential for a successful clathrin dependent endocytic process (Kirchhausen, 1999; Mousavi 
et al., 2004; Rappoport et al., 2004) reopened the question of endocytosis and CagA 
translocation. To be able to rule out completely the possibility that endocytic processes are 
related with the CagA translocation, two inhibitors of clathrin were used: Mono-
dansylcadaverine (MDC) and Dynasore. Each inhibitor disturbs a different part of the clathrin 
dependent endocytosis. MDC is claimed to inhibit the recycling of clathrin for the formation 
of new Clathrin Coated Pits (CCP) and therefore, Clathrin Coated Vesicles (CCV) are not 
formed (Phonphok and Rosenthal, 1991). Dynasore, on the other hand, is a specific inhibitor 
of the ATPase activity of Dynamin (Macia et al., 2006). Dynamin is a protein associated with 
the recruitment of clathrin molecules to membranes as well as with the final excision of CCP 
from the membranes to form CCVs (Rappoport et al., 2003) (Ehrlich et al., 2004) (Roux et al., 
2006). As presented in figure 3-33A and 3-33B, the use of these two inhibitors shows that 
CagA translocation requires an intact clathrin pathway, since no CagA phosphorylation is 
detected in their presence. Any possible inhibitory effect on the bacteria could be ruled out in 
time experiments or by direct exposure of bacteria to the inhibitor (Figures 3-33C and 3-33C). 
These results implied that the CagA phosphorylation requires clathrin or clathrin components 
for CagA to be translocated into the cytosol. If a successful uptake via CCV is necessary for 
CagA translocation, the question arises, what mechanisms are necessary for the CagA 
transport from the lumen of the clathrin formed vesicle into the cytoplasm in order for CagA 
to be phosphorylated by Src kinases?. 
Fibroblast Growth Factor 1 (FGF-1) is able to escape the lumen of endocytic vesicles and to 
enter the cytoplasm. In the studies by Malecki et al. (Malecki et al., 2002) several methods are 
described to examine if extracellular added FGF-1 is translocated into the cytoplasm after 
endocytosis through events linked to acidification of the endosome or to changes of vesicle 
membrane potentials. They used ammonium chloride (NH4Cl) and Monensin A (Na+/H+ 
antiporter, inhibits acidification of endosomal lumen), as well as Bafilomycin A and 
Concanamycin A, both vacuolar proton pump inhibitors. In their study, they found that FGF-1 
was blocked by treatments that altered the membrane potentials. In a following paper, they 
discovered that the translocation effect was supported by Hsp90 (Wesche et al., 2006), a 
chaperone protein that has been associated as well with the IL-8 induction by H. pylori Cag 
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apparatus (Yeo et al., 2004). To evaluate if CagA translocation into the cytoplasm uses a 
similar mechanism as the FGF-1, infections were done in presence of Monensin A, 
Concanamycin A (inhibitor of vacuolar ATPases), Bafilomycin A (inhibitor of Vacuolar Type 
H ATPases), Ammonium Chloride (inhibits acidification of endosomal lumen) and 
Geldanamycin (Hsp90 specific inhibitor). Neither of the disrupted processes (the acidification 
of the lumen of endosomes, disruption of changes on membrane potentials and the inhibition 
of Hsp90) were able to inhibit the CagA phosphorylation (Figure 3-34 and Table 3-1). The 
question which mechanism “triggers” the translocation of CagA from the lumen of 
endosomes to the cytoplasm could not be answered. It is possible that the apparatus uses an 
unknown mechanism to transport CagA from the lumen of endosomes to the cytoplasm, or 
another role of the clathrin pathway has to be considered. Further information and research on 
toxins and viruses could give an idea which other processes are required for the escape of 
proteins from the endocytic lumen into the cytoplasm, in order to elucidate the mechanism of 
CagA into the cytoplasm. 
The fact that clathrin or some of the components associated with its pathway are needed for 
the translocation of CagA by the Cag apparatus had to be confirmed visually through 
immunofluorescence detection of clathrin and Cag apparatus components. After infection 
with GFP-expressing P12 wild type strain and the cagPAI mutant P12 ∆cagPAI, detection of 
clathrin confirmed a co-localization event of clathrin molecules with bacteria in a Cag-
dependent manner (Figure 3-36A). Furthermore, double immunostaining against clathrin and 
CagY showed some co-localization events between these two proteins, relating the presence 
of a Cag apparatus with clathrin-rich areas. These results could add H. pylori to the new list of 
bacteria using the clathrin pathway, as recently discovered for Listeria monocytogenes, which 
uses clathrin dependent endocytosis to enter the cells (Bonazzi and Cossart, 2006). Many 
other pathogens use clathrin to gain access into the cells, as it is the case for some viruses like 
Hepatitis C (Helle and Dubuisson, 2008) or Adenoviruses (Meier and Greber, 2004). Because 
of this common “necessity” of getting into the cell, it makes the use of this pathway a 
plausible option for viruses, toxins or facultative intracellular bacteria. In the case of H. 
pylori, bacteria do not seem to be keen in entering the cells. Could it be that they use clathrin 
only to get CagA inside the cell? And if it is so, how? Is there a protein from the Cag 
apparatus that functions as “translocating” protein once they are found in the endosomal 
compartment? What could be the possible trigger for this event to occur? With the results 
presented here, it can be said that the acidification and/or changes of the transmembrane 
potential in the endosomes are not required. Further studies are necessary to elucidate the 
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mechanisms involving the necessity of clathrin endocytosis and its components for the CagA 
translocation. 
4.4 IL-8 induction and CagA translocation are two different 
events 
A functional Cag apparatus is not only able to translocate CagA into the eukaryotic cell. Its 
functionality has been linked to the capacity of inducing the production of IL-8 in human 
cells. During the experiments performed trying to explain the interaction between the Cag 
apparatus and integrin β1, the capacity of IL-8 induction in different steps of this interface 
was evaluated. Figure 4-4 presents a proposed model of H. pylori interaction with integrin β1 
and the effects associated with it: CagA translocation and IL-8 induction. 
4.4.1 IL-8 and integrin β1 
4.4.1.1 Role of ILK pathway 
By evaluating the necessity of a signal transduction process by the integrin β1 to ILK, in 
which no effect was seen on CagA translocation, it was surprising to find out that the capacity 
of IL-8 induction by the Cag apparatus was abolished, leaving only small induction levels. 
This small induction can be associated to the effective CagA translocation and 
phosphorylation, since it has been shown that CagA in the cell is responsible for some levels 
of IL-8 induction (Brandt et al., 2005) (Chang et al., 2006). Previously IL-8 induction via the 
Cag apparatus had been associated to the activation of NOD1 by the peptidoglycan from H. 
pylori. It was assumed that peptidoglycan was able to enter into the cytoplasm of cells when it 
“crossed” the cellular membrane for the injection of the CagA protein. Once in the cytoplasm, 
protein NOD1 signaling was responsible for IL-8 induction associated with the Cag apparatus 
(Viala et al., 2004). With the results obtained here, the relevance of the NOD1 signaling, as 
only signal pathway to be responsible for IL-8 induction, should be reconsidered. Even 
though CagA has been successfully translocated in ILK deficient AGS cells, implying 
peptidoglycan translocation into the cytoplasm of the cells, no IL-8 was induced at the levels 
usually seen for intact systems in ILK deficient cells.  
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Figure 4-4 Final model for Cag apparatus interaction with integrin β1. 
Upon Cag apparatus contact with the integrin β1, an elevation of intracellular calcium takes place, activating 
the calpains and inducing integrin aggregation. Both effects related to Cag apparatus functionality are 
independent from each other. IL-8 induction might be induced upon activation of the integrin linked kinase 
(ILK), which can phosphorylate the AKT/PKB pathway and indirectly the NFkB translocation into the 
nucleus (Shown for Angiogenesis). ILK can as well inactivate the GSK3β by phosphorylation leading 
indirectly to the translocation of AP-1 to the nucleus. Both components AP-1 and NFkB are necessary for 
IL-8 induction. CagA translocation might require the clathrin or clathrin components at the point of contact 
to stabilize the “pore”, or to induce endocytosis of CagA for later translocation. The inhibitors and their 
targets are shown in red. The associated processes are shown in blue. 
4.4.1.2 Effect of integrin β1 activation 
CagA translocation and IL-8 induction are independent events. This is supported by the fact 
that IL-8 induction is severely reduced in conditions were Mn2+ is present (Figure 3-27), 
which is capable to constitutively activate integrin β1. These data are similar to the data 
obtained with ILK deficient cells. When cells were exposed to MnCl2, CagA translocation 
was more efficient compared to CagA translocation in its absence. However, the IL-8 
induction was inversely proportional to the CagA phosphorylation increment. 
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Both experiments support as well the possibility that the IL-8 induction is directly connected 
with the capacity of the Cag apparatus to bind and modify the structure of integrin β1. IL-8 
induction via integrin β1 is commonly known. It has been proven that binding of invasin to 
cells induces the production of IL-8, and that this induction is independent of the 
internalization effect triggered by its interaction with integrin β1α5 (Schulte et al., 1998). In 
their experiments, the phosphatydylinositol-3 kinase (PI3-K) was blocked using Wortmannin, 
a fungal product that specifically inhibits PI3-Ks. The same inhibitor was tested for IL-8 
induction via the Cag apparatus (Figure 3-35) obtaining similar results. However, the data 
showing a defective IL-8 induction when ILK-levels are reduced would support a possible 
pathway between integrin and IL-8 induction. As explained by Legate KR et al. (Legate et al., 
2006), the integrin β1 - ILK pathway activates the Akt/PBK pathway that induces the 
translocation of NFkB into the nucleus. Since IL-8 induction requires NFkB, both pathways 
are similar and not excluding each other (Figure 4-4).  
4.4.1.3 Role of integrin extracellular domains 
If integrin β1 is directly related with IL-8 induction via Cag apparatus, the effect should start 
at the moment there is contact between Cag T4SS and the extracellular part of integrin β1. For 
that, antibodies against the different domains of integrin β1 were used to evaluate their effect 
on IL-8 induction. As summarized in figure 3-29, AIIB2, which inactivates the capacity of 
integrin β1 to bind to their substrate, worked as agonist of IL-8 induction in infections of cells 
exposed to the antibody. The levels of IL-8 induction are almost doubled compared to normal 
conditions. This effect could be associated with the increment of available integrins for the 
apparatus to “dock on” as they lost attachment. Since the binding of this antibody does not 
have any effect on CagA translocation, the independence of IL-8 and CagA phosphorylation 
events is demonstrated. This independence can be recognized better by examination of the 
effects of IL-8 in presence of antibody clone 9EG7. This antibody is the only one able to 
inhibit CagA translocation. However, it has only a very small effect on IL-8 induction, not 
proportional with the CagA phosphorylation effect seen earlier. This IL-8 reduction could be 
associated with the lack of CagA in the cytoplasm of the cells, as explained for ILK siRNA 
effects on IL-8 before. The data collected with the other antibodies, show a relation of 
antibody epitope localization on integrin β1 and IL-8 induction. The closer the antibodies’ 
epitopes got to the transmembrane region, the higher the effect on IL-8 reduction. At the same 
time, the antibody clone LM534, defined as a neutral antibody, was able to induce IL-8 
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without the presence of the bacteria. The induction by the Cag apparatus in presence of this 
antibody was dramatically reduced, as the apparatus and the antibody could use the same 
mechanism. In previous experiments not shown here, IL-8 induction by H. pylori was 
analyzed in presence of PMA. In this case, even though both, bacteria and PMA were able to 
induce IL-8 production, PMA did not reduce the IL-8 induction. It actually appeared as PMA 
and H. pylori effects on IL-8 were additive, what would indicate two different mechanisms. 
Further experiments using only the F(ab’) parts of the LM534 can elucidate if a crosslinking 
effect of the βTD of integrin β1 could be the cause of this induction and therefore also the 
mechanism used by H. pylori to induce IL-8. 
4.4.2 Involvement of cellular processes in IL-8 induction 
Together, these results indicate that CagA translocation and IL-8 induction are two 
independent events on the cell, even though both are related with Cag apparatus functionality. 
At the same time, this data opens the possibility that the interaction with the integrin is the 
possible trigger for IL-8 induction. Keeping this possibility open, IL-8 induction via Cag 
apparatus was evaluated under depletion of cholesterol from the membrane. The disruption of 
lipid rafts had a surprising effect on IL-8 induction. In this case, the effect seems to be strain 
specific, as for P12, there was an agonist effect, while strain 26695 showed an inhibitory 
effect (Figure 3-31). The difference cannot be explained, since both strains presented a 
reduction in CagA translocation when cells were treated with MBC. These data confirm that 
IL-8 induction and CagA translocation are different events in the process of CagA 
translocation and Cag interaction with the cell. However, it does not explain the role of 
integrin β1 clustering in IL-8 induction. 
Changes on the topology of the membrane can be achieved by the use of proteases like 
thrombin and trypsin. These two proteases are able to digest several extracellular epitopes of 
transmembrane proteins. On the other hand, integrins and other growth factor receptors are 
resistant to digestion by these proteases. To evaluate the possibility that a second receptor 
associated with integrins is responsible for the functionality of the Cag apparatus, pre-
digestion of extracellular proteins was followed by infection with different H. pylori wild 
strains containing a functional Cag apparatus. The treatment did not have any visible effect on 
CagA phosphorylation after a 4 hours infection (Table 3-1). In IL-8 induction, however, alone 
the presence of trypsin increased 10-fold the amount of IL-8 in comparison with untreated 
cells. Since trypsin induces detachment of cells from the surface, the effect of detachment was 
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analyzed. This showed a significant difference in comparison with only the presence of 
trypsin. The effect of detachment can be explained with the fact that the amount of integrins 
available to interact with the Cag apparatus is higher than that on the attached cells. The effect 
of trypsin digestion increasing the IL-8 induction was, on the other hand, unexpected. 
Considering that integrin β1 is resistant to trypsin digestion (Sczekan and Juliano, 1990), one 
way that cells could be stimulated by the use of a protease would be through activation of 
PARs, Protease Activated Receptors. PARs are a family of seven transmembrane spanning 
proteins that are activated by cleavage of their amino-terminal exodomain by proteases like 
trypsin (PAR4) and thrombin (PAR1). As with other transmembrane domains, their activation 
induces the phosphorylation of their carboxyl-terminal YSIL domain and induces the 
recruitment of clathrin Adaptor Proteins (AP-2) to be endocytosed (Trejo, 2003). It will not be 
surprising that their activation would involve integrin β1 and in this way influence the IL-8 
response by the cell to the Cag apparatus. 
The effects on IL-8 observed as the endocytic processes were disrupted cannot be considered 
sufficiently reliable to determine a relationship between Cag apparatus and the cell. The 
secretion of IL-8 into the supernatant can be inhibited unspecific during exposure of the cells 
to these inhibitors.  
The role of Cag apparatus in IL-8 translocation had been examined here. It can be concluded 
that the events “CagA translocation/phosphorylation” and “IL-8 induction” associated with a 
functional Cag T4SS are two independent events. CagA translocation can take place, without 
inducing IL-8 in the levels expected for a functional apparatus, and IL-8 can be induced 
without CagA translocation as well. 
4.5 The composition of the Pilus-like structure of the Cag 
apparatus 
During live imaging recording of infection events, a specific and conserved behavior of 
bacteria was observed. Bacteria strains containing flagella (P12, P145 and P217) showed a 
preference for cells that had lost adhesion. As the trypsin experiments caused the loss of 
adhesion of the cells, it was observed that this bacterial tropism was not present anymore. 
Their preference was limited to those cells showing a signal of apoptosis, such as “blebbing” 
of their membrane or increment of auto-fluorescence observed after excitation with a 488 nm 
wavelength light source. This behavior, additionally to the fact that CagA translocation and 
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the related event “Hummingbird phenotype” increased in conditions where cells were 
stressed, indicated that a stress related unknown molecule could be activating and/or 
stimulating the Cag apparatus. Taking advantage of this knowledge, and with the necessity to 
increase the amount of bacteria expressing the already pilus-like structures to be associated 
with the Cag apparatus (Rohde et al., 2003) for Cryo-EM studies, AGS cells were exposed to 
a PBS solution without bivalent cations. This procedure stresses the cells and makes 
themsecrete a possible substance able to induce the Cag apparatus formation. It was 
discovered that after the exposure of bacteria to this exudate, the amount of apparati increased 
about 20% - 25% compared to those only in the PBS solution.  
The pilus-like structures formed during the treatment could be confirmed to consist of two 
different structures: A sheathed form and a naked one. It looks like the sheathed form is 
composed of naked form (inside) covered by a molecule that has not been identified yet. 
However, it could be shown that the naked form contains CagC protein, making this pilus-like 
structure part of the H. pylori T4SS. The naked form seems to be formed by oligomers 
assembled to construct a tubular structure with 2 - 3 nm of diameter in the inside and 20-25 
nm of diameter on the outside. The sheath covering the naked core form, who’s molecular 
composition has not been identified, does not show any repetitive structure.  
For A. tumefaciens, the VirB system has been observed with a pilus-like structure with 10 nm 
diameter. Its formation is promoted by the VirB1 and on its surface is found the VirB5 (Aly 
and Baron, 2007; Zupan et al., 2007).  However, in the EM images only one structure having 
as major component the VirB2 protein was observed. Khaled et al. were able to detect VirB2 
by immuno-EM only on detached T-pili, but they were not bound to the bacteria. In our case, 
the sheathed form, containing the core CagC structure could be observed getting out of the 
bacteria (Figure 3-38B). One of the genes found in the H. pylori cagPAI might encode a 
coating molecule to form the sheath. In ongoing research, this sheath will be identified and a 
better picture of the components of the Cag apparatus pilus-like structure will be elucidated. 
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5 Conclusions 
Helicobacter pylori, as many other bacterial pathogens, contains within its virulence arsenal 
the Cag Type IV Secretion System. Epidemiological studies have revealed a correlation of the 
severity of gastric H. pylori-associated pathologies with the presence of CagA and VacA, but 
not with the presence of a functional Cag apparatus. The effect of CagA on the host cells has 
been related with its translocation into the cell by the T4SS. During the evaluation of possible 
effects of CagA in the motility of neutrophils-like cells, it was discovered that not only the 
presence of CagA was disturbing the motility towards a gradient, but also the possibility was 
opened that this effect seen is independent of the successful translocation and phosphorylation 
of CagA. If that would be the case, a new immunomodulating activity of CagA could be 
added to the many functions associated to this multifacetted toxin. It could explain why only 
CagA presence, and not a functional secretion system, is associated with disease. 
While establishing the effect of the Cag T4SS on motility, the essentiality of integrin β1 for 
the translocation and phosphorylation of the CagA by the Cag apparatus was discovered. In 
previous studies, performed by the team of Prof. Dr. Rainer Haas, the theory of the necessity 
of a receptor on the cell membrane interacting with the T4SS for translocation of CagA was 
formulated. During this doctoral study, it has been determined that integrin β1 is the receptor 
for the Cag Type IV Secretion System and the signaling related to the integrin β1 is 
responsible for the IL-8 induction. In the case of CagA translocation, only the extracellular 
and transmembrane domains play an important role, what gives the integrin β1 the function of 
a “docking” molecule. It seems that the capability of integrin β1 to change conformations 
from extend to bend has made it a perfect “docking” molecule for the apparatus. Even though, 
neither the intracellular domains nor the ILK-related pathways of integrin β1 are relevant for 
CagA translocation, functions related with clustering seem to be relevant for the CagA 
translocation. Both functions, the capacity of bending and forming clusters, could play an 
independent but important role in the CagA translocation. While the binding to an activated 
form of the integrin β1 increases the efficiency of CagA translocation, as seen in the presence 
of MnCl2, clustering of integrins could stabilize the binding of the apparatus to the cells. At 
the same time, the capacity of “bending” of the extracellular domain of integrin β1 could 
reduce the distance between the tip of the pilus-like structure of the apparatus and the cell 
membrane and facilitate the translocation of CagA. How this translocation occurs, is one of 
the many questions that have to be answered in future research. 
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Another discovery made was the involvement of clathrin dependent endocytosis in CagA 
phosphorylation. The participation of clathrin or clathrin associated proteins open the 
possibility of an endocytic process necessary for translocation. However, the failure to inhibit 
CagA translocation by disrupting endocytic transport by microtubules or actin, as well as 
endosome maturation related processes, as acidification and changes in membrane potential, 
makes it difficult to accept an uptake of Cag components necessary for CagA translocation. 
Another possibility to explain the involvement of clathin or clathrin associated proteinscould 
be the necessity of these proteins for the stabilization of the pore created by the Cag apparatus 
in order to get CagA inside the cell. Both theories should be considered in following studies 
relating the Cag apparatus interaction with the eukaryotic cell.  
Knowing a little bit more about the behavior of H. pylori on the first minutes of infection and 
under different conditions, a way to stimulate the formation of a pilus-like structure without 
the presence of eukaryotic cells was found. The presence of such structures has been 
identified in past research to be related with the Cag apparatus. Knowing a way to induce 
their formation can help to produce enough material for Cryo-EM studies realized in 
conjunction with Dr. Valério Mathias at the Max-Planck Institute in Martinsried. These 
studies will not only determine the structure of the Cag apparatus and the components seen,  
they will also help to determine which proteins from the Cag apparatus are associated with its 
formation. Equally interesting will be to discover the molecule or molecules produced by the 
AGS cells that can induce the formation of the structure associated with the Cag T4SS.  
It is only to hope, that the efforts done here to learn more about the interaction of H. pylori’s 
Cag T4SS will allow in the future a better understanding of the biomechanics by which 
pathogens, especially Helicobacter pylori, are able to deliver substrates into the cells. By 
understanding the minimal requirements for their success, the mechanism could be copied and 
used for targeted delivery of compounds to cancer cells, or even parasites hidden in the depths 
of an organism. 
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8 Abbreviations 
This are the abbreviations used in this work,  
Table 8-1 General abbreviations 
α Anti- 
βTD Beta Tail domain 
∆ Delta (deletion) 
Aa Amino acid 
Amp Ampicillin 
AP Alkaline phosphatase 
BCIP  Salt of 5-Brom-4-Chlor-3-Indolylphopshate-p-toluidine 
BSA Bovine Serum Albumina 
CA Constitutively Active 
Cam Chloramphenicol 
CCP Clathrin Coated Pits 
CCV Clathrin Coated Vesicles 
DN Dominant Negative 
EDTA Ethylen-diamine-tetraacetate 
EGF Epithelial Growth Factor 
EGF (1-4) EGF-like domains (1 to 4) 
EGFR Epithelial Growth Factor Receptor 
ELISA Enzyme-linked Immunosorbent Assay 
EM Electron microscopy 
EPEC Enteropathogenic Escherichia coli 
FACS Fluorescence Activated Cell Sorting 
FAK Focal Adhesion Kinase 
FCS Fetal Calf Serum 
FGF1 Fibroblast Growth Factor 1 
FITC Fluorecein-Isothiocyanate 
fMLP Formyl-Methionine-Leucine-Phenylalanine 
GFP Green fluorescent protein 
Hsp Heat shock protein 
IgG Immunoglobulin type G 
IL Interleukine 
ILK Integrin-Linked Kinase 
ITGB1 Integrin beta 1 
Kan Kanamycin 
KO Knockout 
LB Luria-Bertani 
MBC Methyl-β-Cyclodextrin 
MDC Mono-dansylcadaverine 
MIDAS Metal Ion-dependent adhesion site 
MOI Multiplicity of Infection 
NBT Nitrotetrazolium blue chloride 
NFκB Nuclear Factor kappa B 
PARs Protease Activated Receptors 
PBS Phosphate-buffered solution 
PE  Phycoerithrin 
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PFA Paraformalaldehyde 
pI pH of the Isoelectric point 
Pox Peroxidase 
PSI Plexin, Semaphorins and Integrins 
RAD Argininge-Alanine-Asparagine 
RGD Arginine-Glycine-Asparagine 
SDS Sodium Dodecyl Sulfate 
siRNA Small interference RNA 
spp Species 
T3SS Type III Secretion System 
T4SS Type IV Secretion System 
TBS  Tris-buffered Solution 
TFS3 Type IV secretion 3 
Tris Tris (hydroxymethyl) aminomethane 
WHO World Health Organisation 
 
Table 8-2 Units 
°C Grade Celcius 
µ Micro-, 10-6
A Ampers 
bp Base pairs 
cm2 Square centimeters 
Da Daltons 
g Standard gravities 
g Grams 
h Hour 
k Kilo, 103
l Liter 
m Milli-, 10-3
M Molar (mol/l) 
n Nano-, 10-9
rpm Revolutions per minute 
U Unit 
V Volts 
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